Document:

EX-10.4

 Exhibit 10.4 

EXECUTION VERSION 
 Dated
12 DECEMBER 2019 
  
  

 
 EVERARC HOLDINGS LIMITED 

THE DIRECTORS 
 THE
FOUNDERS 
 THE FOUNDER ENTITIES 

THE BANKS 
  

PLACING AGREEMENT 

  
 1 

 Contents 
  

							
	Clause	  	 	  	Page	 
	1	  	Definitions and interpretation	  	 	4	
			
	2	  	Appointment of the Banks	  	 	6	
			
	3	  	Applications for Admission	  	 	7	
			
	4	  	The Offer	  	 	8	
			
	5	  	Subscription for Units by the Founders and Independent Non-Founder Directors	  	 	9	
			
	6	  	Subscription for Units by the AI Placees	  	 	10	
			
	7	  	Settlement	  	 	11	
			
	8	  	Commissions, fees and expenses	  	 	14	
			
	9	  	Representations, warranties and undertakings	  	 	17	
			
	10	  	Indemnities	  	 	19	
			
	11	  	Exclusions of liability and arm’s length transactions	  	 	25	
			
	12	  	Contribution	  	 	27	
			
	13	  	Withholding and gross up	  	 	29	
			
	14	  	Limits on liability	  	 	30	
			
	15	  	Conditions to the Offer and Termination	  	 	30	
			
	16	  	Default by one or more of the Banks	  	 	35	
			
	17	  	Notices	  	 	36	
			
	18	  	General	  	 	38	
			
	19	  	Law and jurisdiction	  	 	44	
		
	Schedule 1 Liability caps	  	 	47	
		
	Schedule 2 Warranties	  	 	48	
		
	Schedule 3 Undertakings	  	 	74	
		
	Schedule 4 Selling Restrictions	  	 	86	
		
	Schedule 5 Documents for delivery	  	 	88	
		
	Schedule 6 Form of certificate	  	 	98	
		
	Schedule 7 Definitions	  	 	104	
		
	Appendix 1 Form of Accredited Investor Letter	  	 	116	

  
 1 

 THIS AGREEMENT is dated 12 DECEMBER 2019 

PARTIES: 
  

	(1)	 EverArc Holdings Limited, registered in the British Virgin Islands with No. 2025707, whose
registered office is at Kingston Chambers, PO Box 173, Road Town, Tortola (the Company); 

  

	(2)	 William N. Thorndike, Jr., a US citizen, residing at [***] (Mr. Thorndike);

  

	(3)	 W. Nicholas Howley, a US citizen, residing at [***] (Mr. Howley);

  

	(4)	 Tracy Britt Cool, a US citizen, residing at [***] (Ms. Britt Cool);

  

	(5)	 Vivek Raj, a citizen of India, residing at [***] (Mr Raj); 

 

	(6)	 Haitham Khouri, a US citizen, residing at [***] (Mr Khouri and, together with Mr. Thorndike,
Mr. Howley, Ms. Britt Cool and Mr Raj, the Founders); 

  

	(7)	 The Directors named in column (1) of the table set out in Part B of Schedule 1 (the Independent Non-Founder Directors); 

  

	(8)	 Llanerch Everarc LLC, registered in Ohio with No. 4408544, whose registered office is at 700 W. St. Clair
Ave., Suite 414, Cleveland, Ohio 44113-1274, United States of America (Llanerch Everarc); 

  

	(9)	 TVR Everarc LLC, registered in Texas with No. 803478510, whose registered office is at 5900 Balcones
Drive, STE 100, Austin, TX 78731, United States of America (TVR Everarc); 

  

	(10)	 EverArc Founders, LLC, registered in Delaware with No. 7485581, whose registered office is at 160
Greentree Drive, Suite 101, City of Dover, County of Kent, Delaware 19904, United States of America (EverArc Founders, together with Llanerch Everarc and TVR Everarc the Founder Entities); 

 

	(11)	 UBS AG, London Branch, a company incorporated under the laws of Switzerland acting through its London
branch (registered Branch number BR004507) with its principal place of business at 5 Broadgate, London EC2M 2QS, United Kingdom (UBS); and 

  
 2 

	(12)	 Morgan Stanley & Co. International plc, incorporated in England and Wales with No. 02068222,
whose registered office is at 25 Cabot Square, London E14 4QA, United Kingdom (Morgan Stanley and, together with UBS, the Banks). 

WHEREAS 
  

	(A)	 The Company was incorporated with limited liability and indefinite life under the laws of the British Virgin
Islands under the BVI Companies Act on 8 November 2019, with number 2025707, under the name EverArc Holdings Limited. 

  

	(B)	 On 14 November 2019, the Company issued 100 Founder Shares to EverArc Founders. 

 

	(C)	 The Company will apply to the FCA for approval of the Final Prospectus and to the FCA and the London Stock
Exchange for the whole of its Ordinary Share capital and all of the Warrants, issued and to be issued under the arrangements referred to in this Agreement (including, without limitation, any Ordinary Shares to be issued upon exercise of any of the
Warrants), to be admitted to the standard listing segment of the Official List and to trading on the London Stock Exchange’s main market for listed securities. 

 

	(D)	 The Company proposes to issue 34,000,000 New Shares in aggregate pursuant to the arrangements referred to in
this Agreement, with matching Warrants being issued to subscribers for New Shares in the Offer on the basis of one matching Warrant per New Share (with each New Share and matching Warrant being hereinafter referred to as a Unit).

  

	(E)	 In connection with the Offer, the Company proposes to issue 1,500,000 Units in aggregate to the Founders,
Llanerch Everarc and TVR Everarc. 

  

	(F)	 Outside the Offer, the Company proposes to issue 30,000 Units in aggregate to the Independent Non-Founder Directors. 

  

	(G)	 It is proposed that the Banks will severally, and not jointly or jointly and severally, agree to use their
reasonable endeavours to procure subscribers for the (i) Units not being subscribed for by the Founders or the Independent Non-Founder Directors under clause 5 of this Agreement and (ii) Default AI
Placee Units (such Units and Default AI Placee Units being hereinafter referred to as the Underwritten Units) or, failing which, themselves to subscribe for such Underwritten Units, in each case at the Offer Price and pursuant to the
arrangements referred to in this Agreement and on the terms and subject to the conditions set out herein. For the avoidance of doubt, the Banks shall not be obliged to procure subscribers for, or to themselves subscribe or pay for, any Units being
subscribed for by the Founders or the Independent Non-Founder Directors. 

  

	(H)	 It is proposed that, in connection with the Offer, the Company will issue 1,183,500 Units in aggregate to the
AI Placees, and the Banks will subscribe for any Units that an AI Placee defaults on its subscription for, at the Offer Price and pursuant to the arrangements referred to in this Agreement and on the terms and subject to the conditions set out
herein. 

  
 3 

	(I)	 On Admission, the share capital of the Company will be USD 340,300,000 divided into 34,030,000 Ordinary Shares
of no par value and 100 Founder Shares. In addition, the Company will have 34,030,000 Warrants in issue. 

  

	(J)	 Insofar as any Units are to be made available in the United States in connection with these arrangements, they
are to be made available to Qualified Institutional Buyers and Accredited Investors in reliance on Rule 144A or another exemption from, or pursuant to a transaction not subject to, the registration requirements of the Securities Act and, in the case
of Accredited Investors, subject to the delivery of an Accredited Investor Letter. Any offers or sales of Units to be made pursuant to these arrangements outside the United States will be made in offshore transactions within the meaning of and in
accordance with Regulation S under the Securities Act. The detailed terms and conditions governing the offering arrangements are set out in full in the Disclosure Package and the Final Prospectus. 

 

	(K)	 In connection with the Offer and the Applications for Admission, the Company has prepared and delivered copies
of the Disclosure Package and has prepared and will deliver copies of the Final Prospectus dated the date of this Agreement, each for use in connection with the Offer. 

THE PARTIES AGREE as follows: 
  

	1	 Definitions and interpretation 

 

	1.1	 Words defined in Schedule 7 have, where used in this Agreement (including in the Schedules and the Recitals),
the meanings given to them in that Schedule. 

  

	1.2	 In this Agreement: 

  

	 	(a)	 the table of contents and the headings are inserted for convenience only and do not affect the interpretation
of this Agreement; 

  

	 	(b)	 references in this Agreement to clauses, Schedules and Recitals are to clauses of, and Schedules and Recitals
to, this Agreement (except where the context otherwise requires) and references to this Agreement include the Schedules and Recitals; 

  

	 	(c)	 references to a statutory provision are references to it as from time to time amended, consolidated or re-enacted (with or without modification), provided that no modification subsequent to the date of this Agreement shall extend or increase the liability of any party under this Agreement, and shall include all
instruments, orders, regulations or other subordinate legislation made under it; 

  
 4 

	 	(d)	 references to a person include an individual, body corporate (wherever incorporated), unincorporated
association or partnership (including a limited partnership) wherever formed or organised and any government entity, in each case wherever formed or organised; 

 

	 	(e)	 references to a person include its successors in title; 

 

	 	(f)	 references to any gender shall include the other genders; 

 

	 	(g)	 words importing the plural include the singular and vice versa; and 

 

	 	(h)	 references to dates and times are to London dates and times. 

 

	1.3	 References to any document in the agreed form mean that document in the form of the draft or proof
agreed by Company’s Counsel and Banks’ Counsel and initialled on their behalf for the purposes of identification only or as otherwise evidenced as being in agreed form by communications between Company’s Counsel and Banks’
Counsel, with such alterations as may subsequently be agreed by or on behalf of the Company, the Founders, the Founder Entities and/or the Banks (as the context may require). No such initialling shall imply approval of all or any part of its
contents by or on behalf of the person initialling it or any of the parties to this Agreement. 

  

	1.4	 Each reference in this Agreement to any or all of the Banks or the Settlement Bank by any description or in any
capacity includes a reference to it in each other capacity in which it may act pursuant to this Agreement (or otherwise with the agreement of the Company) in connection with the Offer. 

 

	1.5	 Except where the context otherwise requires, material and materially mean material in the context
of the Company and/or the Offer and/or the underwriting of the Underwritten Units and/or Admission and/or dealings in the Ordinary Shares and Warrants following Admission. 

 

	1.6	 Each reference in this Agreement to a breach of any of its provisions includes a reference to any of the
representations, warranties, undertakings or covenants given in this Agreement being or becoming untrue, inaccurate or misleading. 

  

	1.7	 Each reference to the terms and conditions of the Offer are to those terms and conditions as set out in the
relevant Offer Documents and as implied by law, regulation and any applicable market usage. 

  

	1.8	 Each reference to “includes” or “including” shall mean “includes without
limitation” or “including without limitation”. 

  
 5 

	2	 Appointment of the Banks 

 

	2.1	 The Company confirms its appointment of: 

 

	 	(a)	 each of the Banks as joint bookrunners to the Offer; 

 

	 	(b)	 each of the Banks as joint global co-ordinators for the purpose of co-ordinating the Offer; and 

  

	 	(c)	 each of the Banks as its agent in procuring Placees for the Underwritten Units on its behalf and in connection
with its role as underwriter to the Offer, 

 and each Bank confirms its acceptance of such appointment, on and subject to
the terms of this Agreement. 
  

	2.2	 The Company agrees that each of the Banks will be authorised to enter into contracts for sale and subscription
in respect of the Underwritten Units on their behalf, in each case on the terms of this Agreement. 

  

	2.3	 The appointments of the Banks contained in this clause 2 confer on each of the Banks (as applicable) on behalf
of the Company all powers, authorities and discretions which are necessary for, or reasonably incidental to, such appointments or the performance of their respective functions. In particular, they include the power to appoint sub-agents or to delegate, with power to sub delegate, the exercise of any powers, authorities and discretions to third parties, provided always that (unless such person is a member of the relevant Bank’s
Group) each of the Banks agrees that it will not appoint a person as sub-agent or delegate the exercise of its powers, authorities or discretions to a person without the Company’s prior consent (such
consent not to be unreasonably withheld or delayed). 

  

	2.4	 The Company agrees to ratify and confirm everything lawfully done by any of the Banks or any of their agents or
delegates in the exercise of the powers, authorities and discretions conferred by this Agreement. 

  

	2.5	 The Company, the Founder Entities and the Founders acknowledge that the duties of the Banks to the FCA cannot
be overridden by its duties to the Company pursuant to this Agreement or otherwise. For the avoidance of doubt, nothing in this Agreement shall oblige any Bank to take (or omit from taking) any action where such Bank believes that taking such action
(or failing to take such action) would likely result in a breach of its legal or regulatory responsibilities, duties or obligations (including, without limitation, any obligations it may have to the FCA). 

 

	2.6	 The Company, each of the Directors, each of the Founder Entities and each of the Founders acknowledges and
agrees that none of the Banks (or any other Indemnified Person) is responsible for, or has authorised or will authorise the contents of, the Disclosure Package and the Final 

  
 6 

	 	
Prospectus (and any amendment or supplement to any of them), the Presentation Materials or any other Offer Document (except to the extent, if any, authorised by any Bank for the purposes of
Section 21 of FSMA) and that none of the Banks (or any other Indemnified Person) has been requested to verify (or is or shall be responsible for verifying), the accuracy, completeness or fairness of any information in any of the Offer Documents
(or any supplement or amendment to any of the foregoing) or any other information published in connection with the Offer. 

  

	2.7	 The Company authorises each of the Banks to give to the Registrar and/or to Euroclear any instructions
consistent with this Agreement and/or the Offer Documents that it reasonably considers to be necessary for, or incidental to, the performance of its functions as a joint global coordinator and joint bookrunner in connection with the Offer, Admission
and the applications for the Depositary Interests to be transferred through and held in dematerialised form through CREST (including, without limitation, delivery to Euroclear of the letter referred to in clause 15.1(h)). 

 

	2.8	 The Company, the Founder Entities, the Founders and the Directors each undertake to the Banks not to revoke the
appointments, authorities or instructions contained in this clause 2 before the earlier of (i) the termination of this Agreement and (ii) the Closing Date. 

 

	3	 Applications for Admission 

 

	3.1	 The Company will make or procure the making of the Applications for Admission. The Company, each of the
Directors, each of the Founder Entities and each of the Founders severally undertakes to the Banks to use its or their best endeavours to secure Admission by no later than 8.00 a.m. on the Closing Date, or such other time and/or date as the Company
and the Banks agree (in the case of each of the Founders and the Directors, to the extent it is within their respective powers to do so). 

  

	3.2	 The Company and the Directors undertake to apply to the FCA for formal approval of the Final Prospectus for the
purposes of, and in accordance with, the Listing Rules and the Prospectus Regulation Rules and shall use all reasonable endeavours to obtain such approval as soon as practicable and in any event before publishing the Final Prospectus.

  

	3.3	 The Company, each of the Directors, each of the Founder Entities and each of the Founders severally undertakes
to the Banks that it or he will, at all times, cooperate with, and provide to, the Banks all information and assistance and do or procure anything to be done (including, without limitation, executing any documents, providing any information and (in
the case of the Company only) paying all relevant fees) that may be reasonably requested by the Banks or that may be required by the Banks to satisfy their respective obligations under, or in connection with, this Agreement, the Offer, the
Applications for Admission, the Listing Rules, the Prospectus Regulation Rules, the DTRs, the Admission and Disclosure Standards, the rules and regulations of the London Stock Exchange and Euroclear, MAR and/or all applicable laws and regulations in
connection with the Offer and/or the Applications for Admission and to provide to the FCA any 

  
 7 

	 	
information or explanation that the FCA may require for the purpose of verifying whether the Listing Rules, the Prospectus Regulation Rules, the DTRs, MAR and/or all applicable laws and
regulations in connection with the Offer and/or the Applications for Admission are being, and have been, complied with by the Company. 

  

	4	 The Offer 

  

	4.1	 In carrying out their obligations under this Agreement, the Banks are relying on the indemnities,
representations, warranties and undertakings contained in this Agreement. 

  

	4.2	 Subject to the satisfaction or waiver (in accordance with clause 15.2) of the Conditions and to this Agreement
not having been terminated under clause 15.6 or clause 16 and to the Company, each of the Directors, each of the Founder Entities, each of the Founders and each of the Independent Non-Founder Directors
complying with their respective obligations under clause 7, each of the Banks agrees severally, and not jointly or jointly and severally: 

  

	 	(a)	 to use its reasonable endeavours to procure, as agent for the Company, subscribers for its Relevant Proportion
of the Underwritten Units; and 

  

	 	(b)	 to the extent that Placees are not procured to subscribe for all of the Underwritten Units pursuant to clause
4.2(a), subject at all times to clause 4.5, itself to subscribe (or procure the subscription by one or more nominated subscribers) for its Relevant Proportion of such unplaced Underwritten Units. 

 

	4.3	 The execution of this Agreement by the Banks constitutes their irrevocable application for those Underwritten
Units for which they are required to subscribe for pursuant to clause 4.2(b). 

  

	4.4	 Subscriptions by the Banks for Underwritten Units under clause 4.2 will be made in cash at the Offer Price on
the Closing Date and otherwise on the terms of this Agreement and the terms set out in the Disclosure Package and the Final Prospectus. 

  

	4.5	 The Company, each of the Directors, each of the Founder Entities and each of the Founders confirms,
acknowledges and agrees that none of the Banks shall be obliged to subscribe for or pay for the Founder Committed Units or the Independent Non-Founder Director Committed Units. 

 

	4.6	 The Company, each of the Directors, each of the Founder Entities and each of the Founders acknowledges and
agrees that any information it or he receives or has received regarding the identity of persons expressing interest in acquiring Underwritten Units in the Offer and the prices at which they may be willing to do so will be based on non-binding indications of interest from those persons, implying no assurance or obligation that such persons will subsequently acquire Underwritten Units at the prices indicated or otherwise. The Company, each of
the Directors, each of the Founder Entities and each of the Founders agrees that any such information obtained or received by it or him or any of such person’s officers or employees will, save as required by law

  
 8 

	 	
or regulation or any governmental or regulatory body, be held in confidence and recognises that such information may constitute inside information in relation to the Company and/or its securities
for the purposes of MAR and/or the CJA and that use of such information may constitute insider dealing, unlawful disclosure of inside information or market manipulation under Articles 14 or 15 of MAR. The Company, each of the Directors, each of the
Founder Entities and each of the Founders severally agrees to conduct itself or himself (and, where relevant, direct its officers and employees to conduct themselves) in compliance with the CJA and MAR by reference to such information.

  

	5	 Subscription for Units by the Founders and Independent Non-Founder
Directors 

  

	5.1	 Each of the Founders confirms, represents, warrants, undertakes and agrees that it shall subscribe for Units in
the following proportions (the Founder Committed Units): 

  

									
	 Founder / Founder Entities
	  	Number of Units	 	  	USD Amount	 
	 William N. Thorndike, Jr.
	  	 	500,000	 	  	$	5,000,000	 
	 Llanerch Everarc (W. Nicholas Howley)
	  	 	500,000	 	  	$	5,000,000	 
	 Tracy Britt Cool
	  	 	30,000	 	  	$	300,000	 
	 TVR Everarc (Vivek Raj)
	  	 	100,000	 	  	$	1,000,000	 
	 Haitham Khouri
	  	 	370,000	 	  	$	3,700,000	 

  

	5.2	 Subscriptions by the Founders for the Founder Committed Units under clause 5.1 will be made in cash at the
Offer Price on the Closing Date and otherwise on the terms of this Agreement and the Offer Documents. 

  

	5.3	 Each of the Independent Non-Founder Directors confirms, represents,
warrants, undertakes and agrees that he shall subscribe for Units in the following proportions (the Independent Non-Founder Director Committed Units): 

 

									
	 Independent Non-Founder
Director
	  	Number of Units	 	  	USD Amount	 
	 Adam L Hall
	  	 	7,500	 	  	$	75,000	 
	 Bram Belzberg
	  	 	7,500	 	  	$	75,000	 
	 John Staer
	  	 	7,500	 	  	$	75,000	 
	 Michael Tobin OBE
	  	 	7,500	 	  	$	75,000	 

  
 9 

	5.4	 Subscriptions by the Independent Non-Founder Directors for the
Independent Non-Founder Directors Committed Units under clause 5.3 will be made in cash at the Offer Price on the Closing Date and otherwise on the terms of their letters of appointment and will be satisfied
by way of set- off by the Company against the lump sum amount payable by the Company to the Independent Non-Founder Directors on Admission in respect of each Independent
Non-Founder Director’s directors fees for his first year of appointment. 

  

	6	 Subscription for Units by the AI Placees 

 

	6.1	 Each of the AI Placees listed below has agreed to subscribe for Units (the AI Placee Units) in the
following proportions: 

  

									
	 AI Placee
	  	Number of AI Placee
Units	 	  	USD Amount	 
	 Bob and Kathleen Henderson Family Trust
	  	 	325,000	 	  	 	3,250,000	 
	 Bratenahl Capital Partners, LTD.
	  	 	250,000	 	  	 	2,500,000	 
	 James Skulina
	  	 	250,000	 	  	 	2,500,000	 
	 Bernie Iversen
	  	 	125,000	 	  	 	1,250,000	 
	 Meadowbrook Compounding Company LLC
	  	 	50,000	 	  	 	500,000	 
	 Ardaugh Partners
	  	 	50,000	 	  	 	500,000	 
	 Arthur Joseph Lika
	  	 	40,000	 	  	 	400,000	 
	 Robert Wagman
	  	 	30,000	 	  	 	300,000	 
	 Scott Smith
	  	 	25,000	 	  	 	250,000	 
	 Kian Ghazi
	  	 	20,000	 	  	 	200,000	 
	 Adrienne Snyder
	  	 	10,000	 	  	 	100,000	 
	 Sean Loren
	  	 	7,500	 	  	 	75,000	 
	 Jonathan Salinas
	  	 	1,000	 	  	 	10,000	 

  

	6.2	 Subscriptions by the AI Placees for the AI Placee Units under clause 6.1 will be made in cash at the Offer
Price by no later than 8.00 a.m. on the Closing Date. 

  

	6.3	 The Company shall arrange to settle directly with AI Placees in respect of AI Placee Units, and such
arrangements shall include the requirement that no AI Placee Units shall be allotted or issued to an AI Placee unless and until cleared funds in respect of the AI Placee Units to be subscribed for by such AI Placee, as set forth against his or her
name in clause 6.1, and a letter in the form of Appendix 1 duly executed by the AI Placee have been received. 

  
 10 

	6.4	 The Company shall notify the Banks by no later than 10.00 a.m. on the Closing Date of any AI Placee who has
defaulted on his or her obligation to pay the subscription price due from him or her or to provide a letter in the form of Appendix 1 (the aggregate of all such AI Placee Units in relation to which such default has occurred being the Default AI
Placee Units) with full supporting information. 

  

	6.5	 In the event that any AI Placee fails to pay any amount due from it in respect of any AI Placee Units in
accordance with clause 6.3 above, or fails to provide a duly executed letter in the form of Appendix 1 on a timely basis (or the contents of such letter are inaccurate) or otherwise fails to comply with the terms and conditions of the Offer, the
Banks may re-allocate and sell to other investors such Units or exercise such other rights or take such other actions as the Banks deem appropriate in their sole discretion. 

 

	7	 Settlement 

Registrar 
  

	7.1	 The Company will provide the Registrar with all necessary authorisations and information to enable the
Registrar to perform its duties in connection with the Offer and as contemplated by this Agreement, the Offer Documents and any agreements between the Company and the Registrar. 

CREST 
  

	7.2	 The Company will, through the Depositary, submit: 

 

	 	(a)	 the CREST Application Form (and any legal opinions required by Euroclear) to Euroclear prior to Admission; and

  

	 	(b)	 the CREST Enablement Letter to Euroclear immediately following Admission. 

 

	7.3	 The Company will supply all such information, give all such undertakings, execute all such documents, pay all
such fees and do or procure to be done all such other things as may be required in connection with the application for the admission of the Depositary Interests to, and their enablement for settlement in, CREST. 

 

	7.4	 The Company will procure that the Depositary Interests are (with effect from Admission) and remain a
participating security (as defined in the CREST Rules) within CREST. 

  
 11 

 Allotment of Units and issue of Depositary Interests 

 

	7.5	 Subject to clause 7.6, the Company shall, prior to and conditional only on Admission, allot the New Shares and
the Warrants comprising the Units (other than any Certificated Units), fully paid up in cash and free from all Encumbrances, to the Depositary (or its nominated custodian) and shall procure that: 

 

	 	(a)	 the Registrar shall promptly (and without registration fee) enter the name of the Depositary (or its nominated
custodian) in the register of members of the Company and the register of Warrant holders, in each case held and maintained in the BVI, as the holder of the New Shares and the Warrants comprising the Units (other than any Certificated Units);

  

	 	(b)	 the Depositary shall issue the Depositary Interests: 

 

	 	(i)	 in respect of the New Shares and the Warrants comprising the Underwritten Units (other than any Certificated
Units), to the Settlement Bank or to the Placees as the Banks may in their absolute discretion direct (on behalf of themselves and the other Banks), including to the Settlement Bank as nominee for all or any of the Placees; 

 

	 	(ii)	 in respect of the New Shares and the Warrants comprising the Founder Committed Units, to the Founders in the
proportions set out in clause 5.1; and 

  

	 	(iii)	 in respect of the New Shares and the Warrants comprising the Independent
Non-Founder Director Committed Units in the proportions set out in clause 5.3; and 

  

	 	(c)	 the Depositary shall issue instructions to Euroclear to credit, prior to and conditionally only on Admission,
Depositary Interests in respect of the New Shares and the Warrants: 

  

	 	(i)	 comprising the Underwritten Units (other than any Certificated Units) to the CREST stock accounts of the
Settlement Bank and/or Placees as the Banks may in their absolute discretion direct (on behalf of themselves and the other Banks); 

  

	 	(ii)	 comprising the Founder Committed Units to the CREST stock accounts of the Founders; and 

 

	 	(iii)	 comprising the Independent Non-Founder Director Committed Units to the
CREST stock accounts of the Independent Non-Founder Directors, 

 so that they are
enabled for settlement as at and from Admission. 
  

	7.6	 The Company shall, prior to and conditional only on Admission, allot the New Shares and the Warrants comprising
the Certificated Units, fully paid up in cash and free from all Encumbrances, to, and shall procure that the Registrar shall despatch definitive share certificates to, such persons (if any) as subscribe for Certificated Units: 

 

	 	(i)	 if requested by any of the Banks, to the Settlement Bank or to Placees as the Banks may in their absolute
discretion direct (on behalf of themselves and the other Banks) in respect of any Underwritten Units; 

  
 12 

	 	(ii)	 if requested by any of the Founders, to the relevant Founder in respect of any Founder Committed Units;

  

	 	(iii)	 if requested by any of the AI Placees, to the relevant AI Placee in respect of any AI Placee Units; or

  

	 	(iv)	 if requested by any of the Independent Non-Founder Directors, to the
relevant Independent Non-Founder Directors in respect of any Independent Non-Founder Director Committed Units, 

as soon as practicable after Admission. 
  

	7.7	 The Company confirms that it has instructed the Depositary to issue Depositary Interests in respect of New
Shares and Warrants to the Settlement Bank or to the Placees as the Banks may in their absolute discretion direct (on behalf of themselves and the other Banks), including to the Settlement Bank as nominee for all or any of the Placees (in respect of
the Underwritten Units), to the Founders (in respect of the Founder Committed Units) and to the Independent Non-Founder Directors (in respect of the Independent
Non-Founder Director Committed Units) as required in connection with the Offer and to perform the obligations and actions attributed to it under the Prospectus, the Depositary Interest Deed Poll, the
Depositary Agreement and this Agreement in its capacity as depositary. 

  

	7.8	 The Company undertakes to the Banks, the Founders, and the Independent
Non-Founder Directors that the New Shares and Warrants comprising the Underwritten Units, the Founder Committed Units and the Independent Non-Founder Director Committed
Units will be allotted and issued fully paid: 

  

	 	(a)	 subject to the Memorandum and Articles of Association and the terms and conditions set out in the Offer
Documents; and 

  

	 	(b)	 on terms that the New Shares (and any Ordinary Shares to be issued pursuant to exercise of any of the Warrants)
will, when issued, rank pari passu in all respects with the Ordinary Shares then in issue, including with respect to the right to receive all dividends and other distributions declared, paid or made after Admission on the Ordinary Share
capital of the Company, 

 together with all rights attaching to them and free from all Encumbrances. 

  
 13 

 Payment by the Banks 

 

	7.9	 Subject to the satisfaction or waiver (in accordance with clause 15.2) of the Conditions and to this Agreement
not having been terminated under clause 15.6 or clause 16 and to the Company, each of the Directors, each of the Founders, and each of the Independent Non-Founder Directors complying with their obligations
under this clause 6, the Settlement Bank (on behalf of the Banks) will pay to the Company a sum representing the aggregate subscription price of the Underwritten Units subscribed by Placees and/or the Banks pursuant to clause 4.2 less the amounts
deducted in accordance with clause 8.7, on the Closing Date. 

  

	7.10	 The payment referred to in clause 7.9 will be made in cleared funds available on the same day to the accounts
notified by the Company to the Settlement Bank in writing by not later than 2.00 p.m. on the second Business Day prior to Admission. Each Bank’s obligation is to pay its Relevant Proportion of the sums payable by the Settlement Bank pursuant to
clause 7.9. Without prejudice to this obligation, the Settlement Bank shall only be obliged to make payment under clause 7.9 on behalf of another Bank to the extent that the Settlement Bank has received payment from such Bank. 

 

	7.11	 Payment under clause 7.9 will constitute a complete discharge for the Banks of their obligations under this
Agreement. 

 Payment by the Founders and the Independent Non-Founder Directors

  

	7.12	 Subject to the satisfaction or waiver (in accordance with clause 15.2) of the Conditions and to this Agreement
not having been terminated under clause 15.6 or clause 16 and to the Company and each of the Directors complying with their obligations under this clause 6, each of the Founders will pay to the Company a sum representing the subscription price of
the Founder Committed Units subscribed for by such Founder under clause 5.1 as soon as practicable after the date of Admission (and in any event within 2 Business Days of the date of Admission. 

 

	7.13	 The payment referred to in clause 7.12 will be made in cleared funds available on the same day to the accounts
notified by the Company to the Founders in writing by not later than 2.00 p.m. on the second Business Day prior to Admission. 

  

	8	 Commissions, fees and expenses 

Commissions and fees 
  

	8.1	 Subject to the satisfaction or waiver (in accordance with clause 15.2) of the Conditions and to this Agreement
not having been terminated under clause 15.6 or clause 16: 

  

	 	(a)	 the Company undertakes to pay to the Settlement Bank (on behalf of the Banks) on the Closing Date an
underwriting commission of an amount equal to 1.9 per cent of the gross proceeds of the sale of Underwritten Units, to be divided between the Banks in equal proportions; and 

  
 14 

	 	(b)	 in addition to the amount payable under clause 8.1(a) the Company shall on the Closing Date pay an additional
commission of 0.6 per cent of the gross proceeds of the sale of Underwritten Units, to be divided between the Banks by the Company in its absolute discretion. 

 

	8.2	 Payment of commission in accordance with clause 8.1 (including any VAT chargeable thereon in accordance with
clause 8.11) shall be made in cleared funds on the Closing Date by deduction of the amount of such commission (including any VAT chargeable thereon in accordance with clause 8.11) from the payment to be made by the Settlement Bank pursuant to clause
7.9. 

 Expenses 
  

	8.3	 Subject to clauses 8.4, 8.5, 8.6 and 8.7, whether or not the obligations of the Banks under this Agreement
become unconditional or are terminated, the Company, EverArc Founders or the Founders, as the context may require, shall promptly upon the request of any Bank reimburse such Bank the amount of any Offer Expenses which such Bank may have paid or
incurred. 

  

	8.4	 A request by a Bank for reimbursement of Offer Expenses under this clause 8 shall be in writing and shall
itemise the Offer Expenses (by type) paid or incurred by the relevant Bank and for which it is requesting reimbursement. For the avoidance of doubt, however, subject to the provisions of clause 8.11 the Banks shall not be required to provide VAT
receipts in respect of any Offer Expenses for which they may request reimbursement under clause 8.3. 

  

	8.5	 In the event that this Agreement becomes unconditional, each Bank’s Offer Expenses shall be paid by the
Company. 

  

	8.6	 In the event that this Agreement does not become unconditional and/or otherwise is terminated, each Bank’s
Offer Expenses shall be paid by EverArc Founders or the Founders. 

 Payment of commissions, fees and expenses 

 

	8.7	 The Settlement Bank (on behalf of the Banks) will be entitled and is authorised to deduct from the amount
payable by it to the Company pursuant to clause 7.9 all commissions, fees, expenses and other amounts payable by the Company under this clause 8 (other than those Offer Expenses which are being met directly by the Company). 

 

	8.8	 Deduction of amounts under clause 8.7 will discharge the Company’s obligations (as applicable) to pay
those amounts but only to the extent of the amounts deducted and any further amounts payable by the Company shall be paid promptly on demand therefor under clause 8.3. 

  
 15 

	8.9	 Notwithstanding that any or all of the Banks may, for certain purposes, be acting (as agents or otherwise) for
the Company in connection with the Offer and any arrangements contemplated by this Agreement, each of them may retain any commissions, fees or other amounts payable to it by the Company and any other commissions or benefits it receives in connection
with the Offer, or with any other arrangements contemplated by this Agreement for its own account; and any Underwritten Units which a Bank is obliged to subscribe for may be retained or dealt with by it for its own account in its absolute discretion
(subject to any separate arrangements which may be agreed among the Banks). 

 Stamp duty/stamp duty reserve tax

  

	8.10	 The Company will pay any stamp duty, stamp duty reserve tax (“SDRT”) or similar tax or duty
payable to ensure that those persons becoming entitled to be registered as holders of any Units (or any New Share or Warrant) or Depositary Interests are so registered and any stamp duty SDRT or similar tax or duty payable in connection with such
persons’ acquisition of (or agreement to acquire), or the issue of any of the Units (or any New Share or Warrant) or Depositary Interest, under the arrangements contemplated in this Agreement in each case together with any interest or penalties
payable in respect thereof, save to the extent that such interest or penalty is attributable to any unreasonable delay on behalf of the Banks in remitting to any Tax Authority any amount deducted pursuant to clause 8.7 or paid by the Company
pursuant to this clause 8.10. 

 VAT 
  

	8.11	 Where a sum is payable under this Agreement to any of the Banks or any other Indemnified Person (for the
purposes of this clause 8.11 only, each a Payee), the Company will, in addition, pay, or cause to be paid, to such Payee (or, in the case of any amounts referred to in clause 8.7, the Settlement Bank may deduct (in accordance with clause
8.7)) in respect of VAT: 

  

	 	(a)	 where the payment (or any part of it) constitutes the consideration (or any part thereof) for any supply of
services, such amount as equals any VAT properly payable thereon (against delivery to the Company of a valid VAT invoice in respect thereof); 

  

	 	(b)	 where the payment is to reimburse the Payee for any cost, fee, charge or expense incurred by it or them (except
where the payment falls within clause 8.11(c) below), such amount as equals any VAT charged to or incurred by the Payee in respect of any cost, fee, charge or expense which gives rise to or is reflected in the payment and which the Payee certifies
is not recoverable by it (taken together with the other members of any group of which the Payee is a member for VAT purposes) by repayment or credit (such certificate to be conclusive in the absence of manifest error); and 

 

	 	(c)	 where the payment is in respect of costs or expenses incurred by the Payee as agent for the Company and except
where section 47(2A) or section 47(3) of the Value Added Tax 

  
 16 

	 	
Act 1994 applies, such amount as equals the amount included in the costs or expenses in respect of VAT, provided that in such a case the Payee will use reasonable endeavours to procure that the
actual supplier of the goods or services which the Payee received as agent issues its own VAT invoice directly to the Company. 

Save to the extent otherwise provided in this Agreement, sums payable by the Company to a Payee shall be paid in pounds sterling in immediately
available funds to such bank account as the Payee shall notify in writing to the party making the payment. 
  

	9	 Representations, warranties and undertakings 

Representations and warranties 
  

	9.1	 The Company represents, warrants and undertakes to each of the Banks in the terms of the Warranties set out in
Part A of Schedule 2. 

  

	9.2	 Each of the Founder Directors severally represents, warrants and undertakes to each of the Banks in the terms
of the Warranties set out in Parts A and B of Schedule 2. 

  

	9.3	 Each of the Independent Non-Founder Directors severally represents,
warrants and undertakes to each of the Banks in the terms of the Warranties set out in paragraphs 1, 7 and 8 of Part A of Schedule 2 and the entirety of Part B of Schedule 2. 

 

	9.4	 Each of the Founders and each of the Founder Entities severally represents, warrants and undertakes to each of
the Banks in the terms of the Warranties set out in Part C of Schedule 2, save that the Warranties set out in paragraph 1.3 of Part C of Schedule 2 shall not apply to the Founders. 

 

	9.5	 The Warranties given pursuant to clauses 9.1 to 9.4 (inclusive) are given as at the date of this Agreement and
are repeated and given as at: 

  

	 	(a)	 the Applicable Time; 

 

	 	(b)	 the date of the Final Prospectus; 

 

	 	(c)	 the date of any Supplementary Prospectus published by the Company; and 

 

	 	(d)	 the Closing Date, 

in each case by reference to the facts and circumstances subsisting at such time. 

 

	9.6	 Each certificate to be delivered pursuant to paragraphs 7 to 10 (inclusive) of Part B and paragraphs 8 to 11
(inclusive) of Part C of Schedule 5 will have effect as a representation and warranty, as of its date, by the Company, the Directors, the Founder Entities and/or the Founders (as applicable) to each of the Banks as to the matters contained therein.

  
 17 

	9.7	 Each Director, each of the Founder Entities and each Founder agrees that, if and to the extent he or it incurs
any liability under the Warranties or in connection with the Offer, he or it will not seek any contribution or seek to recover any sum from the Company in respect of such liability. For the avoidance of doubt, however, this clause 9.7 shall not
preclude a Director from making a claim under any insurance policy maintained by the Company. 

  

	9.8	 Subject to clause 9.9, where any Warranty is expressed to be qualified by reference to the awareness and/or
knowledge and/or information and/or belief of any person or words to similar effect, it is deemed to include a statement to the effect that the Warranty has been made after due and careful enquiry. 

 

	9.9	 Each Independent Non-Founder Director shall only be liable in respect
of those Warranties set out in paragraphs 1, 7 and 8 of Part A of Schedule 2 to the extent he had knowledge of the subject matter giving rise to the claim having made due and careful enquiry. 

 

	9.10	 Without prejudice to any of their rights under this Agreement, if, at any time prior to Admission, any Bank
becomes aware that any of the Warranties was, is, has become or is reasonably likely to become, untrue, inaccurate, misleading or breached in any respect, the Banks may (without prejudice to their right to terminate this Agreement pursuant to clause
15.6 or clause 16) require the Company at its own expense to amend, update or supplement any of the Offer Documents (and, if requested by the Banks, such amendment, update or supplement to be in a form approved by the Banks) and/or require the
Company, at the Company’s own expense, to make such announcements and/or despatch such communications and/or take such other steps as the Banks consider necessary or desirable in connection with the untruth, inaccuracy or misleading nature of
the Warranty concerned. If the Company fails to comply with any such requirement, the Banks may require that the Company shall: 

  

	 	(a)	 cease to communicate any Offer Document which contains any reference to the Banks; and/or

  

	 	(b)	 notify any person to whom any Offer Document has been despatched and any other person known to be relying on
any Offer Document, of the relevant circumstances which render such Offer Document untrue, inaccurate or misleading or not in compliance with applicable legal or regulatory requirements. 

 

	9.11	 Each of the Company, each of the Founder Entities and the Founders acknowledges that each of the Banks is
entering into this Agreement in reliance on the Warranties and that each Warranty shall be separately construed and shall not be limited by reference (express or implied) to the terms of any other Warranty or any other term of this Agreement.

  
 18 

	9.12	 Each party giving a Warranty under this Agreement severally undertakes to each Bank: 

 

	 	(a)	 not to do, or omit to do, anything which would or might cause any Warranty given by it to become untrue,
inaccurate, misleading or breached at any time (by reference to the facts and circumstances existing at that time) between the date of this Agreement and the closing on the Closing Date (“Completion”); and 

 

	 	(b)	 promptly to give notice to each of the Banks if it becomes aware of a fact or circumstance which constitutes a
breach of any of the Warranties given by it or has caused or would or might cause any Warranty given by it to become untrue, inaccurate or misleading at any time (by reference to the facts and circumstances existing at that time) before the
Completion or if it becomes aware, before Completion, of a fact or circumstance which would or might give rise to a claim under any of the indemnities as contained in, or given pursuant to, clause 10 or any other provision of this Agreement.

 Undertakings 
  

	9.13	 The provisions of Schedule 3 shall have effect as undertakings on the part of the persons specified in the
relevant paragraphs of Schedule 3 to each of the Banks. 

  

	9.14	 In connection with the Offer, each of the Banks severally agrees to the terms of the selling restrictions set
out in Schedule 4. 

  

	10	 Indemnities 

General indemnity 
  

	10.1	 The Company agrees to indemnify and hold harmless each Indemnified Person against all or any claims, actions,
judgments, liabilities, awards, demands, investigations or proceedings (in each case whether or not successful, compromised or settled) (each a Claim) threatened, brought, alleged, asserted, established, made or instituted against or which otherwise
involve any Indemnified Person in any jurisdiction by any person whatsoever (including any regulatory or government agency), and against all losses, damages, liabilities, costs, charges, or expenses (including properly incurred fees, disbursements
and expenses of legal counsel) and any Tax (other than in respect of any stamp duty, SDRT or similar tax or duty in respect of which an amount has: (i) been deducted by the Settlement Bank pursuant to clause 8.7; (ii) been paid by the Company
in accordance with clause 8.10, or (iii) not been paid under clause 8.10 solely because the exception relating to certain interest and penalties expressly set out therein applied, or in relation to VAT in respect of which an amount:
(a) has been deducted by the Settlement Bank pursuant to clause 8.7; (b) has been paid by the Company under clause 8.11; or (c) is recoverable by the relevant Indemnified Person from a Tax Authority and would have been payable under clause
8.11(b) had it not been recoverable) (each a Loss), on demand, whether joint or several, which any Indemnified Person may suffer or incur (including, but not limited to, all Losses suffered

  
 19 

	 	
or incurred in investigating, preparing for or disputing, providing evidence in connection with or defending any Claim and/or in establishing its right to be indemnified pursuant to this clause
10.1 or to receive contribution pursuant to clause 12 and/or in seeking advice regarding any Claim (whether or not such Indemnified Person is an actual or potential party to such Claim or such Claim is defended or disputed successfully) or
mitigating any Loss on its part or otherwise enforcing its rights under this Agreement or in any way related to or in connection with this indemnity, clause 12 or settling any Claim), which in each case shall be additional and without prejudice to
any rights which an Indemnified Person may have at common law or otherwise, if the Claim or Loss arises, directly or indirectly, out of, or is attributable to, or connected with, anything done or omitted to be done by any person (including the
relevant Indemnified Person) in connection with the Offer, Admission or the arrangements contemplated by the Offer Documents (or any amendment or supplement to any of them), or any of them, or this Agreement or any other agreement relating to the
Offer or Admission, prior to, on or after the date of this Agreement including, but not limited to any and all Losses or Claims whatsoever, as incurred in connection with or arising out of: 

 

	 	(a)	 the Offer Documents (or any amendment or supplement thereto), or any of them, not containing or fairly
presenting, or being alleged not to contain or not to fairly present all information required to be contained therein or any statement in such document being, or being alleged to be in any respect, untrue, inaccurate, incomplete or misleading or not
based on reasonable grounds or the omission or alleged omission in any Offer Document (or any amendment or supplement thereto), or any of them, to state a fact necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading; and/or 

  

	 	(b)	 the issue, publication, distribution, approval or content of the Offer Documents (or any amendments or
supplements thereto), or any of them, or any other documents or materials in connection with the offer or Admission; and/or 

  

	 	(c)	 the breach, or alleged breach, by the Company and/or any Director of any of the Warranties, covenants or
undertakings, or any other obligation of the Company or any of the Directors contained in this Agreement or any other agreement to be entered into by any of them in connection with the Offer, Admission or the arrangements contemplated by the Offer
Documents (or any amendment or supplement thereto), or any of them, or this Agreement; and/or 

  

	 	(d)	 the failure, or alleged failure, by the Company and/or any Director and/or any of the Company’s agents,
employees or advisers (in each case other than the relevant Indemnified Person) to comply with FSMA, the FS Act, the BVI Companies Act, MAR, the Listing Rules, the DTRs, the Prospectus Regulation Rules, the Prospectus Regulation, the Admission and
Disclosure Standards, the rules and regulations of the London Stock Exchange, the CREST Regulations or any other laws, requirements or regulations (whether 

  
 20 

	 	
of governmental or regulatory bodies or otherwise) of any jurisdiction which are relevant or applicable to the Offer, Admission, the arrangements contemplated by the Offer Documents (or any
amendment or supplement thereto), or any of them, or this Agreement or any other agreement relating to the Offer; and/or 

  

	 	(e)	 the allotment and issue of the New Shares and Warrants comprising the Units; and/or 

 

	 	(f)	 the performance by an Indemnified Person of services to the Company in connection with the Offer including,
without limitation: 

  

	 	(i)	 acting as a person who has authorised (or being alleged to have authorised) the contents of the Offer Document
(or any amendment or supplement thereto), or any of them, or any part thereof for any purpose; and/or 

  

	 	(ii)	 acting as a person who has communicated or approved (or being alleged to have communicated or approved) the
contents of any financial promotion made in connection with the Offer or the Applications for Admission for the purpose of section 21 FSMA; and/or 

  

	 	(iii)	 (to the extent not otherwise covered by this Clause 10) the performance of any of its obligations or services
(including, without limitation, advisory services) under or in connection with this Agreement or the Offer or Admission or any other agreement relating to the Offer, either before, on or after the date of this Agreement; and/or

  

	 	(g)	 the Applications for Admission; and/or 

 

	 	(h)	 the making or implementation of the Offer and the subscription for Units by the AI Placees.

  

	10.2	 No UBS Indemnified Person shall be entitled to any indemnity from the Company under clause 10.1 in relation to
any Claim or Loss if, and only to the extent that, the Claim or Loss concerned is (in relation to clauses 10.1(b) and 10.1(f) only) determined in a final judgment by a court or arbitral tribunal of competent jurisdiction to have resulted primarily
from a UBS Indemnified Person’s: fraud; gross negligence; or breach of its duties owed under the rules of the FCA or the regulatory system (as defined in the FCA Handbook), provided always that the finally and judicially determined fraud, gross
negligence or breach of regulatory duty will only negate the indemnification of it and each other UBS Indemnified Person and will not negate the indemnification of any Morgan Stanley Indemnified Person. 

 

	10.3	 No Morgan Stanley Indemnified Person shall be entitled to any indemnity from the Company under clause 10.1 in
relation to any Claim or Loss if, and only to the extent that, the Claim or Loss concerned is (in relation to clauses 10.1(b) and 10.1(f) only) determined in a final judgment by a court or arbitral tribunal of competent jurisdiction to have resulted
primarily from a Morgan Stanley Indemnified Person’s: fraud; gross negligence; or breach of its duties owed under the rules of the 

  
 21 

	 	
FCA or the regulatory system (as defined in the FCA Handbook), provided always that the finally and judicially determined fraud, gross negligence or breach of regulatory duty will only negate the
indemnification of it and each other Morgan Stanley Indemnified Person and will not negate the indemnification of any UBS Indemnified Person. 

  

	10.4	 No Indemnified Person shall be entitled to any indemnity from the Company under clause 10:

  

	 	(a)	 in respect of any corporation or similar tax payable in respect of any fees or commissions payable to it
pursuant to this Agreement or on its net income, profits or gains arising in respect of the acquisition, holding or disposal of any Underwritten Units for which the Banks have subscribed pursuant to this Agreement; or 

 

	 	(b)	 in relation to any Losses to the extent that such Losses are attributable directly or indirectly to a decline
in the market value of the Underwritten Units and are suffered or incurred by an Indemnified Person as a result of it having been required to subscribe for Underwritten Units pursuant to clause 4.2 unless (but only to the extent that) such Losses
are attributable to, caused by, result from or would not have arisen, in each case either directly or indirectly, but for the neglect or default of the Company, the Founder Entities and/or the Founders, a breach by the Company, any of the Founder
Entities and/or any of the Founders of any of its or their obligations under this Agreement or any other agreement relating to the Offer (or any amendment or supplement to any of them) or any breach of any Warranties, undertakings or covenants given
by the Company, any of the Founder Entities and/or any of the Founders contained in this Agreement. 

 Conduct and
settlement 
  

	10.5	 The Company will inform the relevant Indemnified Person promptly if it becomes aware of any Claim or potential
Claim against such Indemnified Person arising out of or in connection with the Offer, this Agreement or any other agreements or arrangements relating to the Offer. The Company will not, without the prior written consent of the relevant Indemnified
Person(s), settle or compromise or consent to the entry of any judgment with respect to any Claim whatsoever in respect of which indemnification or contribution could be sought by an Indemnified Person under clause 10 or clause 12, unless such
settlement, judgement, compromise or consent (i) includes an express and unconditional release of each Indemnified Person from all Losses arising out of or in connection with such Claim and (ii) does not include a statement as to, or an
admission of, fault, culpability or a failure to act, by or on behalf of any Indemnified Person. 

  

	10.6	 The Company shall not be liable under this Clause 10 for any settlement by an Indemnified Person of any Claim
effected without its prior written consent (such consent not to be unreasonably withheld or delayed) but if any Claim is settled with such consent or if there is a final judgment for the claimant, the Company shall indemnify the Indemnified Person
from and against any Losses incurred in connection with such settlement or judgment as aforesaid. Notwithstanding the 

  
 22 

	 	
foregoing sentence, if at any time an Indemnified Person shall have requested the Company to reimburse such Indemnified Person for fees and expenses of its legal advisers, the Company agrees that
it shall be liable for any settlement of the Loss or Claim effected without its prior written consent if: (i) such settlement is entered into more than 30 days after receipt by the Company of the aforesaid request; and (ii) the Company
shall not have reimbursed such Indemnified Person in accordance with such request prior to the date of such settlement. 

  

	10.7	 Each Indemnified Person shall give written notice promptly to the Company of any action commenced against it
after receipt of a written notice of any Claim or the commencement of any action or proceeding in respect of which a Claim for indemnification may be sought under this clause 10, insofar as may be consistent with the terms of any relevant insurance
policy and provided that to do so would not, in such Indemnified Person’s view, be materially prejudicial to it (or to any Indemnified Person connected to it) or to any obligation of confidentiality or other legal or regulatory obligation which
that Indemnified Person owes to any third party or to any regulatory request that has been made of it, but failure to so notify the Company shall not relieve the Company from any liability hereunder to the extent it is not, in such Indemnified
Person’s view, materially prejudiced as a result thereof and in any event shall not relieve the Company from any liability which it may have otherwise than on account of the indemnity set out in this clause 10. 

 

	10.8	 In case any such Claim shall be brought against any Indemnified Person, the Company shall be entitled to assume
control of the conduct of the defence of any such Claim with legal advisers approved by such Indemnified Person (such consent not to be unreasonably withheld or delayed) and, after notice from the Company to such Indemnified Person of its election
so to assume the control of the conduct of the defence thereof, the Company shall not be liable to such Indemnified Person under this clause 10 for any legal expenses of any other legal advisers or any other legal expenses, in each case subsequently
incurred by such Indemnified Person, in connection with the defence thereof (other than costs of investigation) save in circumstances where such Indemnified Person has elected to reassume control of the conduct of the Claim pursuant to clause 10.9.

  

	10.9	 Notwithstanding the provisions of clause 10.8, the relevant Indemnified Person may elect to re-assume control of the conduct of such Claim and the Company shall bear the fees and expenses of such separate legal advisers to the Indemnified Person, if: 

 

	 	(a)	 the Company has failed to assume conduct of such Claim in a reasonably timely manner; 

 

	 	(b)	 the continued use of the legal advisers chosen by the Company to represent the Indemnified Person would in the
opinion of the Indemnified Person present such legal advisers with a conflict of interest; 

  
 23 

	 	(c)	 in the opinion of the relevant Indemnified Person(s), there may be legal defences available to it and/or other
Indemnified Persons which are different from or additional to those available to the Company; 

  

	 	(d)	 the Indemnified Person is required to appoint its own counsel to comply with the terms of its or his insurance
policy; or 

  

	 	(e)	 the Company and the relevant Indemnified Person otherwise agree that the relevant Indemnified Person may re-assume control. 

 In any such circumstances, the Company shall take all such actions
as may be requested by the relevant Indemnified Person to ensure that the relevant Indemnified Person has conduct of the Claim (or any particular element thereof as notified by such Indemnified Person to the Company) passed to it. To the extent an
Indemnified Person has re-assumed control of the conduct of a Claim pursuant to this Clause 10.9, and to the extent to do so would not, in such Indemnified Person’s view, be materially prejudicial to an
Indemnified Person’s interests and subject to being indemnified to its satisfaction by the Company against any additional or increased Losses it may suffer or incur as a result of so doing, it undertakes to keep the Company reasonably informed
of all material developments (in such Indemnified Person’s view) in respect of such Claim and to consult with the Company in respect of such material developments, provided that the relevant Indemnified Person shall not be under any obligation
to provide the Company with a copy of any document which is or may be legally privileged. 
  

	10.10	 In circumstances where the Company has, in accordance with clause 10.8, so elected to assume control of the
conduct of the defence of any Claim brought against any Indemnified Person: 

  

	 	(a)	 the relevant Indemnified Person retains the right to appoint their own legal advisers to represent such
Indemnified Person in relation to such Claim; and 

  

	 	(b)	 the Company agrees that: 

 

	 	(i)	 the relevant Indemnified Person(s) shall be entitled to be consulted about the conduct of the defence of any
Claim; 

  

	 	(ii)	 it shall provide the relevant Indemnified Person with such information and copies of such documents relating to
the Claim as the Indemnified Person may reasonably request, provided that the Company shall not be under any obligation to provide any Indemnified Person with a copy of any such document which is or may be legally privileged; and

  

	 	(iii)	 it will consider the representations and views of the relevant Indemnified Person(s) in the conduct of such
Claim. 

  
 24 

	10.11	 In the absence of a conflict of interest, in no event shall the Company be liable for fees, costs and expenses
of more than one legal adviser (in addition to its own legal advisers, if any) in any jurisdiction, for all Indemnified Persons in connection with any one Claim or separate but similar or related Claims in the same jurisdiction.

  

	10.12	 The provisions of this clause 10 will remain in full force and effect notwithstanding the completion of all
matters and arrangements referred to in or contemplated by this Agreement 

  

	11	 Exclusions of liability and arm’s length transactions 

 

	11.1	 No Claim shall be made by any of the Company, any of the Directors, any of the Founder Entities, any of the
Founders or any of their respective Affiliates or associates (or any of the directors, officers or employees of any of them) in any jurisdiction against any Indemnified Person to recover any Losses which any person may suffer or incur arising out of
or in connection with the Offer or this Agreement or any other agreements or arrangements relating to the Offer unless (in relation to clauses 10.1(b) and 10.1(g) only) such Losses are determined in a final judgment by a court or arbitral tribunal
of competent jurisdiction to have resulted from such Indemnified Person’s: fraud; gross negligence; or breach of its duties owed under the rules of the FCA or the regulatory system (as defined in the FCA Handbook). 

 

	11.2	 Notwithstanding any rights or claims which any of the Company, any of the Directors, any of the Founder
Entities, any of the Founders or any of their respective Affiliates or associates (or any of the directors, officers or employees of any of them) may have or assert against any of the Banks in connection with the Offer, this Agreement, Admission or
any other agreements or arrangements relating to the Offer or Admission, no claim shall be made by the Company or any Director, any of the Founder Entities, any of the Founders or by any of their respective Affiliates or associates (or any of the
directors, officers or employees of any of them) against any director or any other officer and/or employee of any Indemnified Person in respect of any conduct, action or omission by the individual concerned in connection with the Offer, this
Agreement, Admission, or any other agreements or arrangements relating to the Offer or Admission. 

  

	11.3	 Each of the Company, the Founders, the Founder Entities and the Directors agrees and acknowledges that each
Indemnified Person is acting solely pursuant to a contractual relationship with the Company on an arm’s length basis with respect to the Offer (including in connection with determining the terms of the Offer), and on the terms, and with the
obligations and duties expressly stated in this Agreement and that such person is not acting as a financial adviser or fiduciary to the Company, the Founders, the Founder Entities, the Directors or any of their respective Affiliates or associates
(or any of the directors, officer or employees of any of them) or any other person in respect of the Offer. It is acknowledged by all parties that: 

  

	 	(a)	 the Indemnified Persons may be engaged in a broad range of transactions that involve interests that differ from
those of the Company, the Founders, the Founder Entities, the 

  
 25 

	 	
Directors or any of their respective Affiliates or associates (or any of the directors, officer or employees of any of them) or any other person and the Indemnified Persons may take into account
any factors (including those solely in its interest) they consider appropriate in performing duties or exercising rights under this Agreement; and 

  

	 	(b)	 no Indemnified Person has advised as to, or is required to give, the Company, the Founders, the Founder
Entities, the Directors or any other person, any general financial or strategic advice or any legal, tax, investment, accounting, regulatory or other specialist or technical advice in connection with the Offer in any jurisdiction, and the Company,
the Founders, the Founder Entities, the Directors and any such other person have consulted their own, and will rely on their own expertise and that of, specialist legal, tax, investment, accounting or regulatory advisers to the extent they deem
appropriate, and in respect of the due diligence investigations in connection with the Offer and no Indemnified Person shall have any responsibility to the Company, the Founders, the Founder Entities, the Directors or any other person with respect
thereto. 

  

	11.4	 No Indemnified Person shall have any liability for any claims brought by or against any person (and the
Company, the Founders, the Founder Entities and the Directors or any of their respective Affiliates or associates (or any of the directors, officer or employees of any of them) confirm they will not make any claim against any Indemnified Person) in
respect of the timing, terms and structure of the Offer, or that the Offer Price was set at a level that is too high or too low, or with respect to any sales of any New Shares or Warrants by investors following allocation to them of such New Shares
or Warrants. 

  

	11.5	 The parties further agree that it is not their intention to create a fiduciary relationship between the
Company, the Founders, the Founder Entities and the Directors on the one hand and either of the Banks on the other. 

  

	11.6	 The Company, the Founders, the Founder Entities and the Directors acknowledge and agree: 

 

	 	(a)	 each of the Banks is and has been acting for the Company and no one else in connection with the Offer and the
Admission and will not regard, and have not regarded, any other person as their client and have not been and will not be responsible to anyone other than the Company for providing the protections afforded to clients of each of the Banks nor for
providing advice in relation to the Offer, the Admission or any of the transactions contemplated by this Agreement; 

  

	 	(b)	 any advice, whether written or oral, given by a Bank to the Company, or any communications between a Bank and
the Company, may not be used or relied upon by any third party and may not be disclosed to any third party without the prior written approval of the relevant Bank (other than the Company’s professional advisers who may place no reliance on such
advice); 

  
 26 

	 	(c)	 each of the Banks is a full service securities firm and they, along with their respective Affiliates, are
engaged in various activities, including securities trading, investment management, financing and brokerage activities and financial planning and benefits counselling for both companies and individuals; 

 

	 	(d)	 in the ordinary course of the activities referred to in clause (c), each of the Banks and their respective
Affiliates may actively trade the debt and equity securities (or related derivative securities) of the Company and its related bodies corporate for their own account and for the accounts of their customers and may at any time hold long and short
positions in such securities; 

  

	 	(e)	 no Bank is obliged to disclose to the Company, the Founders, the Founder Entities or the Directors or utilise
for the benefit of the Company, the Founders, the Founder Entities or the Directors any non-public information which a Bank obtains in the course of its business; and 

 

	 	(f)	 each of the Banks will use and rely on information provided by or on behalf of the Company in performing their
obligations under this Agreement, without having independently verified the information, and the Banks do not assume responsibility for the accuracy and completeness of the information or any other information on which it may rely in connection with
this Agreement. 

  

	11.7	 Nothing in this Agreement, including this clause 11, shall exclude or restrict any duty or liability of any
Indemnified Person which it has under FSMA or under the regulatory system (as defined in the FCA Handbook) to the extent such exclusion or restriction is prohibited by the FCA Handbook. 

 

	12	 Contribution 

  

	12.1	 If the indemnification provided for in clause 10 is for any legal reason (including because such
indemnification would be contrary to public policy) unavailable to, or insufficient to, hold harmless an Indemnified Person in respect of any Claims and/or Losses referred to therein, then the Company shall contribute to the aggregate amount of such
Claims or Losses incurred by such Indemnified Person, as incurred: 

  

	 	(a)	 in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand,
and the Banks, on the other hand, from the offering of the Units pursuant to this Agreement; or 

  

	 	(b)	 if the allocation provided by clause 12.1(a) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause 12.1(a) but also the relative fault of the Company, on the one hand, and of the Banks, on the other hand, in connection with the acts or statements or omissions which
resulted in such Claims or Losses, as well as any other relevant equitable considerations. 

  
 27 

	 	
The relative benefits received by the Company, on the one hand, and the Banks, on the other hand, in connection with the offering of the Units pursuant to this Agreement shall be deemed to be in
the same respective proportions as, with respect to the Company, the total net proceeds from the offering of the Units pursuant to this Agreement (before deducting expenses) received by the Company and with respect to the Banks, the total fees and
commissions received by the Banks, bear to the total gross proceeds from the offering of the Units. 

  

	12.2	 The relative fault of the Company, on the one hand, and the Banks, on the other hand, will be determined by
reference to, among other things, whether any such act or alleged act or untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the Banks
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such act, statement or omission. 

  

	12.3	 The Company and the Banks agree that it would not be just and equitable if contribution pursuant to this clause
12 were determined by pro rata allocation (even if the Banks were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this clause 12. The
aggregate amount of Claims and Losses incurred by an Indemnified Person and referred to above in this clause 12 will be deemed to include (but not be limited to) all Losses suffered or incurred in investigating, preparing for, disputing, providing
evidence in connection with or defending any Claim and/or in establishing its right to be indemnified pursuant to clause 10 or to receive contribution pursuant to this clause 12 and/or in seeking advice regarding any Claim (whether or not such
Indemnified Person is an actual or potential party to such Claim or such Claim is defended or disputed successfully) or mitigating any Loss on its part or otherwise enforcing its rights under this Agreement or in any way related to or in connection
with the indemnity contained in clause 10 or this clause 12 or settling any Claim). 

  

	12.4	 Notwithstanding any other provision of this clause 12: 

 

	 	(a)	 no Indemnified Person shall be entitled to recover more by way of a contribution under this clause 12 than it
would have been able to recover had the indemnities in clause 10 been available to such Indemnified Person; and 

  

	 	(b)	 the Company shall not be liable to pay any amount pursuant to this clause 12 in excess of the amount it would
have been liable to pay had the indemnities in clause 10 been available to such Indemnified Person. 

  

	12.5	 Notwithstanding the provisions of this clause 12, none of the Banks will be required to contribute any amount
in excess of the commission received by it (and which it is not liable to pay to any other underwriter or intermediary under this Agreement or otherwise) in relation to the Underwritten Units placed, underwritten or subscribed for by such Bank
pursuant to this Agreement. 

  
 28 

	12.6	 No person guilty of fraudulent misrepresentation (whether within the meaning of Section 11(f) of the
Securities Act or otherwise) will be entitled to contribution in respect of Losses and/or Claims that have resulted from such fraudulent misrepresentation from any person who was not guilty of such fraudulent misrepresentation.

  

	12.7	 For the purposes of this clause 12, each UBS Indemnified Person shall have the same rights to contribution as
UBS, and each Morgan Stanley Indemnified Person shall have the same rights to contribution as Morgan Stanley. 

  

	12.8	 The Banks’ respective obligations to contribute pursuant to this clause 12 are several in proportion to
their Relevant Proportions and are not joint or joint and several. 

  

	13	 Withholding and gross up 

 

	13.1	 All sums payable to any Bank or any other Indemnified Person under this Agreement (for the purposes of this
clause 13 only, each a Payee) shall be paid free and clear of all deductions or withholdings unless the deduction or withholding is required by law, in which event (and except in the case of interest) the relevant person making the payment
shall pay such additional amount as shall be required to ensure that the net amount received by the Payee will equal the full amount which would have been received by it had no such deduction or withholding been made. 

 

	13.2	 If ) any sum payable to a Payee under this Agreement or any sum withheld in accordance with this Agreement from
any payment made to the Payee (other than, in either case, any fees or commissions payable or paid pursuant to this Agreement) is subject to Tax (or would be subject to Tax but for the availability of any Relief) or is required to be brought into
any computation of income, profit or gains for the purposes of any charge to Tax, the person liable under this Agreement to make such payment (or that would have been so liable, but for the amount withheld) shall pay such additional amount as shall
be required to ensure that the total amount received by the Payee, less the Tax chargeable thereon (or that would be so chargeable but for the availability of Relief in respect of that charge to Tax), is equal to the amount that would otherwise be
so received (additional payments being made promptly following demand by the Payee or, if later, when the sum so payable to the Payee under this Agreement is paid). 

  
 29 

	14	 Limits on liability 

Financial amount 
  

	14.1	 The liability of each of the Founders (whether in their capacity either as Founders or Founder Directors), each
of the Founder Entities and each of the Independent Non-Founder Directors under this Agreement shall not exceed the amounts set out opposite their respective names in column (2) of the tables set out in
Schedule 1, provided always that: 

  

	 	(a)	 the aggregate liability of Mr Howley and Llanerch Everarc shall not exceed an aggregate amount of US$2,500,000;
and 

  

	 	(b)	 the aggregate liability of Mr Raj and TVR Everarc shall not exceed an aggregate amount of US$500,000.

 Time 
  

	14.2	 No Claim may be brought against any of the Independent Non-Founder
Directors, any of the Founder Entities or the Founders under this Agreement unless notice has been given of such claim in the period ending on the day falling 180 days after the publication of the Company’s audited, consolidated annual report
and accounts for the financial year ending 31 October 2020 (or if the Company’s accounting reference date has changed, the Company’s annual report and accounts for the first accounting period of 12 months (or more) ending after the
Closing Date). 

  

	14.3	 The limitations in this clause 14 shall not apply in relation to: 

 

	 	(a)	 any breach of this Agreement resulting from fraud, bad faith, dishonesty or gross negligence on the part of the
person for whose benefit the limitation would otherwise have applied; or 

  

	 	(b)	 any breach of the Warranties set out in paragraph 1 of Part C of Schedule 2. 

 

	14.4	 The limitations in clause 14 shall not apply in relation to any claim arising from a breach or default by:

  

	 	(a)	 the relevant Founder in relation to its obligations to subscribe for Founder Committed Units under clause 5; or

  

	 	(b)	 the relevant Independent Non-Founder Director in relation to its
obligations to subscribe for Independent Non-Founder Director Committed Units under clause 5. 

  

	15	 Conditions to the Offer and Termination 

Conditions to the Offer 
  

	15.1	 The obligations of the Banks under this Agreement are conditional upon: 

 

	 	(a)	 the Final Prospectus being formally approved by the FCA pursuant to the Listing Rules and the Prospectus
Regulation Rules and being published and made available in the manner specified in the Prospectus Regulation Rules, in each case not later than 3.00 p.m. on the date of this Agreement (or such later time or date as the Banks may agree with the
Company); 

  
 30 

	 	(b)	 each condition (other than Admission) to the Depositary Interests being admitted to CREST as a participating
security in accordance with the CREST Rules being satisfied on or before Admission; 

  

	 	(c)	 no matter referred to in section 87G of FSMA arising or being noted between the date of publication of the
Final Prospectus and Admission; 

  

	 	(d)	 any Supplementary Prospectus (as approved by the Banks in their absolute discretion) being formally approved by
the FCA in accordance with FSMA and the Prospectus Regulation Rules and published and made available in accordance with the Prospectus Regulation Rules, in each case before Admission; 

 

	 	(e)	 the Company, each Director, each of the Founders, each of the Founder Entities and each of the Independent Non-Founder Directors having complied with all their respective obligations and having satisfied all Conditions to be satisfied by any of them, in each case under this Agreement or under the terms and conditions of
the Offer which fall to be performed or satisfied on or prior to Admission; 

  

	 	(f)	 the Warranties being true and accurate in all respects and not misleading in any respect at the date of this
Agreement, the date of the Final Prospectus, the Applicable Time, the date of any Supplementary Prospectus and the Closing Date, as though, in each case, they had been given and made on such dates and times by reference to the facts and
circumstances then subsisting; 

  

	 	(g)	 no matter having arisen prior to Admission which in the good faith opinion of the Banks might reasonably be
expected to give rise to a Claim under clause 10; 

  

	 	(h)	 the delivery to the Banks on or before at least one day before Admission of a letter or letters from the
Depositary addressed to Euroclear dated the date of Admission confirming to Euroclear that all the outstanding conditions for the admission of all of the Depositary Interests to CREST have been satisfied; 

 

	 	(i)	 in the opinion of the Banks, acting in good faith, there having been no Material Adverse Change, whether or not
foreseeable at the date of this Agreement; 

  

	 	(j)	 the Company and the relevant counterparty (as applicable) entering into the Warrant Instrument, the Corporate
Administration Agreement, the Registrar Agreement and the Depositary Agreement and those agreements becoming unconditional in accordance with their terms (save in respect of any condition relating to this Agreement becoming unconditional) and
remaining in full force and effect and having not lapsed or been amended or terminated prior to Admission; 

  
 31 

	 	(k)	 each of the Insider Letters having been entered into by the relevant parties and having become unconditional in
accordance with its terms and the obligations in such letters being legal, valid, binding and enforceable; 

  

	 	(l)	 the Depositary entering into the Depositary Interest Deed Poll; 

 

	 	(m)	 the Company, the Founders and the Founder Entities (as the context may require) delivering to the Banks the
documents listed in Schedule 5 by not later than the times and dates specified therein; 

  

	 	(n)	 delivery, on the date of any Supplementary Prospectus and on the date of (and prior to) Admission, to the Banks
of: 

  

	 	(i)	 a certificate in the form set out in Part A of Schedule 6 by the Company; 

 

	 	(ii)	 a certificate in the form set out in Part B of Schedule 6 by each of the Founders and the Founder Entities;

  

	 	(o)	 the Company allotting the New Shares and Warrants, prior to and conditional only on Admission, in accordance
with the terms of this Agreement; and 

  

	 	(p)	 Admission taking place by not later than 8.00 a.m. on the Closing Date (or such later time and/or date as the
Company and the Banks may agree). 

  

	15.2	 The Banks will be entitled (acting jointly), in their absolute discretion and on such terms as they think
appropriate, to waive fulfilment, in whole or in part, of any or all of the Conditions (to the extent permitted by law or regulation) by giving notice in writing to the Company. 

 

	15.3	 The Company and the Banks may agree in writing to extend the time and/or date by which any of the Conditions
are required to be fulfilled to no later than 3.00 p.m. on the Long Stop Date. If the time for fulfilment or waiver of any of the Conditions is so extended, references in this Agreement to the time and/or date specified for the fulfilment of a
Condition are to the time as so extended. 

  

	15.4	 The Company, the Directors, each of the Founders and each of the Founder Entities will use their respective
best endeavours to procure that each of the Conditions is fulfilled by the time and/or date referred to therein (or, if no time or date is specified, by 8:00 a.m. on the Closing Date) or by such later time and/or date (if any) as may be agreed by
the Banks pursuant to clause 15.3. 

  

	15.5	 In the event of the publication of any Supplementary Prospectus referred to in clause 15.1(d), the Banks shall
have the right to postpone the Closing Date for such period, not exceeding five Business Days, as the Banks may in their absolute discretion determine. 

  
 32 

 Termination of this Agreement 

 

	15.6	 If, at any time before Admission, any Bank becomes aware that any of the events described in clause 15.7 have
occurred, it may in its absolute discretion (on behalf of the Banks): 

  

	 	(a)	 allow the Offer to proceed on the basis of the Final Prospectus subject (if the relevant Bank so requests) to
the publication by the Company of a Supplementary Prospectus, provided that the Company shall not publish or cause to be published any such Supplementary Prospectus without the prior written consent of the relevant Bank; or 

 

	 	(b)	 terminate this Agreement, notice of such termination to be then communicated as soon as is practicable to any
Director orally or by email or otherwise, and the provisions of clause 15.8 will apply. 

  

	15.7	 The events which will entitle any of the Banks to terminate this Agreement under clause 15.6 are:

  

	 	(a)	 any of the Warranties being untrue, inaccurate or misleading in any respect when made or becoming untrue,
inaccurate or misleading in any respect by reference to the facts and circumstances existing from time to time or any matter arising which in the opinion of the Banks (acting in good faith) might reasonably be expected to give rise to a Claim under
clause 10; or 

  

	 	(b)	 any Condition has not been satisfied by the time and date it is required to have been satisfied or waived (if
capable of waiver) by the Banks or if any matter or circumstance arises as a result of which it is reasonable to expect that any of the Conditions will not be satisfied at the required time(s) (if any) and continue to be satisfied at Admission;

  

	 	(c)	 it shall come to the notice of any of the Banks that any statement contained in any Offer Document (or any
amendment or supplement thereto) is or has become untrue, inaccurate or misleading in any respect or any matter has arisen, which would, if the Offer were made at that time, constitute an omission from the Offer Documents, or any of them (or any
amendment or supplement to any of them); or 

  

	 	(d)	 any matter referred to in section 87G of FSMA having arisen or been noted between publication of the Final
Prospectus and Admission; or 

  

	 	(e)	 a breach by the Company, a Director, a Founder, a Founder Entity or an Independent Non-Founder Director of any of their respective obligations under this Agreement (to the extent such obligations fall to be performed prior to Admission); or 

 

	 	(f)	 in the opinion of the Banks, any Material Adverse Change having occurred (whether or not foreseeable at the
date of this Agreement); or 

  
 33 

	 	(g)	 the Applications for Admission are refused by the FCA and/or the London Stock Exchange and/or Euroclear (as
applicable) and/or are withdrawn by the Company; or 

  

	 	(h)	 if: 

  

	 	(i)	 there has occurred any change in the financial markets in the United States, the United Kingdom, the British
Virgin Islands, any member state of the EEA or the international financial markets, any outbreak of hostilities or escalation thereof, any act of terrorism or war or other calamity or crisis or any change or development involving a prospective
change in national or international political, financial or economic conditions, exchange rates or exchange controls; or 

  

	 	(ii)	 trading generally on the New York Stock Exchange, the NASDAQ Stock Market or the London Stock Exchange has been
suspended or limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of such exchanges or by such system or by order of the SEC, the National Association of Securities Dealers, Inc.,
the Financial Industry Regulatory Authority or any governmental authority, or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States or in the United Kingdom or in the British
Virgin Islands or in any member state of the EEA; or 

  

	 	(iii)	 a banking moratorium has been declared by the United States, the United Kingdom, the British Virgin Islands, a
member state of the EEA or New York State authorities; or 

  

	 	(iv)	 there has occurred an adverse change or a prospective adverse change in United States or United Kingdom or
British Virgin Islands taxation affecting the Units or Depositary Interests or in each case the transfer thereof or exchange controls have been imposed by the United States, the United Kingdom, the British Virgin Islands or a member state of the
EEA, 

 in each case the effect of which (either singly or together with any other event referred to in this clause
15.7(h)) is such as to make it, in the sole opinion of the Banks, acting in good faith, impracticable or inadvisable to market the Underwritten Units and/or to proceed with Admission and/or to enforce contracts for the sale of the Underwritten Units
and/or which may prejudice the success of the Offer and/or dealing in the Depositary Interests representing the New Shares and/or Warrants in the secondary market. 

Consequences of failure to complete 
  

	15.8	 If any of the Conditions have not been fulfilled (or waived by the Banks pursuant to clause 15.2) in all
respects on or before the time and/or date specified in clause 15.1(p) (or such later time 

  
 34 

	 	
and/or date for fulfilment of such Condition as may be agreed pursuant to clause 15.3) or become incapable of being satisfied, or this Agreement is terminated pursuant to clause 15.6 or clause
16, then the obligations of the Banks under this Agreement will immediately cease and determine and: 

  

	 	(a)	 no party to this Agreement will have any Claim against any other party, except for accrued rights or
obligations under this Agreement; 

  

	 	(b)	 such termination shall be without prejudice to any obligations of the Company, any of the Directors, any of the
Founders or any of the Founder Entities in respect of Units which have already been issued, subscribed and paid for, or sold and paid for, at the time of such termination; 

 

	 	(c)	 the Company will forthwith pay to the Settlement Bank (on behalf of itself and on behalf of the other Banks)
the Offer Expenses payable by it in accordance with clause 8 and shall, for the avoidance of doubt, remain liable to pay any further fees, commissions or expenses that may be due, or subsequently become due, under and in accordance with the terms of
the Indemnity Letter; 

  

	 	(d)	 the Applications for Admission will be withdrawn and the parties will procure that Admission will not become
effective; and 

  

	 	(e)	 the provisions of clauses 1 and 8 to 19 (inclusive) will remain in full force and effect.

  

	16	 Default by one or more of the Banks 

 

	16.1	 If one or more of the Banks (a Defaulting Bank) fails (or, in the opinion of any of the Banks, excluding
any Defaulting Bank, is likely to fail) to subscribe for the Underwritten Units which it or they are obliged to subscribe for under this Agreement (the Defaulted Underwritten Units), the Banks (excluding any Defaulting Bank) will (on behalf
of themselves and the other Banks) have the right but not the obligation, within 48 hours thereafter (or such longer period as the Banks (excluding any Defaulting Bank) may agree with the Company), to make arrangements for one or more of the non-defaulting Banks, or any other underwriters, to procure subscribers for or, failing which, to subscribe for, all, but not less than all, of the Defaulted Underwritten Units in such amounts as may be agreed upon
and upon the terms herein set forth. 

  

	16.2	 If the Banks (excluding any Defaulting Bank) have not completed arrangements of the type described in clause
16.1 within the 48-hour (or other agreed) period referred to in that clause, then: 

  

	 	(a)	 if the number of Defaulted Underwritten Units does not exceed ten per cent of the number of Underwritten Units
to be subscribed for on such date, each of the non-defaulting Banks will be obliged, severally and not jointly or jointly and severally, to procure subscribers for,

  
 35 

	 	
or to subscribe for, the full amount thereof in the proportions that their respective underwriting obligations under this Agreement bear to the underwriting obligations of all non-defaulting Banks; or 

  

	 	(b)	 if the number of Defaulted Underwritten Units exceeds ten per cent of the number of Underwritten Units to be
subscribed for on such date, this Agreement will terminate without liability on the part of any non-defaulting Bank and the provisions of clause 15.8 will apply. 

 

	16.3	 Neither termination of this Agreement nor any other action taken under this clause 16 will relieve any
Defaulting Bank from liability in respect of its default. 

  

	16.4	 In the event of any such default or likely default which does not result in a termination of this Agreement,
the Banks (excluding any Defaulting Bank), on behalf of themselves and the other Banks, will have the right to postpone the Closing Date for a period not exceeding ten Business Days as the Banks (excluding any Defaulting Bank), on behalf of
themselves and the other Banks, shall determine in order to prepare any necessary Supplementary Prospectus and/or to effect any required changes in any other documents or arrangements. The term Bank as used in this Agreement will include any
person substituted under this clause 16 with like effect as if such person had originally been a party to this Agreement with respect to such Underwritten Units. 

 

	17	 Notices 

  

	17.1	 Any notice to be given by one party to another party in connection with this Agreement shall be in writing in
English and signed by or on behalf of the party giving it. It shall be delivered by hand, fax, registered post or courier using an internationally recognised courier company. 

 

	17.2	 A notice shall be effective upon receipt and shall be deemed to have been received (i) at the time of
delivery, if delivered by hand, registered post or courier or (ii) upon confirmed completion of transmission if delivered by fax (subject to the sender not receiving a notification from its system’s administrator that the fax was
undeliverable). Where delivery occurs outside Working Hours, notice shall be deemed to have been received at the start of Working Hours on the next following Business Day. 

 

	17.3	 The addresses and, where applicable, fax numbers of the parties for the purpose of clause 17.1 are as follows:

  

			
	 (a)   if to the Company:
	  	
		
	 Address:
	  	C/o – Oak Fund Services, Regency Court, Glategny
		  	Esplanade, St. Peter Port, Guernsey
		
	 Marked for the attention of:
	  	Mark Woodall
		
	 (b)   if to Mr. Thorndike:
	  	
		
	 Address:
	  	 [***]

		  	

  
 36 

			
	 (c)   if to Mr. Howley:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (d)   if to Ms. Britt Cool:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (e)   if to Mr. Khouri:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (f)   if to Mr. Raj:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (g)   if to EverArc Founders:
	  	
		
	 Address:
	  	160 Greentree Drive, Suite 101, City of Dover,
		  	County of Kent, Delaware 19904, United States of
		  	America
		
	 Marked for the attention of:
	  	The Managers
		
	 (h)   if to Llanerch Everarc:
	  	
		
	 Address:
	  	700 W. St. Clair Ave., Suite 414, Cleveland, Ohio
		  	44113-1274, United States of America
		
	 Marked for the attention of :
	  	Nick Howley and Dominic Perry
		
	 (i)  if to TVR Everarc:
	  	
		
	 Address:
	  	5900 Balcones Drive, STE 100, Austin,
		  	TX 78731, United States of America
		
	 Marked for the attention of :
	  	The Managers
		
	 (j)  if to Mr. Bram Belzberg:
	  	
		
	 Address:
	  	 [***]

		  	

  
 37 

			
	 (k)   if to Mr. John Staer:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (l)  if to Mr. Michael Tobin OBE:
	  	
		
	 Address:
	  	 [***]

		  	
		
	 (m) if to Mr. Adam L. Hall:
	  	
		
	 Address:
	  	 [***]

		
	 (n)   if to UBS:
	  	
		
	 Address:
	  	5 Broadgate, London EC2M 2QS, United Kingdom
		
	 Fax number:
	  	+44 (0) 207 336 2074
		
	 Marked for the attention of:
	  	Thomas Raynsford
		
	 (o)   if to Morgan Stanley:
	  	
		
	 Address:
	  	25 Cabot Square, London E14 4QA, United
		  	 Kingdom

		
	 Fax number:
	  	+44 (0) 207 425 8990
		
	 Marked for the attention of:
	  	Head of Equity Capital Markets

  

	17.4	 Each party shall notify the other parties in writing of a change to its details in clause 17.3 from time to
time. 

  

	18	 General 

  

	18.1	 This Agreement may be entered into in any number of counterparts and by the parties to it on separate
counterparts, and each of the executed counterparts, when duly exchanged or delivered, shall be deemed to be an original, but taken together, they shall constitute one and the same instrument. 

 

	18.2	 Any counterpart may take the form of an electronic copy of this Agreement and that counterpart:

  
 38 

	 	(a)	 will be treated as an original counterpart; 

 

	 	(b)	 is sufficient evidence of execution of the original; and 

 

	 	(c)	 may be produced in evidence for all purposes in place of the original. 

Any party delivering the electronic counterpart will, within seven days of electronic exchange, deliver the wet ink original of that
counterpart to the Banks’ Counsel by express courier. 
  

	18.3	 This Agreement is binding on and enures for the benefit of the successors, assignees or legal personal
representatives of the parties and each Indemnified Person. No purchaser of Underwritten Units from any Bank shall be deemed to be a successor or assignee by reason merely of such purchase. 

 

	18.4	 No party may assign any of its rights under this Agreement without the prior written consent of the other
parties. 

  

	18.5	 Each Indemnified Person that is not a party to this Agreement will have the right under the Contracts (Rights
of Third Parties) Act 1999 to enforce its rights against the Company under clauses 10 and 12 provided that, save to the extent notified in writing to the relevant Indemnified Person, the relevant Bank (without obligation) will have the sole conduct
of any action to enforce or otherwise deal with such rights on behalf of its Indemnified Persons. 

  

	18.6	 Save as provided in clause 18.5 and in paragraph 3.2 of Schedule 3, a person who is not a party to this
Agreement has no rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this Agreement but this does not affect any right or remedy of a third party which exists or is available apart from that Act. Under no
circumstances shall any consent be required from any Indemnified Person that is not a party to this Agreement (or any other third party) for the termination, rescission, amendment or variation of this Agreement, whether or not such termination,
rescission, amendment or variation effects or extinguishes any benefit or right conferred on such Indemnified Person or other third party. The Banks will not have responsibility to any Indemnified Person or any other third party under or as a result
of this Agreement. 

  

	18.7	 The rights and remedies of the parties to this Agreement or any Indemnified Person shall not be affected by any
failure to exercise or delay in exercising any right or remedy or by the giving of any indulgence by any other party or by anything whatsoever except a specific waiver or release in writing and any such waiver or release shall not prejudice or
affect any other rights or remedies of the parties or any Indemnified Person. No single or partial exercise of any right or remedy shall prevent any further or other exercise thereof or the exercise of any other right or remedy.

  

	18.8	 Notwithstanding any other rule of law or equity, any release, waiver or compromise or any other arrangement of
any kind whatsoever which any Bank may adopt or effect in connection with this Agreement will not affect any right or privilege of any other party to this Agreement nor any other rights or privileges of any such party at law, in equity or otherwise.

  
 39 

	18.9	 No amendment of this Agreement or of any of the documents referred to in this Agreement will be effective
unless it is in writing (which for this purpose does not include email), refers specifically to this Agreement and is duly executed by each party hereto, and shall include any variation, supplement, deletion or replacement however effected. No third
party shall be required to agree any modification or amendment. 

  

	18.10	 Each provision of this Agreement is severable and distinct from the others and, if any provision is, or at any
time becomes, to any extent or in any circumstances invalid, illegal or unenforceable for any reason, that provision shall to that extent be deemed not to form part of this Agreement but the validity, legality and enforceability of the remaining
provisions of this Agreement shall not be affected or impaired, it being the parties’ intention that every provision of this Agreement shall be and remain valid and enforceable to the fullest extent permitted by law. 

 

	18.11	 At any time after the date of this Agreement the Company shall, and shall use all reasonable endeavours to
procure (so far as it is within its power to do so) that any necessary third party shall, at the cost of the Company, execute such documents and do such acts and things as the Banks may reasonably require for the purpose of giving full effect to all
the provisions of this Agreement by which he, she or it is bound 

  

	18.12	 Each party acknowledges and agrees that: 

 

	 	(a)	 this Agreement, the other documents referred to in this Agreement (including, without limitation, the Indemnity
Letter) and any other agreement entered into pursuant to this Agreement constitute the entire agreement between the parties and supersede any previous agreement, understanding, undertaking or arrangement between the parties relating to the subject
matter of this Agreement; 

  

	 	(b)	 in entering into this Agreement it does not rely on any statement, representation, assurance or warranty of any
person (whether a party to this Agreement or not and whether made in writing or not) other than as expressly set out in this Agreement; and 

  

	 	(c)	 nothing in this clause, and no other limitation in this Agreement, shall exclude or limit any liability for
fraud. 

  

	18.13	 Notwithstanding any provision to the contrary in the Indemnity Letter, each of the Founders, each of the
Founder Entities and each of the Banks agrees that the Indemnity Letter shall remain in full force and effect (and that the indemnification contained in that letter shall continue to apply for the benefit of the Banks) until this Agreement becomes
wholly unconditional in accordance with its terms, save that, to the extent that there is a conflict between the provisions of this Agreement and the Indemnity Letter, the provisions of this Agreement shall prevail. Each Bank agrees that
compensation in respect of the same Losses may only be recovered once under the terms of this Agreement and the Indemnity Letter. 

  
 40 

	18.14	 The rights, powers, indemnities, representations, warranties and undertakings in this Agreement are in addition
to and are not to be construed to limit, affect or prejudice, any other right or remedy available to any Indemnified Person against any person (whether or not a party to this Agreement). 

 

	18.15	 Each of the representations, warranties, agreements, undertakings and indemnities set out in this Agreement
shall remain in full force and effect regardless of any investigation made by or on behalf of any Bank and notwithstanding the issue, sale, transfer or delivery of and payment for the New Shares or Warrants or completion of the Offer.

  

	18.16	 If the Company has entered into or enters into any agreement or arrangement with any adviser for the purpose
of, or in connection with, the Offer and the terms of which provide that the liability of the adviser to the Company or any other person is excluded or limited in any manner and the Banks or any other Indemnified Person may have joint and/or several
liability with such adviser to the Company or to any other person arising out of the performance of its duties under this Agreement then the Company will: 

  

	 	(a)	 not be entitled to recover any amounts from the Banks or any other Indemnified Person in excess of what would
have been the net amount of such person’s liability in the absence of such exclusion or limitation; 

  

	 	(b)	 indemnify the Banks and/or any other Indemnified Person in respect of any increased liability to any third
party which would not have arisen in the absence of such exclusion or limitation; and 

  

	 	(c)	 take such other action as any of the Banks and/or such other Indemnified Person may require to ensure that none
of the Banks are prejudiced as a consequence of such agreement or arrangement. 

  

	18.17	 The degree to which any Indemnified Person shall be entitled to rely on the work of any adviser to the Company,
the Directors, the Founders or any of them or any other third party will be unaffected by any exclusion or limitation referred to in clause 18.15 which the Company, the Directors, the Founders or any of them may have agreed with the third party.

  

	18.18	 The Banks will not be required to place or to procure that there are placed on deposit any sums of money
received by it or any of its agents for the Underwritten Units. All amounts payable to the Company under this Agreement will not be treated as client money subject to any regulations made under or pursuant to FSMA and/or the FS Act.

  
 41 

	18.19	 The obligations of each of the Banks under this Agreement are several and not joint or joint and several and no
Bank shall be liable to any other person for any failure of or default by another party to comply with its obligations hereunder or in connection with the Offer. Other than as expressly set out in this Agreement, nothing contained or implied in this
Agreement constitutes a Bank the partner, agent or representative of the other Bank for any purpose or creates any partnership, agency or trust between them and neither of them has the authority to bind the other in any way. 

 

	18.20	 Any agreement, covenant, representation, warranty or undertaking pursuant to this Agreement on the part of two
or more parties shall, save where the contrary is expressly provided, be deemed to be made on a several basis. Other than where joint action is expressly provided for, each of the Banks and the Indemnified Persons shall (except as otherwise agreed
among them) have the right to protect and enforce each of its rights without joining any of the others in any proceedings. 

  

	18.21	 Each of the Banks and each Indemnified Person shall (except as otherwise agreed among them) have the right to
protect and enforce each of its rights without joining any of the others in any proceedings. 

  

	18.22	 Any liability to a Bank, Director or the Company under this Agreement may in whole or in part be released,
compounded or compromised and time or indulgence may be given by such Bank, Director or the Company in its absolute discretion as regards any person under such liability without in any way prejudicing or affecting the rights of such Bank the Company
against any other person under the same or a similar liability, whether joint and several or otherwise. 

  

	18.23	 Any date or period specified in this Agreement may be postponed or extended by mutual agreement in writing
between the Company (for itself and on behalf of the Directors) and the Banks. Time shall be of the essence in this Agreement, both in relation to the times, dates and periods specified in it and any time, dates and period which may, by agreement in
writing between the parties, be substituted for them. 

  

	18.24	 The provisions of this Agreement are without prejudice to any liabilities which any of the parties may have
under any rule of law or equity (including, without limitation, the BVI Companies Act, FSMA, the FS Act, the Exchange Act and the Securities Act) to the extent they cannot be excluded or restricted as provided under this Agreement.

  

	18.25	 Subject to Admission, each of the Founders irrevocably and unconditionally waives for the benefit of the
Company, each of the Banks and each person who agrees to acquire Units pursuant to the Offer any failure, prior to the date of this Agreement, by any person at any time duly and properly to comply with the
pre-emption provisions of, or any provisions imposing restrictions on transfer under, the BVI Companies Act or the Memorandum and Articles of Association (or any other agreement as to pre-emption or restrictions on transfer in existence at any time to which they were party) in respect of any allotment, issue, sale or transfer of any shares of any class in the

  
 42 

	 	
capital of the Company at that or any other time and any allotment, issue, sale or transfer to be made pursuant to the Offer and each of the Founders consents to the issue and transfer of the
Units pursuant to the Offer. 

  

	18.26	 It is acknowledged that the Company has discussed with the Banks their principles for allocation, the factors
all parties believe to be relevant to the allocation of the Underwritten Units and have agreed the objectives and process for the allocation. 

  

	18.27	 The Company acknowledges and agrees that the subscription for the Units pursuant to this Agreement, including
the determination of the Offer Price and any related discounts and commissions, is an arm’s length commercial transaction between the Company, on the one hand, and each of the Banks, on the other hand. 

 

	18.28	 Any document, opinion or analysis (including any valuation analysis) provided by any Bank in connection with
the transactions contemplated by this Agreement will be solely for the use of the board of directors of the Company and the Founders and, except as required by law, applicable regulation or requirement of an applicable regulatory authority, may not
be disclosed, quoted, reproduced, summarised, described or referred to (other than to the Company’s and the Founders’ professional advisers or insurers) without the relevant Bank’s prior written consent. 

 

	18.29	 In connection with the Offer, each Bank and any of its respective Affiliates acting as an investor for its own
account may acquire Units, New Shares and/or Warrants and in that capacity may retain, purchase or sell for its own account such Units, New Shares and/or Warrants and any securities of the Company or related investments and may offer or sell such
securities or other investments otherwise than in connection with the Offer. Accordingly, references in this Agreement or the Offer Documents to the Units, New Shares and/or Warrants being issued, offered, sold or placed should be read as including
any issue, offering, sale or placement of such Units, New Shares and/or Warrants to the Banks and any relevant Affiliates acting in such capacity. The Banks do not intend to disclose the extent of any such investment or transactions otherwise than
in accordance with any legal or regulatory obligation to do so. 

  

	18.30	 The Company, each of the Directors, each of the Founder Entities and each of the Founders acknowledges that
none of the Banks or any other Indemnified Person is advising the Company or any other person as to any general financial or strategic advice or any legal, tax, investment or accounting or regulatory matters in any jurisdiction. The Company, each of
the Directors, each of the Founder Entities and each of the Founders shall consult with its own advisers concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated
hereby, and no Bank shall have any responsibility or liability to the Company, any of the Directors, any of the Founder Entities or any of the Founders with respect thereto. The Company, each of the Founder Entities and each of the Founders further
acknowledges and agrees that any review by any Banks of the Company, the Offer and other matters relating thereto will be performed solely for the benefit of the Banks and shall not be performed on behalf of the Company, any of the Founder Entities,
any of the Founders or any other person. 

  
 43 

	18.31	 Interest shall run (before and after judgment) on any sums due and payable hereunder from the due date for
payment thereof until the date of actual payment at the Agreed Rate. 

  

	18.32	 The Company, the Founder Entities and the Founders agree to indemnify each Bank against any loss incurred by
such Bank as a result of any judgment or order being given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the “Judgment Currency”) other than pounds sterling and as a result
of any variation between: (i) the rate of exchange at which the pounds sterling amount is converted into Judgment Currency for the purpose of such judgment or order; and (ii) the rate of exchange at which such Bank is able to purchase
pounds sterling, at the business day nearest the date of judgment, with the amount of the Judgment Currency actually received by the relevant Bank. The foregoing indemnity shall constitute a separate and independent obligation of the Company, the
Founder Entities and the Founders and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term “rate of exchange” shall include any premium and costs of exchange payable in connection with
the purchase of or conversions into the relevant currency. 

  

	18.33	 The Company, each of the Directors, each of the Founder Entities and each of the Founders severally
acknowledge, and agree, that the Banks may provide their services under this Agreement and earn (and retain) all fees payable under this Agreement notwithstanding the existence of material interests within the Banks and their associates and/or
Affiliates. 

  

	19	 Law and jurisdiction 

 

	19.1	 This Agreement and any non-contractual obligations arising out of or in
connection with it or its subject matter, existence, negotiation, validity, termination or enforceability (including non-contractual disputes or claims) shall be governed by and construed in accordance with
English law. 

  

	19.2	 Subject to clause 19.3, the parties irrevocably agree for the benefit of each of the Banks that the courts of
England are to have exclusive jurisdiction to hear any action or proceedings and/or settle any disputes which arise out of or in connection with this Agreement, its subject matter, existence, negotiation, validity, termination or enforceability, or
any non contractual obligations arising out of or connected with it and irrevocably submit to the jurisdiction of such courts. 

  

	19.3	 Notwithstanding the provisions of clause 19.2, in the event that any Bank or any of such Bank’s
Indemnified Persons becomes subject to proceedings relating to or in connection with this Agreement, or arising in connection with the Offer and/or Admission, brought by a third party (the Foreign Proceedings) in the courts of any country
other than England (the Foreign Jurisdiction), such Indemnified Person shall be entitled, without objection by the Company, the Directors, the Founder Entities or the Founders either: 

  
 44 

	 	(a)	 to join the Company, the Directors, the Founder Entities, the Founders and/or any other person to the Foreign
Proceedings; and/or 

  

	 	(b)	 to bring separate proceedings for any breach of this Agreement and/or for a contribution or an indemnity under
this Agreement against the Company, the Directors, the Founder Entities, the Founders, and/or any other person in the Foreign Jurisdiction, provided that such separate proceedings arise out of or are in connection with the subject matter of the
Foreign Proceedings. 

  

	19.4	 Regardless of whether the courts of any country other than England have jurisdiction to consider a dispute
falling within this clause 19, the Company irrevocably undertakes that it will neither issue nor cause to be issued originating or other process in respect to such a dispute in any jurisdiction other than England. 

 

	19.5	 The Company, the Directors, the Founder Entities and the Founders each irrevocably waive their right to raise
any objection to the jurisdiction of any courts referred to in this clause 19 on the ground of forum non conveniens, public policy or otherwise, and further irrevocably agrees that a judgment or order of any such court in connection with this
Agreement shall be conclusive and binding on it and may be enforced against it in the courts of any other jurisdiction. 

  

	19.6	 The taking of proceedings by the Banks under this clause 19 in any one or more jurisdictions will not (and will
not be construed so as to) limit the right of the Banks to bring proceedings in any other jurisdiction(s), if and to the extent permitted by law, including, without limitation, the courts having jurisdiction by reason of any other party’s
domicile. Legal proceedings by the Banks in any one or more jurisdictions shall not preclude legal proceedings by either of them in any other jurisdiction, whether by way of substantive action, ancillary relief, enforcement or otherwise.

  

	19.7	 The parties agree that the documents which commence any proceedings under this clause 19 and any other
documents required to be served in relation to such proceedings may be served on any party in accordance with clause 17. These documents may, however, be served in any other manner permitted by law. 

 

	19.8	 Each of the Company, the Directors (except Mike Tobin OBE), the Founder Entities and the Founders hereby
irrevocably authorises and appoints Law Debenture Corporate Services Limited of Fifth Floor, 100 Wood Street, London EC2V 7EX, United Kingdom to accept on its behalf service of all legal process arising out of or in connection with this Agreement.
Further, each of the Company, the Directors (except Mike Tobin OBE), the Founder Entities and the Founders agrees: 

  

	 	(a)	 to maintain an agent for service of process in England; 

  
 45 

	 	(b)	 to procure that the agent will, prior to Admission on the Closing Date, confirm in writing to the Banks its
acceptance of such appointment; 

  

	 	(c)	 that failure by Law Debenture Corporate Services Limited to notify their appointor of the process will not
invalidate the proceedings concerned; and 

  

	 	(d)	 that if this appointment is terminated for any reason, their appointer will appoint a replacement agent having
an address in England and will ensure that the new agent notifies the Banks of its acceptance of appointment within 10 Business Days of such appointment,. If any of the Company, the Founders, the Founder Entities and the Directors do not make such
an appointment within 10 Business Days of such cessation, then the Banks, acting reasonably, may do so on behalf of the Company, the Founders, the Founder Entities and the Directors and at the cost of the Company, the Founders, the Founder Entities
and the Directors and shall notify the Company, the Founders, the Founder Entities and the Directors if it does so, 

(such agent as appointed from time to time, the “Agent”) 

 

	19.9	 Each party agrees that, without preventing any other mode of service, any document in an action (including, but
not limited to, a claim form or any other document to be served under the Civil Procedure Rules) may be served on any party by being delivered to or left for that party at its address for service of notices under clause 17 or, in the case of each of
the Company, the Founders, the Founder Entities and the Directors by being delivered to the Agent. For the avoidance of doubt, all correspondence with the agent shall be delivered in accordance with clause 17. 

This Agreement has been executed by each of the parties or their duly authorised attorneys on the date stated at the beginning of this Agreement. 

  
 46 

 Schedule 1 

Liability caps 
 Part A
– Founders 
  

			
	 (1) Name
	  	 (2) Liability cap

	 William N. Thorndike, Jr.
	  	 $2,500,000

	 W. Nicholas Howley
	  	 $2,500,000

	 Tracy Britt Cool
	  	 $150,000

	 Vivek Raj
	  	 $500,000

	 Haitham Khouri
	  	 $1,850,000

 Part B – Independent Non-Founder Directors 

 

			
	 (1) Name
	  	 (2) Liability cap

	 Adam L. Hall
	  	 $75,000

	 Bram Belzberg
	  	 $75,000

	 John Staer
	  	 $75,000

	 Michael Tobin OBE
	  	 $75,000

 Part C – Founder Entities 

 

			
	 (1) Name
	  	 (2) Liability cap

	 EverArc Founders, LLC
	  	 $200,000

	 Llanerch Everarc LLC
	  	 $2,500,000

	 TVR Everarc LLC
	  	 $500,000

  
 47 

 Schedule 2 

Warranties 
 Part A
– Warranties given by the Company, the Founder Directors and (in certain cases) the Independent Non-Founder Directors 
  

	1	 Offer Documents 

 

	1.1	 Each of the Disclosure Package and the Final Prospectus (or any amendment or supplement to either of them) did
not and will not as of its date (and, if amended or supplemented, as of the date of such amendment or supplement) and will not as of the Applicable Time or the Closing Date contain any untrue, inaccurate, incomplete or misleading statement of a
material fact or omit to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. 

 

	1.2	 Each of the Offer Documents (other than the Pathfinder Prospectus and the Final Prospectus) or any amendment or
supplement to any of them did not and will not as of its date (and, if amended or supplemented, as at the date of such amendment or supplement) and will not as of the Applicable Time or the Closing Date contain any untrue, inaccurate, incomplete or
misleading statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances in which they were made, not misleading. 

 

	1.3	 Without prejudice to the generality of paragraphs 1.1 and 1.2 above, each of the Offer Documents (and any
amendment or supplement to any of them) contain, or will when published contain, all particulars and information required by (and comply with) the BVI Companies Act, FSMA, the FS Act, the CJA, the Listing Rules, the Prospectus Regulation Rules, the
Prospectus Regulation, MAR, the rules and regulations of the London Stock Exchange, the CREST Regulations and all other relevant statutes and regulations in any jurisdiction and all such information as, having regard to the matters referred to in
section 87A FSMA, investors and their professional advisers would reasonably require, and reasonably expect to find therein, for the purpose of making an informed assessment of the assets and liabilities, financial position, profits and losses, and
prospects of the Company and of the rights attaching to the New Shares and/or Warrants comprising the Units and that information is presented in a form which is comprehensible and easy to analyse. 

 

	1.4	 The Pathfinder Prospectus (other than in respect of the number of Units and information derived therefrom which
is subsequently included in the Final Prospectus), as of its date of issue (and, if amended or supplemented, as of the date of such amendment or supplement), did not contain any untrue, inaccurate, incomplete or misleading statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; and the Pathfinder Prospectus, as of its date of issue, complied with the requirements
of Prospectus Regulation Rule 3.3. 

  
 48 

	1.5	 All forecasts, estimates, elaborations of market data, expressions of opinion, intention, belief or expectation
contained in the Offer Documents (and any amendment or supplement to any of them) are, or when made, will be, truly and honestly held and have been made, or when made will be made, on reasonable grounds after due and careful consideration and
enquiry. 

  

	1.6	 There are no facts or matters known to the Warrantor omitted from any of the Offer Documents as at their
respective dates (following publication, if applicable), the omission of which would make any statement of a material fact or expression of opinion, intention or expectation contained in any of the Offer Documents misleading in any respect.

  

	1.7	 The section in the Final Prospectus entitled “Summary” is written in a clear, concise and
comprehensible manner and in non-technical language and its content (i) provides the key information that investors need in order to understand the nature and risks of the Company and of the securities
concerned and (ii) provides, in conjunction with the Final Prospectus, appropriate information about essential elements of the securities concerned, in each case in order to aid investors when considering whether to invest in such securities.

  

	1.8	 There are no matters other than those disclosed in the Final Prospectus or otherwise in writing to the FCA or
the London Stock Exchange or Euroclear (copies of such letters have been provided to each of the Banks) which the Warrantor considers should be taken into account by the FCA or the London Stock Exchange or Euroclear in considering the Applications
for Admission. 

  

	1.9	 The statements set forth in Part VII (Taxation), Part VIII (Additional Information) (under the headings
“Share Capital”, “Memorandum and Articles of Association of the Company”, “Founders Preferred Shares”, “Directors’ Letters of Appointment”, “City Code”, “Material Contracts” and
“BVI Law”), Part IX (Terms & Conditions of the Warrants), and Part XI (Depositary Interests) of the Pathfinder Prospectus and the Final Prospectus, insofar as they purport to constitute a summary of the laws and documents referred
to therein, and subject to any limitations or exclusions expressly referred to therein, are true, accurate, complete and fair in all material respects and not misleading in any material respect. 

 

	1.10	 The Company and the Directors will use the net proceeds received by the Company from the sale of the Units in
the manner and for the purpose(s) specified in the Disclosure Package and the Final Prospectus. 

  

	1.11	 Prior to the date hereof, the Company has not selected any specific Acquisition targets and the Company has
not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any prospective Acquisition targets. 

  
 49 

	1.12	 The description appearing in Part I of the Pathfinder Prospectus and the Final Prospectus (Investment
Opportunity and Strategy) does not contain any untrue statement of material fact or omit any material fact necessary to make the statements therein, in light of the circumstances under which the statements are made, not misleading and fairly
summarises (i) the process of Acquisition to be implemented by the Company, (ii) the Company’s objective in effecting an Acquisition and (ii) the type of business that the Company intends to acquire in the context of the
Acquisition. 

  

	1.13	 The statistical, industry and market related data and information included in the Offer Documents is based on,
or derived from, sources which are, so far as the Warrantor is aware, reputable and accurate industry sources and all such data and information has been accurately reproduced and, so far as the Warrantor is aware and is able to ascertain from the
relevant sources, no facts have been omitted which would render such data or information inaccurate or misleading. 

  

	1.14	 The Presentation Materials have been accurately compiled and were (as at the dates thereof or if subsequently
amended, as at the date of such amendment) true and accurate in all material respects and not misleading. The information contained in the Presentation Materials is consistent with the Pathfinder Prospectus and the Final Prospectus and there is no
material information disclosed in the Presentation Materials that is not disclosed in the Pathfinder Prospectus and the Final Prospectus. 

  

	1.15	 There has been no distribution by the Warrantor of, and prior to the Closing Date the Warrantor shall not
distribute, any offering material in connection with the offer and sale of the Units other than the Offer Documents (or any amendment or supplement to them) other than with the approval of the Banks. 

 

	2	 Verification Notes 

 

	2.1	 The Verification Notes have been read by the Directors and approved by them. The information, materials and
assertions expressed in the Verification Notes have been provided with due care and attention and in good faith and have been prepared and given by persons reasonably believed by the Warrantor to have the knowledge and responsibility to enable them
properly to provide such information, materials and assertions. 

  

	2.2	 All statements of fact in the Verification Notes are true and accurate in all material respects and none is by
itself or by omission misleading in any material respect. There are no facts which are known to any of the Directors which materially adversely affect (whether by omission or otherwise) the accuracy or completeness of any of the statements contained
in the Verification Notes. All expressions of opinion, belief, intention or expectation contained in the Verification Notes are truly and honestly held and have been made on reasonable grounds after due and careful enquiry. 

  
 50 

	3	 Disclosure 

  

	3.1	 All statements made or factual information supplied by (or on behalf of and with the knowledge of) the
Warrantor to the Banks, the FCA and/or the London Stock Exchange was when given (and remains), or when made will be, true and accurate in all material respects and not (or, when made, will not be) incomplete in any material respect or misleading and
all statements, forecasts, estimates and expressions of opinion, belief, intention and expectation so supplied were when given (and remain) fairly and honestly given, expressed or held and have been made on reasonable grounds after due and careful
consideration and enquiry and are reasonably based. There are no facts which have not been disclosed to the FCA which by their omission make any statements made misleading or which are otherwise material for disclosure to the FCA.

  

	3.2	 All information provided by or on behalf of the Company to any of the Banks in connection with their due
diligence enquiries or similar requests for information in connection with the Offer has been supplied in good faith. 

  

	3.3	 So far as the Warrantor is aware there is no information other than that contained in the Pathfinder Prospectus
and the Final Prospectus (all such matters having been disclosed with sufficient prominence) which the Company is required by MAR, the CJA, the Listing Rules, the DTRs, the Prospectus Regulation Rules, the Prospectus Regulation, FSMA or the FS Act
to publish, whether to correct a misleading impression as to the market in or the price or value of the New Shares and/or Warrants or to avoid behaviour which could constitute insider dealing, unlawful disclosure of inside information or market
manipulation under Articles 14 or 15 of MAR or the CJA or which is otherwise relevant to the London Stock Exchange or the FCA or Euroclear in considering the Applications for Admission. 

 

	3.4	 The Warrantor is not aware of any facts or circumstances now subsisting or proposed or reasonably likely to
come about which are not disclosed in the Pathfinder Prospectus and the Final Prospectus (all such matters having been disclosed with sufficient prominence) and which: 

 

	 	(a)	 would (or are likely to) lead to any obligation for the Company to make any announcement pursuant to FSMA, the
FS Act, MAR, the Prospectus Regulation Rules, the Listing Rules, the DTRs, the City Code or any other applicable law or regulation; or 

  

	 	(b)	 if made public would be expected to have a material effect on the market price of the New Shares and/or
Warrants or upon the Company. 

  

	4	 Listing 

  

	4.1	 The Company has applied for the whole of its Ordinary Share capital and all of the Warrants, issued and to be
issued under the arrangements referred to in this Agreement (including, without limitation, Ordinary Shares to be issued upon exercise of any of the Warrants), to be admitted to the Standard Segment of the Official List and to trading on the London
Stock Exchange’s main market for listed securities. 

  
 51 

	4.2	 The Company has, or will immediately prior to Admission have, satisfied all relevant conditions for listing and
other requirements of the Listing Rules, the Prospectus Regulation Rules and the Admission and Disclosure Standards. 

  

	5	 Historical Financial Information and Accountants’ Reports 

 

	5.1	 The Historical Financial Information has been prepared and presented in conformity with all relevant statements
of standard accounting practice and financial reporting standards currently in force, with the Prospectus Regulation Rules and with IFRS; and: 

  

	 	(a)	 gives a true and fair view of the state of affairs and financial condition of the Group as at the dates stated
and of its profits and/or losses, cashflows and, where relevant, recognised gains and losses or changes in equity for the periods specified; 

  

	 	(b)	 in accordance with such accounting standards and such accounting principles, makes proper provision for all
liabilities, whether actual, deferred or contingent; 

  

	 	(c)	 complies with all applicable law and regulation; and 

 

	 	(d)	 has been prepared after due and careful consideration and enquiry by the Company and on the basis of
preparation set out in Part VI (Financial Information on the Company) of the Pathfinder Prospectus and the Final Prospectus and are presented therein on the basis of the accounting policies set out in Part VI (Financial Information on the Company)
of the Pathfinder Prospectus and the Final Prospectus. 

  

	5.2	 To the extent applicable, the Historical Financial Information has been presented and prepared in a form
consistent with that which will be adopted in the Company’s next published annual financial statements having regard to accounting standards and policies and legislation applicable to such annual financial statements. 

 

	5.3	 The Company did not have at the Accounts Date any material liability (whether actual, deferred, contingent or
disputed), investment or commitment which, in accordance with generally accepted accounting principles and practice (on the basis on which the Historical Financial Information has been prepared) should have been disclosed or provided for in the
Historical Financial Information and which has not been so disclosed or provided for. 

  

	5.4	 The Company does not have any off-balance sheet arrangements,
investment or liability. 

  

	5.5	 Proper provision or, as appropriate, disclosure in accordance with generally accepted accounting principles and
practice (on the basis on which the Historical Financial Information has been prepared) has been made in the Historical Financial Information for Taxation (whether actual, deferred or contingent). 

  
 52 

	5.6	 The Reporting Accountants are independent public accountants with respect to the Company within the meaning of
the guidelines on independence issued by the Institute of Chartered Accountants in England and Wales. 

  

	5.7	 All information requested by the Reporting Accountants in connection with the preparation of the
Accountants’ Reports has been supplied to them in good faith after due and careful enquiry. All factual information supplied to the Reporting Accountants in connection with the preparation of any Accountants’ Report was when supplied and
remains true and accurate in all respects and was not (by itself or by omission) misleading in any respect and all other information (including any forecast or projection) supplied in connection with the preparation of any Accountants’ Report
was carefully prepared and given in good faith. No information has been withheld from the Reporting Accountants which might reasonably have affected the contents of the Accountants’ Reports in any respect. 

 

	5.8	 There are no facts known, or which on reasonable enquiry ought to have been known, to the Company which have
not been taken into account in the preparation of any of the Accountants’ Reports which could reasonably be expected to have a material effect on any of the information or projections contained therein. 

 

	5.9	 Save as disclosed in paragraph 11 of Part VIII of the Final Prospectus, since the date of the Company’s
incorporation, there has been no significant change in the financial or trading position of the Company and no Material Adverse Change relating to the Company or circumstances likely to lead to a Material Adverse Change relating to the Company.

  

	5.10	 Save as disclosed in paragraph 14 of Part VIII of the Final Prospectus, since the date of its incorporation the
Company has not conducted any business or traded and there have been no transactions entered into by the Company which are material in the context of the Company or the Offer. 

 

	5.11	 The Company has not, nor will it have prior to Admission, any indebtedness nor is it a party to any borrowing
facility. 

  

	5.12	 Since incorporation of the Company, there has been no dividend or distribution of any kind declared, paid or
made by the Company on any class of its share capital. 

  

	5.13	 The Company does not have any material assets. 

  
 53 

	6	 Working capital 

 

	6.1	 Taking into account the net proceeds receivable by the Company under the Offer and the subscription for Founder
Committed Units by the Founders, the working capital available to the Company is sufficient for the Company’s present requirements, that is for the next 18 months following the date of the Final Prospectus. 

 

	7	 Financial position and prospects procedures 

 

	7.1	 The Directors have established procedures which provide a reasonable basis for them to make proper judgements
on an ongoing basis as to the financial position and prospects of the Company. 

  

	7.2	 The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that:

  

	 	(a)	 transactions are executed in accordance with management’s general or specific authorisations;

  

	 	(b)	 transactions are recorded as necessary to permit preparation of returns and reports, complete and accurate in
all material respects, to regulatory bodies as and when required by them and financial statements in accordance with IFRS and applicable statutory accounting requirements (including the BVI Companies Act) and to maintain accountability for assets;

  

	 	(c)	 access to assets is permitted only in accordance with management’s general or specific authorisation; and

  

	 	(d)	 the recorded accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. 

  

	7.3	 There are no weaknesses in the Company’s internal control over financial reporting (whether or not
remedied) and no change in the Company’s internal control over financial reporting of the Company is contemplated or has occurred which has or would be reasonably likely to materially affect the Company’s internal control over financial
reporting of the Company and there has been no fraud that involves any member of management or any other employee of the Company. 

  

	8	 Corporate governance 

 

	8.1	 The Directors have reviewed the compliance of the Company with the provisions of the UK Corporate Governance
Code published by the Financial Reporting Counsel and, save as disclosed in the paragraphs headed “Strategic Decisions – Corporate governance” of Part III of the Pathfinder Prospectus and the Final Prospectus, will be in
compliance with the provisions of the UK Corporate Governance Code and have established procedures to allow the Company to comply with its provisions following Admission. 

  
 54 

	8.2	 The Directors have established procedures that, as at and from Admission, will enable the Company and the
Directors to comply with the Listing Rules, the Disclosure Requirements, the DTRs and the rules of the London Stock Exchange on an ongoing basis, in each case as applicable to the Company. 

 

	8.3	 The Company does not have an external management company as defined in the Listing Rules and the discretion of
the Directors to make strategic decisions on behalf of the Company has not been limited or transferred to another person and the Directors have the capability to act on key strategic matters in the absence of a recommendation from any other person.

  

	8.4	 There are no shadow directors of the Company. 

 

	8.5	 The statutory books, books of accounts and other records legally required to be kept by the Company are up-to-date, complete and accurate in all material respects and no notice or allegation that any of such books or records is incorrect or should be rectified has been received.
All accounts, documents and returns required by law to be delivered or made to the registrar of companies in the British Virgin Islands or any other authority have been duly and correctly delivered or made without material omission or default.

  

	9	 Related party transactions 

 

	9.1	 Save as disclosed in paragraph 15 of Part VIII of the Final Prospectus, the Company has not entered into and
will not enter into any related party transaction (within the meaning set out in IFRS or Listing Rule 11) in the period covered by the financial information contained in the Final Prospectus and up to, and including, the Closing Date.

  

	9.2	 Save as disclosed in paragraph 3.3 of Part VIII of the Final Prospectus, without prejudice to 9.1 above, there
are no loans made by the Company to, nor are there any debts owing to the Company from, any of the shareholders of the Company and/or any of the Directors of the Company and/or any associate of any of them. 

 

	10	 Tax 

  

	10.1	 Save as set out in the paragraphs headed “British Virgin Islands taxation” and “United
Kingdom taxation” of Part VII of the Pathfinder Prospectus and the Final Prospectus, and subject to any limitations or exclusions expressly referred to therein, no stamp or similar duty, SDRT, capital duty or other issue, transfer,
documentary or similar taxes or duties are payable under the laws of the United Kingdom or the British Virgin Islands by or on behalf of any person (excluding, for the avoidance of doubt, any tax payable in respect of any fees or commissions payable
pursuant to this Agreement) in connection with the execution and delivery of this Agreement, or the allotment, issue, subscription or delivery by the Company of the Units pursuant to the Offer, or the issue of the Depositary Interests.

  
 55 

	10.2	 The Company is not subject to Tax on its income, profits or gains (if any) in the British Virgin Islands and is
not, and never has been, treated as resident or having a permanent establishment in any other jurisdiction for Tax purposes (including for the purposes of any double tax arrangement or treaty). 

 

	10.3	 The Company is not liable to pay and has not incurred any liability to tax chargeable under the laws of any
jurisdiction (other than the jurisdiction of its incorporation) by virtue of having a permanent establishment or other place of business in such other jurisdiction. 

 

	10.4	 No register of Shares, Founder Shares, Warrants or Depository Interests is kept by or on behalf of the Company
outside the British Virgin Islands, and none of the New Shares and/or Warrants are “paired” (within the meaning given in section 99 of the Finance Act 1986) with any shares issued by a body corporate incorporated in the United Kingdom.

  

	10.5	 The Company is, to the extent required, registered for the purposes of VAT and has complied with the terms of
legislation relating to VAT. 

  

	10.6	 The Company is not nor has it been treated as a member of a group for the purposes of VAT legislation with any
company and has not applied for such treatment. 

  

	10.7	 Since incorporation: 

 

	 	(a)	 the Company has not incurred any liability to Tax other than Tax in respect of normal trading income or
receipts arising from transactions entered into by it in the ordinary course of business; and 

  

	 	(b)	 no disposal has taken place which has had the effect of crystallising a liability to Tax.

  

	10.8	 Since incorporation the Company has not incurred any liability to tax on its income, profits or gains (if any);
and the Company has not done anything which, to the best of the Warrantor’s knowledge, would cause the Company to become liable to Tax on its income, profits or gains. 

 

	10.9	 Since incorporation the Company has not paid or become liable to pay, and there are no circumstances by reason
of which it is likely to become liable to pay, to any Tax Authority any penalty, fine, surcharge or interest in respect of Tax (including, without limitation, in respect of any failure to make any return, give any notice or supply any information to
any relevant Tax Authority, or any failure to pay Tax on the due date for payment). 

  

	10.10	 All transactions between the Company and any third party have been and are on fully arm’s length terms. To
the best of the Warrantor’s knowledge, there are no circumstances in existence which may cause any Tax Authority to make any adjustment for Tax purposes to the terms on which 

  
 56 

	 	
any transaction between the Company and any third party is treated as taking place and no such adjustment has been made or asserted against the Company in writing by any Tax Authority, where in
either case the Company may or will incur any liability (or increase in liability) to Tax as a result of such adjustment. 

  

	10.11	 All material information, returns, computations and notices of the Company for Taxation purposes have been made
for all purposes up to and including the date hereof within the requisite period and on a proper basis and all such information, returns, computations and notices are
up-to-date and correct and, so far as the Warrantor is aware, are not, nor are likely to be, the subject of any dispute involving the Company, or claim against the
Company, by any Tax Authority. 

  

	11	 Insolvency 

  

	11.1	 The Company: 

  

	 	(a)	 is, and immediately after the Closing Date will be, solvent as such term is understood under the laws of the
British Virgin Islands and it will not be unable to pay its debts within the meaning of section 123 of the Insolvency Act 1986 or any analogous law or regulation; 

 

	 	(b)	 has not had a controller appointed or is in liquidation, in provisional liquidation, under administration or is
being wound up or has had a receiver appointed to any part of its property; 

  

	 	(c)	 is not subject to any arrangement, assignment, moratorium or composition, protected from creditors under any
statute or being dissolved (in each case, other than to carry out a reconstruction or amalgamation while solvent on terms approved by the other parties to this Agreement); 

 

	 	(d)	 has not had an application or order made (and in the case of an application, which has not been stayed,
withdrawn or dismissed within 30 days), resolution passed, proposal put forward, or any other action taken which is preparatory to or could result in the events described in paragraphs (a) to (c) above; 

 

	 	(e)	 is otherwise able to pay its debts when they fall due; and 

 

	 	(f)	 is not subject to any other proceedings with a substantially similar effect to (a) to (d) under the law of
any jurisdiction. 

  

	11.2	 The Company has not taken any action (including, but not limited to, the convening of meetings to vote on
relevant resolutions), nor have any other steps been taken or legal proceedings commenced or been threatened against the Company for its winding-up or dissolution or for any similar or analogous proceeding in
any jurisdiction or for the Company to enter into any arrangement or composition for the benefit of creditors or for the appointment of a receiver, administrator, provisional liquidator or similar officer. 

  
 57 

	11.3	 There is not outstanding any liability, obligation or commitment of any kind on the part of the Directors or
the Company in relation to any current or pending insolvency proceedings in relation to the Company. 

  

	12	 Litigation 

  

	12.1	 Neither the Company nor any Director, nor any other person for whom the Company is or may be vicariously
liable, has currently or during the 12 months preceding the date of the Final Prospectus any claim against them or is or has been engaged in any litigation or arbitration, prosecution, claim, action, suit or other proceedings or governmental,
regulatory or official investigation or inquiry which is (singly or in the aggregate) material and no such litigation, arbitration, prosecution, claim, action, suit or other proceedings or governmental or official investigation or inquiry are
pending or, so far as the Warrantor is aware, threatened nor are there any circumstances which are likely to give rise to any of the same. 

  

	12.2	 The Company, nor any of its officers or agents or employees in relation to the affairs of the Company has been
a party to any undertaking or assurance given to any court or government agency or the subject of any injunction which is still in force. 

  

	13	 Insurance and indemnification 

 

	13.1	 At Admission, the Company will have directors and officers insurance in place at levels considered by the
Directors, acting reasonably and in good faith, to be adequate. 

  

	13.2	 Each of the Directors has the benefit of an indemnity provided by the Company indemnifying the Director against
liabilities incurred in his office as director, in terms that are in accordance with the BVI Companies Act. 

  

	13.3	 The Company maintains, from well-established and reputable insurers, insurance of the type and in amounts
reasonably considered by the Company and the Directors to be adequate for their business and, to the best of the Warrantor’s knowledge, consistent with insurance coverage maintained by companies carrying on similar businesses or owning assets
of a similar nature. No claim under any policy of insurance taken out in connection with the business or assets of the Company which is material is outstanding and there are no current circumstances likely to give rise to such a claim. Such
insurances are in full force and effect and there exist no circumstances which could render any of such insurances void or voidable. 

  

	14	 Employment 

  

	14.1	 The Company does not have any employees. 

  
 58 

	14.2	 The Directors have each been duly appointed in such capacity and hold their offices in accordance with
applicable law. 

  

	14.3	 No Director has since the Accounts Date given notice nor, so far as the Warrantor is aware, is intending to
give notice terminating their contract of employment or engagement or is under notice of dismissal or termination. 

  

	14.4	 Save as set out in paragraphs 4.2(o)(i) and 9 of Part VIII of the Pathfinder Prospectus and the Final
Prospectus, Admission will not entitle any director, officer, employee or worker of the Company to receive or to exercise any right to any payment or other benefit from the Company. 

 

	14.5	 The Company is in compliance with all applicable employment laws and regulations. 

 

	14.6	 The Company has not put in place any pension scheme and there are no liabilities associated with or arising
from the Company participating in, or contributing to, either currently or in the past, any retirement benefits scheme or arrangement (occupational or personal). 

 

	15	 Licences and other legal requirements 

 

	15.1	 The Company holds or (as applicable) has made all authorisations, orders, filings, registrations,
notifications, permits, certificates, qualifications, licences, permissions, authorisations, approvals, concessions, clearances and consents (each an Authorisation) required for the carrying on of its business or for the execution and
performance of its obligations under this Agreement and any other agreements to be entered into by it in connection with the Offer or for the making of the Offer and such Authorisations are in full force and effect (or will be in full force and
effect prior to Admission) and there are no circumstances which indicate that any of such Authorisations may be revoked, modified, suspended, not granted, withdrawn or not renewed, in whole or in part, and the Company has complied with all such
Authorisations and all legal, regulatory and other requirements which are applicable to its business save to the extent that would not (singly or in the aggregate) be material. 

 

	16	 Business practices 

 

	16.1	 Neither the Company nor any of its Subsidiaries nor any of its or their respective directors or officers nor,
to the Company’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives is aware of or has taken any action, directly or indirectly, that could result in a violation by such persons of any
Anti-Corruption Laws, and the Company and its Subsidiaries and its and their respective directors, officers and, to the Company’s best knowledge, employees, Affiliates, agents or representatives have conducted their business in accordance with
Anti-Corruption Laws. 

  

	16.2	 Neither the Company nor any of its Subsidiaries nor any of its or their respective directors or officers nor,
to the Company’s best knowledge, any of its or their respective employees, Affiliates, 

  
 59 

	 	
agents or representatives are the subject of any investigation, inquiry, claim or enforcement proceedings regarding any offence or alleged offence under any Anti-Corruption Laws by any authority
responsible for investigating potential violations of or otherwise enforcing Anti- Corruption Laws, and no such investigation, inquiry, claim or enforcement proceedings is threatened or, so far as the Company and Directors are aware, pending.

  

	16.3	 The Company has in place policies, procedures and systems designed to ensure (and which are reasonably expected
to continue to ensure) compliance by the Company and its Subsidiaries and its and their respective directors, officers, employees, Affiliates, agents and representatives with applicable Anti-Corruption Laws (Adequate Procedures). Neither the
Company nor the Directors are aware of any violation by the Company or any of its Subsidiaries or any of its or their respective directors, officers, employees, Affiliates, agents or representatives of the Adequate Procedures. 

 

	16.4	 Neither the Company nor any of its Subsidiaries nor any of its or their respective directors or officers nor,
to the Company’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives is, or is owned or controlled by individuals or entities (for the purposes of this paragraph 16, Persons) that are:

  

	 	(a)	 the subject or the target of any Sanctions Laws and Regulations; or 

 

	 	(b)	 located, organised or resident in a country or territory that is the subject of Sanctions Laws and Regulations
(including, without limitation, Crimea, Cuba, Iran, Libya, North Korea, Syria, Russia and Venezuela) (a “Sanctioned Country”). 

  

	16.5	 Neither the Company, its Subsidiaries nor any of its associates or Associated Persons will, directly or
indirectly, use the proceeds received from the Offer, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: (a) to fund any activities or business of or with any Person, or in
any country or territory that, at the time of such funding, is the subject or the target of Sanctions Laws and Regulations; or (b) in any other manner that would result in a violation of Sanctions Laws and Regulations by any Person (including
any person participating in the Offer, whether as underwriter, adviser, investor or otherwise). 

  

	16.6	 There have been no transactions or arrangements between the Company or any of its Subsidiaries or any of its or
their respective directors or officers or, to the Company’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives: (i) with any Person who is the target of Sanctions Laws and Regulations and/or
(ii) or with any person or entity in a Sanctioned Country or which performs contracts in support of projects in or for the benefit of Sanctioned Countries. 

 

	16.7	 The operations of the Company and its Subsidiaries are and have been conducted at all times in material
compliance with, and the Company’s and its Subsidiaries’ respective directors or officers and, to the Company’s best knowledge, its and their respective employees, Affiliates, agents or representatives have complied with, the
applicable money laundering statutes of all jurisdictions 

  
 60 

	 	
in which it or they conduct their operations, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency in such jurisdictions (collectively, the Money Laundering Laws) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or its
Subsidiaries, or any of its or their respective directors or officers or, to the Company’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives or other persons associated with or acting on behalf of
the Company with respect to the Money Laundering Laws is pending or, so far as the Company and Directors are aware, threatened. 

  

	17	 Contracts 

  

	17.1	 Save as disclosed in paragraph 14 of Part VIII (Additional Information) of the Final Prospectus under the
heading “Material contracts”, since its incorporation the Company has not entered into: (a) any material contract outside the ordinary course of its business; or (b) any contract or commitment outside the ordinary course of its
business which contains any provision under which the Company has any entitlement or obligation which is material to the Company as of the date hereof; or (c) any contract or commitment of an unusual or onerous nature which, in the context of
the issue and sale of the New Shares or Warrants, might be material to the conduct of the business of the Company. 

  

	17.2	 Each of the material contracts (being the contracts disclosed in paragraph 14 of Part VIII (Additional
Information) of the Final Prospectus under the heading “Material contracts” (the “Material Contracts”) has been duly authorised, executed and delivered by the Company and constitutes a valid, subsisting and legally binding
agreement, enforceable in accordance with its respective terms except that such enforceability may be limited by applicable bankruptcy, insolvency, reorganisation, moratorium or other similar laws affecting the enforcement of creditors’ rights
generally and general principles of equity. 

  

	17.3	 The summary of the Material Contracts contained in the Final Prospectus is accurate and complete in all
material respects and not misleading. 

  

	18	 Intellectual property 

 

	18.1	 The Company (i) owns or otherwise has the right to use its corporate name, adequate trademarks, trade
names, domain names, licences and inventions, know-how, patents, copyrights and/or other intellectual property (collectively, intellectual property) necessary to conduct its business as described in the
Offer Documents, and (ii) has not received any notice of, nor is aware of any circumstances which may lead to a notice of, any infringement or of conflict with asserted rights of others with respect to any of its intellectual property rights.

  
 61 

	19	 Properties 

  

	19.1	 The Company does not own or lease, and has not at any time owned or leased any real property.

  

	20	 Share capital and Warrants 

 

	20.1	 Save for the Founder Shares and the Warrants, there are in force no options or other agreements which call for
the issue of, or afford to any person the right to call for the issue of, any shares or other securities (including any loan capital) of the Company. 

  

	20.2	 No holder of Ordinary Shares, Founder Shares or Warrants will, after Admission, have any rights, in their
capacity as such, in relation to the Company other than as set out in the Memorandum and Articles of Association of the Company and the Warrant Instrument (as appropriate). 

 

	20.3	 On Admission, the issued and to be issued share capital (including, without limitation, upon exercise of any of
the Warrants) of the Company will be as described in the Final Prospectus. 

  

	20.4	 The Depositary Interests are eligible for admission to, and will be freely transferable in, CREST and the terms
of issue of the Depositary Interests and the Articles of Association comply with all the requirements of Euroclear, the CREST Regulations, the Depositary Agreement and the Depositary Interest Deed Poll. The Depositary Interests do not contravene the
laws of the British Virgin Islands and will, when issued, be freely convertible into Shares or Warrants (as applicable). The holders of Depositary Interests will, on issue of the Depositary Interests, benefit from all the rights attaching to the
Shares or Warrants (as applicable), including voting rights and, in the case of Shares, dividends and participation in corporate actions. 

  

	20.5	 The issued and to be issued share capital (including, without limitation, the New Shares, any Ordinary Shares
to be issued upon exercise of any of the Warrants and the Founder Shares) of the Company has been (or will be, once issued) duly and validly authorised (if so required) and issued, has been (or will be, once issued) issued fully paid and not subject
to any call for the payment of further capital or otherwise assessable and is (or will be, once issued) free of all pre-emptive rights or other material rights or restrictions. 

 

	20.6	 All of the Warrants, when issued, will be duly and validly authorised and issued and are not, or when issued
will not be, subject to calls for further payment or otherwise assessable. 

  

	20.7	 The holders of outstanding shares in the capital of the Company do not have (and the allotment, issue and sale
of the New Shares, the Warrants and/or any Ordinary Shares to be issued upon exercise of any of the Warrants is not subject to) any pre-emptive or similar rights. 

 

	20.8	 The New Shares and the Warrants are freely issuable by the Company to or for the account of the initial
subscribers therefor or allottees thereof and, upon issue, the New Shares and the Warrants will be free from all Encumbrances and the New Shares will rank pari passu in all respects with and be identical to all other Ordinary Shares.

  
 62 

	20.9	 Except as provided for in Schedule 3 to this Agreement, as described in section 4 of Part VIII of the
Pathfinder Prospectus and the Final Prospectus, as set out in the Memorandum and Articles of Association or as required by applicable law, there are (and, immediately following Admission, will be) no restrictions upon: 

 

	 	(a)	 the voting or transfer of the Ordinary Shares or upon the declaration or payment of any dividend or
distribution thereof; and/or 

  

	 	(b)	 the transfer of the Warrants. 

 

	20.10	 The Offer, the New Shares and the Warrants conform to the respective descriptions thereof contained in the
Final Prospectus. 

  

	20.11	 Assuming subscription and payment therefor in accordance with their terms and conditions as described in the
Pathfinder Prospectus and the Final Prospectus, the Ordinary Shares to be issued upon exercise of the Warrants will be validly issued and paid and the rights attached thereto shall conform to the description contained in the Pathfinder Prospectus
and Final Prospectus. The Ordinary Shares to be issued upon exercise of the Warrants will rank pari passu with the outstanding Ordinary Shares of the Company as at the date of their issuance. 

 

	21	 Capacity 

  

	21.1	 The Company has been duly incorporated and is validly existing as a limited liability company under the laws of
the BVI with registered number 2025707. 

  

	21.2	 The Company has full power and authority under its constitutional documents and otherwise to own, lease and
operate its properties and to conduct its business as described in the Pathfinder Prospectus and the Final Prospectus and to enter into and perform its obligations pursuant to the Offer, this Agreement and any other agreement to be entered into by
it in connection with the Offer and to enter into and consummate all transactions in connection therewith. 

  

	21.3	 The Company has power under its Memorandum and Articles of Association and resolutions passed at general
meeting to (i) create, allot and issue the New Shares and/or Warrants comprising the Units, (ii) create, allot and issue the Founder Shares, (iii) effect the Offer in the manner proposed, (iv) pay the commissions, fees and
expenses provided for in this Agreement and (v) enter into and perform this Agreement and any other agreements to be entered into by it in connection with the Offer, without any sanction or consent by members of the Company or any class of
them. 

  
 63 

	21.4	 All other authorisations, approvals, consents and licences required by the Company in order to (i) create,
allot and issue the New Shares and/or Warrants comprising the Units, (ii) create, allot and issue the Founder Shares, (iii) effect the Offer in the manner proposed, (iv) pay the commissions, fees and expenses provided for in this
Agreement and (v) enter into and perform this Agreement and any other agreements to be entered into by it in connection with the Offer, have been obtained and remain in full force and effect. 

 

	21.5	 (i) The Company is not, and (ii) the making of the Offer, the allotment, issue and sale of the New Shares
and Warrants (and the Depositary Interests in respect thereof), the distribution of the Offer Documents and any other documents in connection with the Offer and Admission, the execution, delivery and performance by the Company of this Agreement will
not result: 

  

	 	(a)	 in violation of its Memorandum and Articles of Association or other governing or constitutional documents
(which are in full force and effect on Admission), the violation of any of which would, singly or in aggregate, be material; or 

  

	 	(b)	 in breach or default in the performance or observance of any obligation, agreement, covenant or condition
contained in any contract, any document of title or in any bond, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company is a party or by which the Company may be bound, or to
which any of their properties or assets is subject, the breach or default of any of which, singly or in aggregate, would be material and the Company is not aware of any circumstances likely to give rise to such a breach or default; or

  

	 	(c)	 in violation of any applicable law, statute, rule, licence regulation, judgment, order, writ, claim form or
decree of any government, government instrumentality or court having jurisdiction over the Company or any of their assets or properties, the violation of any of which would, singly or in aggregate, be material. 

 

	21.6	 This Agreement and each agreement to be entered into by the Company in connection with the Offer has been duly
authorised, executed and delivered by the Company and all such agreements constitute valid and legally binding obligations, enforceable against the Company in accordance with their terms. 

 

	22	 No subsidiary undertakings 

 

	22.1	 The Company does not have any subsidiaries, subsidiary undertakings or associates nor holds any interests in
any types of security in any third party company or other legal entity. 

  

	23	 Conflicts of interest 

 

	23.1	 The paragraphs headed “Conflicts of interest” in Part II of the Pathfinder Prospectus and the
Final Prospectus contain an accurate summary of the procedures agreed between the Company, each of the Founders, EverArc Founders and the Independent Non-Founder Directors relating to conflicts of interest.

  
 64 

	24	 Compliance with securities laws 

 

	24.1	 The Offer and the issue of the Offer Documents in the manner contemplated by this Agreement will comply with
the BVI Companies Act, FSMA, the FS Act, MAR, the Prospectus Regulation Rules, the Listing Rules, the DTRs, the rules and regulations of the London Stock Exchange and all other applicable laws, rules and regulations of the United Kingdom and
elsewhere. 

  

	24.2	 The Company has not, directly or indirectly in relation to the Offer or otherwise to the extent it is material,
done any act or engaged in any course of conduct in breach of section 89, section 90 or section 91 FS Act or constituting insider dealing, unlawful disclosure of inside information or market manipulation under Articles 14 or 15 of MAR, in each case
including any regulations made pursuant thereto, or the equivalent provisions under the securities laws applicable in any other relevant jurisdiction nor, so far as the Warrantor is aware, has any person acting on behalf of the Company (other than
the Banks, as to whom no representation is made) done any act or engaged in any course of conduct as described above. 

  

	24.3	 None of the Warrantors, nor the Company nor any person acting on its or their behalf (other than the Banks, as
to whom no representation is made) has made, directly or indirectly, offers or sales of any securities, or has solicited offers to buy, or otherwise has negotiated in respect of, any security in circumstances that would require the registration of
the New Shares, the Warrants or the Founder Shares under the Securities Act. 

  

	24.4	 Subject to compliance by the Banks with the undertakings, representations and warranties set out in Schedule 4,
no registration of the New Shares, the Warrants or the Founder Shares under the Securities Act is required in connection with: 

  

	 	(a)	 the offer, allotment, issue and delivery of the New Shares or the Warrants to the Banks or to subscribers or
purchasers procured by the Banks, or the offer and re-sale by the Banks of the New Shares or the Warrants; or 

  

	 	(b)	 the offer, allotment, issue and delivery of the New Shares or the Warrants to the Founders, as applicable in
the manner contemplated in this Agreement and the Offer Documents. 

  

	24.5	 Save as described in the paragraphs headed “Registration Rights” in Part II of the Pathfinder
Prospectus and the Final Prospectus, there are no persons, so far as the Warrantor is aware, with registration rights or similar rights to have any New Shares, any Warrants or any Founder Shares or securities of the same or similar class as the New
Shares, the Warrants or the Founder Shares registered by the Company under the Securities Act or otherwise. 

  
 65 

	24.6	 None of the Warrantors, nor the Company nor any person acting on its or their behalf (other than the Banks, as
to whom no representation is made) has taken, directly or indirectly, any action designed to cause or result in, or that has constituted or which might reasonably be expected to cause or result in, the stabilisation in violation of applicable laws
or manipulation of the price of any security of the Company to facilitate the sale or resale of the New Shares, the Warrants or the Founder Shares. 

  

	24.7	 The Company is not, nor will it be as a result of the offer and sale of the New Shares, the Warrants or the
Founder Shares contemplated in this Agreement and the application of the proceeds thereof, an “investment company” as such term is defined in the Investment Company Act. 

 

	24.8	 The Company is not a “passive foreign investment company” (PFIC) within the meaning of
Section 1297 of the US Internal Revenue Code of 1986, as amended, and the Company does not expect to become, as a result of the receipt and application of the proceeds of the Offer, a passive foreign investment company. 

 

	24.9	 The Company is a “foreign issuer” (as such term is defined in Regulation S) which reasonably believes
that there is no “substantial US market interest” (as such term is defined in Regulation S) in its equity securities or in any securities of the same class as the New Shares, the Warrants or the Founder Shares. 

 

	24.10	 None of the Warrantors, nor the Company nor any person acting on its or their behalf (other than the Banks, as
to whom no representation is made) has engaged, directly or indirectly, in any directed selling efforts with respect to the offer and sale of the New Shares, the Warrants or the Founder Shares. 

 

	24.11	 None of the Warrantors, nor the Company nor any person acting on its or their behalf (other than the Banks, as
to whom no representation is made) has engaged, directly or indirectly, in any form of general solicitation or general advertising in connection with any offer or sale of the New Shares, the Warrants or the Founder Shares in the United States.

  

	24.12	 None of the Warrantors, nor the Company nor any person acting on its or their behalf (other than the Banks, as
to whom no representation is made) has distributed any offering material in connection with the Offer (including a website posting that is accessible by residents of the United States) other than the Pathfinder Prospectus, the Disclosure Package and
the Final Prospectus (and any amendment or supplement to any of them) or other materials, if any, permitted by the Securities Act and approved by the Banks. 

  

	24.13	 None of the New Shares, the Warrants or the Founder Shares are, or will be at the Closing Date, of the same
class (within the meaning of Rule 144A(d)(3)(i) under the Securities Act) as securities listed on a national securities exchange registered under Section 6 of the Exchange Act, or quoted in a US automated inter-dealer quotation system.

  
 66 

	24.14	 The Final Prospectus contains all the information that, if requested by a prospective purchaser of New Shares,
the Warrants or the Founder Shares, would be required to be provided to such prospective purchaser by Rule 144A(d)(4) under the Securities Act. 

  

	24.15	 The Company has not entered into any contractual arrangement relating to the offer, sale, distribution or
delivery of any New Shares, any Warrants or any Founder Shares other than this Agreement and the other arrangements described in the Pathfinder Prospectus and the Final Prospectus. 

 

	24.16	 The Company will take reasonable precautions designed to ensure that any offer or sale, direct or indirect, in
the United States of any New Shares or any Warrants or any substantially similar securities issued by the Company, within six months subsequent to the date on which the distribution of the New Shares and the Warrants is expected to be completed, is
made under restrictions and other circumstances reasonably designed not to affect the status of the offer and sale of the New Shares and the Warrants in the United States contemplated by this Agreement as transactions exempt from the registration
provisions of the Securities Act. 

  

	25	 Non-investment fund status 

 

	25.1	 The Company is not an alternative investment fund within the meaning of AIFMD. 

 

	25.2	 There is no requirement under applicable law for the Company to be authorised as an “Alternative
Investment Fund” or “Alternative Investment Fund Manager” under AIFMD. 

  
 67 

 Part B – Warranties given by the Directors 

 

	1	 Information relating to the Warrantor 

 

	1.1	 The Banks have been furnished in writing with all information relating to the Warrantor that might reasonably
be considered material in connection with the offer or the Applications for Admission or for disclosure in the Offer Documents or any of them and all such information is true and accurate in all material respects and not misleading and no
information has been omitted from such information which might make such information untrue, inaccurate in all material respects or misleading. 

  

	1.2	 All information contained or referred to in the Director’s Questionnaire completed by the Warrantor was
when given, and remains, true, accurate and complete and not misleading either by omission or misstatement and such Director’s Questionnaire contains all relevant material information relating to the Warrantor. 

 

	1.3	 The statements of fact included in (or to be included in) any of the Offer Documents (and any amendment or
supplement to any of them) insofar as they relate or refer to the Warrantor are (or, when made, will be) fairly presented and do not and will not, as of their respective dates, as at the Applicable Time, as at the date of the Final Prospectus, as at
the date of any Supplementary Prospectus and as at the Closing Date, contain any untrue or inaccurate statement of a material fact or omit to state any fact necessary in order to make the statements therein, in light of the circumstances in which
they are made (or will be made) not misleading. Any expressions of opinion, intention, belief or expectation contained in such documents (insofar as they relate or refer to the Warrantor) are (or when made will be) truly and honestly held and have
been (or will be) made on reasonable grounds after due and careful consideration and enquiry. 

  

	1.4	 The Warrantor has had explained to him by the Company’s Counsel, and fully understands, his
responsibilities and obligations as a director of a listed company, including under the Listing Rules, the DTRs, the Prospectus Regulation Rules, MAR, FSMA, the FS Act and the BVI Companies Act. The Directors have established procedures that enable
the Company to comply with the foregoing legal, regulatory and other requirements on an ongoing basis. 

  

	1.5	 The information contained in the Director’s Responsibility Statement is complete and accurate in all
respects and not misleading in any respect and the Warrantor has read and approved the contents of the Final Prospectus. 

  

	2	 Capacity 

  

	2.1	 The Warrantor has full power and authority to enter into and perform his obligations pursuant to this
Agreement, the relevant Insider Letter and the other agreements to be entered into by him in connection with the Offer, each of which constitutes a valid and legally binding agreement enforceable against him in accordance with its terms.

  
 68 

	2.2	 The Warrantor has duly authorised, executed and delivered this Agreement, the relevant Insider Letter and the
other agreements to be entered into by him in connection with the Offer and all such agreements constitute valid and legally binding obligations, enforceable against the Warrantor in accordance with their terms. 

 

	2.3	 The execution and delivery by the Warrantor of this Agreement, the relevant Insider Letter and the other
agreements to be entered into by it in connection with the Offer and the performance of the obligations of the Warrantor hereunder and thereunder, the distribution of the Offer Documents, the offer, sale and delivery of the New Shares and/or
Warrants comprising the Units and the consummation by it of the transactions contemplated by the Offer Documents will not conflict with or result in a breach of any terms or provisions of, or constitute a default or event of default (however
described) under, or result in the creation or imposition of any lien, charge or encumbrance on any property or assets under, any document, agreement or instrument to which the Warrantor is a party or by which the Warrantor is bound or to which any
of its properties may be subject or infringe any restrictions or the terms of any contract, obligation or commitment of the Warrantor or infringe or violate any applicable law, rule, regulation, judgment, order, authorisation or decree of any
government, governmental body or court, domestic or foreign, having jurisdiction over the Warrantor or any of its properties. 

  

	3	 Established procedures 

 

	3.1	 The Directors have established procedures which provide a reasonable basis for them to make proper judgements
on an ongoing basis as to the financial position and prospects of the Company and which will, from Admission, enable the Company to comply with the Listing Rules, MAR and the DTRs on an ongoing basis. 

 

	4	 Securities laws 

 

	4.1	 The Warrantor is an “accredited investor” as defined in Rule 501(a) under the Securities Act and
understands that the Units have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement of the Securities Act.

  

	4.2	 Neither the Warrantor nor any person acting on their behalf (other than the Banks, as to whom no representation
is made) has engaged, directly or indirectly, in any directed selling efforts with respect to the offer and sale of the New Shares, the Warrants or the Founder Shares. 

 

	4.3	 Neither the Warrantor nor any person acting on their behalf (other than the Banks, as to whom no representation
is made) has engaged, directly or indirectly, in any form of general solicitation or general advertising in connection with any offer or sale of the New Shares, the Warrants or Founder Shares in the United States. 

  
 69 

 Part C – Warranties given by the Founders and the Founder Entities 

 

	1	 Capacity 

  

	1.1	 The Warrantor has full power and authority to enter into and perform its obligations pursuant to this
Agreement, the relevant Founder Insider Letter and, as applicable, the other agreements to be entered into by it in connection with the Offer. 

  

	1.2	 The Warrantor has duly authorised, executed and delivered this Agreement, the relevant Founder Insider Letter
and, as applicable, the other agreements to be entered into by it in connection with the Offer and all such agreements constitute valid and legally binding obligations, enforceable against the Warrantor in accordance with their terms.

  

	1.3	 The Warrantor is a company with limited liability, duly incorporated, validly existing and, insofar as such
concept exists in the jurisdiction in which it is incorporated, in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority under its constitutional documents and otherwise to enter into and perform
its obligations pursuant to the Offer and this Agreement and to enter into and consummate all transactions in connection therewith. 

  

	1.4	 The Warrantor has not taken any action, nor have any other steps been taken or legal proceedings commenced or,
so far as it is aware, threatened against it for its winding up, dissolution or bankruptcy (to the extent that such procedure is applicable to such Warrantor) or for any similar of analogous proceeding in any jurisdiction, or for it to enter into
any arrangement or composition for the benefit of creditors, or for the appointment of a receiver, administrative receiver, trustee or similar officer. 

  

	1.5	 The execution and delivery by the Warrantor of this Agreement, the relevant Founder Insider Letter and the
other agreements to be entered into by it in connection with the Offer and the performance of the obligations of the Warrantor hereunder and thereunder, the distribution of the Offer Documents and the consummation by it of the transactions
contemplated by the Offer Documents will not conflict with or result in a breach of any terms or provisions of, or constitute a default or event of default (however described) under, or result in the creation or imposition of any lien, charge or
encumbrance on any property or assets under, any document, agreement or instrument to which the Warrantor is a party or by which the Warrantor is bound or to which any of its properties may be subject or infringe any restrictions or the terms of any
contract, obligation or commitment of the Warrantor or infringe or violate any applicable law, rule, regulation, judgment, order, authorisation or decree of any government, governmental body or court, domestic or foreign, having jurisdiction over
the Warrantor or any of its properties. 

  
 70 

	2	 Offer Documents 

 

	2.1	 The statements of fact (including, without limitation and for the avoidance of doubt, (i) any statements
regarding the Warrantor’s management expertise and track record and (ii) any expressions of opinion, intention or expectation) included in (or to be included in) any of the Offer Documents (and any amendment or supplement to any of them)
insofar as they refer to the Warrantor are (or when made, will be) fairly presented and do not and will not, as of their respective dates, as at the Applicable Time or as at the Closing Date, contain any untrue or inaccurate or incomplete statement
of a material fact or omit to state any fact necessary in order to make the statements therein, in light of the circumstances under which they are made (or will be made), not misleading and, in the case of any expressions of opinion, intention or
expectation contained in such documents are truly and honestly held and have been made on reasonable grounds after due and careful consideration and enquiry. 

  

	2.2	 Each of the Banks has been furnished in writing with all information relating to the Warrantor that might
reasonably be considered material for disclosure in the Offer Documents or any of them. All such information is true and accurate and not misleading and no information has been omitted from such information which might make such information untrue,
inaccurate or misleading. 

  

	3	 Securities laws 

 

	3.1	 The Company has not, directly or indirectly in relation to the Offer or otherwise to the extent it is material,
done any act or engaged in any course of conduct in breach of section 89, section 90 or section 91 FS Act or constituting insider dealing, unlawful disclosure of inside information or market manipulation under Articles 14 or 15 of MAR, in each case
including any regulations made pursuant thereto, or the equivalent provisions under the securities laws applicable in any other relevant jurisdiction nor, so far as the Warrantor is aware, has any person acting on behalf of the Company (other than
the Banks, as to whom no representation is made) done any act or engaged in any course of conduct as described above. 

  

	3.2	 Neither the Warrantor nor any person acting on their behalf (other than the Banks, as to whom no representation
is made) has engaged, directly or indirectly, in any directed selling efforts with respect to the offer and sale of the New Shares, the Warrants or the Founder Shares. 

 

	3.3	 Neither the Warrantor nor any person acting on their behalf (other than the Banks, as to whom no representation
is made) has engaged, directly or indirectly, in any form of general solicitation or general advertising in connection with any offer or sale of the New Shares, the Warrants or Founder Shares in the United States. 

 

	3.4	 Each of the Founders and the Founder Entities is an “accredited investor” as defined in Rule 501(a)
under the Securities Act and understands that the Units have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration
requirement of the Securities Act. 

  
 71 

	4	 No action to prejudice listing 

 

	4.1	 The Warrantor has not taken and will not take any action following the date hereof which may reasonably be
expected to prejudice the Applications for Admission or otherwise result in Admission not becoming effective. 

  

	5	 Non-public facts or circumstances 

 

	5.1	 The Warrantor is not aware of any non-public fact or circumstance
(excluding, for the avoidance of doubt, any fact or circumstance disclosed in the Disclosure Package and the Final Prospectus) that, if made public, would be expected to have a material effect upon the market price of the Ordinary Shares or upon the
Company or which would require it to make a public announcement under applicable law and regulations. 

  

	6	 Business practices 

 

	6.1	 Neither the Warrantor nor, where the Warrantor is a corporate entity, any of its Subsidiaries nor any of its or
their respective directors or officers nor, to the Warrantor’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives is aware of or has taken any action, directly or indirectly, that could result in a
violation by such persons of any Anti- Corruption Laws, and the Warrantor and, where the Warrantor is a corporate entity, its Subsidiaries and its and their respective directors, officers and, to the Warrantor’s best knowledge, employees,
Affiliates, agents or representatives have conducted their business in accordance with Anti-Corruption Laws. 

  

	6.2	 Neither the Warrantor nor, where the Warrantor is a corporate entity, any of its nor any of its Subsidiaries
nor any of its or their respective directors or officers nor, to the Warrantor’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives are the subject of any investigation, inquiry, claim or enforcement
proceedings regarding any offence or alleged offence under any Anti-Corruption Laws by any authority responsible for investigating potential violations of or otherwise enforcing Anti-Corruption Laws, and no such investigation, inquiry, claim or
enforcement proceedings is threatened or, so far as the Warrantor is aware, pending. 

  

	6.3	 Where the Warrantor is a corporate entity, the Warrantor has in place policies, procedures and systems designed
to ensure (and which are reasonably expected to continue to ensure) compliance by the Warrantor and its Subsidiaries and its and their respective directors, officers, employees, Affiliates, agents and representatives with applicable Anti-Corruption
Laws (Adequate Procedures) and regularly monitors and reviews such Adequate Procedures and 

  
 72 

	 	
compliance therewith. The Warrantor is not aware of any violation by the Warrantor or any of its Subsidiaries or any of its or their respective directors, officers, employees, Affiliates, agents
or representatives of the Adequate Procedures. 

  

	6.4	 Where the Warrantor is a corporate entity, neither the Warrantor nor any of its Subsidiaries nor any of its or
their respective directors or officers nor, to the Warrantor’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives is, or is owned or controlled by individuals or entities (for the purposes of this
paragraph 6, Persons) that are: 

  

	 	(a)	 the subject or the target of any Sanctions Laws and Regulations; or 

 

	 	(b)	 located, organised or resident in a country or territory that is the subject of Sanctions Laws and Regulations
(including, without limitation, Crimea, Cuba, Iran, Libya, North Korea, Syria, Russia and Venezuela). 

  

	6.5	 There have been no transactions or arrangements between the Warrantor or, where the Warrantor is a corporate
entity, any of its Subsidiaries or any of its or their respective directors or officers, or, to the Warrantor’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives, (i) with any Person who is the
target of Sanctions Laws and Regulations and/or (ii) or with any person or entity in a Sanctioned Country or which performs contracts in support of projects in or for the benefit of Sanctioned Countries. 

 

	6.6	 Where the Warrantor is a corporate entity, the operations of the Warrantor and its Subsidiaries are and have
been conducted at all times in material compliance with, and the Warrantor’s or its Subsidiaries’ respective directors or officers and, to the Warrantor’s best knowledge, its and their respective employees, Affiliates, agents or
representatives have complied with the applicable money laundering statutes of all jurisdictions in which it or they conduct their operations, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued,
administered or enforced by any governmental agency in such jurisdictions (collectively, the Money Laundering Laws) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Warrantor or its Subsidiaries, or any of its or their respective directors or officers or, to the Warrantor’s best knowledge, any of its or their respective employees, Affiliates, agents or representatives or other persons associated with
or acting on behalf of the Warrantor with respect to the Money Laundering Laws is pending or, so far as the Warrantor is aware, threatened. 

  
 73 

 Schedule 3 

Undertakings 
  

	1	 General 

  

	1.1	 The Company will duly perform all of its obligations in connection with the Offer, whether arising pursuant to
this Agreement, any of the Offer Documents (and any amendment or supplement to them) or otherwise and neither the Company nor any of the Directors, any of the Founder Entities or Founders will (save as provided in paragraph 1.5 of this Schedule 3),
without the prior written consent of the Banks: 

  

	 	(a)	 seek to modify, vary or supplement any of the terms and conditions of the Offer or to extend the period(s)
during which the Offer is open for application or acceptance; or 

  

	 	(b)	 other than in connection with an Acquisition, for the period from the date of this Agreement and ending on the
date 180 days after Admission, make any material amendments to the Directors’ Letters of Appointment, save for any ordinary course increases in remuneration approved by the Company’s Board of Directors and/or save as disclosed in paragraph
9 of Part VIII of the Final Prospectus. 

  

	1.2	 The Company will as soon as reasonably practicable provide to each of the Banks, during the period commencing
on the date hereof and ending on the date that is 90 days after the Closing Date, as many copies (free of charge) of the Pathfinder Prospectus, the Final Prospectus, any Supplementary Prospectus and any other documentation relating to the Offer as
any of them may reasonably request. 

  

	1.3	 The Company will procure that each of the Final Prospectus and any Supplementary Prospectus is filed, published
and/or issued in accordance with, and complies with, the Prospectus Regulation Rules and the Listing Rules (insofar as they apply) and that: 

  

	 	(a)	 a press release (including pricing details) in the agreed form is delivered to a Regulatory Information Service
in time for release not later than 8.00 a.m. on the date of this Agreement; 

  

	 	(b)	 sufficient copies of the Final Prospectus and any Supplementary Prospectus are made available at the
appropriate times to the public and/or to subscribers for or purchasers of the Units; 

  

	 	(c)	 sufficient copies of the Final Prospectus and any Supplementary Prospectus are made available at the registered
office of the Company, the offices of the Registrar, the National Storage Mechanism and on the Company’s website, in accordance with the requirements of the FCA and the London Stock Exchange; and 

  
 74 

	 	(d)	 the documents described in the Final Prospectus or in any Supplementary Prospectus as being available for
inspection are made available as described therein. 

  

	1.4	 Each of the Company and the Directors undertakes that, insofar as it or he has power to do so, it or he will
ensure that Section 87G of FSMA is fully complied with in connection with the Offer. 

  

	1.5	 The Company will comply with FSMA, the FS Act, the Listing Rules and the Prospectus Regulation Rules so as to
permit the completion of the distribution of the Units as contemplated in this Agreement and in the Offer Documents (and any amendment or supplement to any of them). If at any time after the Final Prospectus has been lodged with the FCA for approval
and prior to Admission: 

  

	 	(a)	 any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of the
Banks, the Company, Company’s Counsel or Banks’ Counsel, to amend or supplement any of the Offer Documents in order that such Offer Documents will not include any untrue or inaccurate statement of a material fact or omit to state a fact
necessary in order to make the statements therein not misleading in any material respect in the light of the circumstances existing at the time it is delivered to a subscriber; 

 

	 	(b)	 there arises or is noted any matter referred to in section 87G of FSMA of which the Company is, or becomes,
aware prior to Admission and which requires the Company to deal with such change or matter in accordance with section 87G of FSMA, the Listing Rules and/or the Prospectus Regulation Rules; or 

 

	 	(c)	 it shall be necessary, in the opinion of such legal advisers, at any such time to amend or supplement any Offer
Document in order to comply with the requirements of FSMA, the FS Act, MAR, the CJA, the Listing Rules, the DTRs and/or the Prospectus Regulation Rules or any other applicable law or regulation (as the case may be), 

the Company, the Founders or the Directors (as the case may be) will promptly: 

 

	 	(d)	 promptly bring such event or condition to the notice of the Banks and shall promptly prepare and file with the
FCA (or procure the filing with the FCA of) such amendment or supplement as may be necessary to correct such statement or omission or to make such Offer Document comply with such requirements. Before amending or supplementing any Offer Document, the
Company will furnish each of the Banks with a copy of each such proposed amendment or supplement, and will not make any such proposed amendment or supplement without the consent of the Banks, provided always that (A) nothing in this paragraph
shall prevent the Company or the Founders or the Directors from complying with their obligations at law or under the Prospectus Regulation Rules, the Listing Rules, the FS Act or FSMA and (B) this paragraph shall be without prejudice to the
rights of the Banks under clause 15; and 

  
 75 

	 	(e)	 provide to the Banks such number of copies of such amendment or supplement as the Banks may reasonably request.

  

	1.6	 Each of the Company, the Founders, the Founder Entities and the Directors undertakes promptly to notify each of
the Banks if it comes to its or his attention at any time on or before Admission that any person wishes to exercise statutory withdrawal rights after the issue by the Company of a Supplementary Prospectus. However, the Founders shall have no right
of withdrawal in the event a Supplementary Prospectus is issued. 

  

	1.7	 The Company will use the net proceeds received by it from the sale of the Units in the manner and for the
purpose specified in the Disclosure Package and the Final Prospectus. 

  

	1.8	 Each of the Company and each of the Founders and the Directors undertakes that it or he will not, directly or
indirectly, use the proceeds received from the Offer or from any exercise of the Warrants or lend, contribute or otherwise make available such proceeds to any Affiliate, subsidiary, joint venture partner or other person: 

 

	 	(a)	 to fund any activities or business of or with any Person, or in any country or territory that, at the time of
such funding, is the subject or the target of Sanctions Laws and Regulations; or 

  

	 	(b)	 in any other manner that would result in a violation of Sanctions Laws and Regulations by any person (including
any person participating in the Offer, whether as a Bank, adviser, investor or otherwise); or 

  

	 	(c)	 in any manner that would result in a violation of Anti-Corruption Laws by any person. 

 

	1.9	 The Company and each of the Directors undertakes that: 

 

	 	(a)	 for the period from the date of this Agreement and ending 90 days following the date of Admission, the Company
shall not, without the prior written consent of the Banks, enter into any agreement, commitment or arrangement which is or may be material in the context of the business or affairs of the Company or in relation to the Offer; and

  

	 	(b)	 for a further period ending 30 days following the date of expiry of the period referred to in paragraph 1.9(a)
of this Schedule 3, the Company shall not, without prior consultation with the Banks, enter into any agreement, commitment or arrangement which is or may be material in the context of the business or affairs of the Company or in relation to the
Offer. 

  

	1.10	 The Company and each of the Directors undertakes that for the period from the date of this Agreement and ending
135 days after Admission, it shall discuss with the Banks any material new developments in its sphere of activity and any change in the Company’s financial condition or in the performance of its business. 

  
 76 

	1.11	 The Company, each of the Directors, each of the Founder Entities and each of the Founders undertakes
immediately to notify the Banks if it comes to its or his knowledge at any time on or before Admission that any of the Warranties in this Agreement was (or may have been) untrue, inaccurate or misleading when given or has ceased (or may have ceased)
to be true and accurate or has become (or may have become) misleading or if it or he becomes aware of any circumstance which would or might cause any of those Warranties to become untrue, inaccurate or misleading if they were repeated at any time on
or before Admission or if it or he becomes aware, prior to such date, that a matter has arisen which might give rise to a claim under any of the indemnities in clause 10. 

 

	1.12	 Except with the prior written consent of the Banks, other than in connection with an Acquisition, the Company
undertakes that it will not, for the period from the date of this Agreement and ending on the date 180 days after Admission, declare, make or pay any dividend or other distribution on any of its share capital nor increase, reduce or modify any part
of it and/or to the extent such dividend, distribution or increase, reduction or modification of the Company’s share capital is in accordance with the Company’s dividend policy as set out in the Final Prospectus. 

 

	1.13	 Each of the Company, each of the Directors, each of the Founder Entities and each of the Founders severally
undertakes that: 

  

	 	(a)	 it or he will not at any time between the date of this Agreement and the date falling 70 days after Admission
(the “Restricted Period”) circulate, distribute, publish, issue, make or despatch (nor authorise any other person to circulate, distribute, publish, issue, make or despatch) any press or public announcement or advertisement,
statement or communication, either individually or jointly with any other person, in relation to the Company or the Offer or otherwise relating to the assets, liabilities, profits, losses, financial or trading condition or the earnings, business
affairs or business prospects of the Company (except for routine communications in the ordinary course of business), whether in response to enquiries or otherwise, without the prior written consent of the Banks, unless, in the judgement of the
Company and Company’s Counsel, and after notification to the Banks, such announcement, advertisement, statement or communication is required by, or issued in accordance with, law or applicable regulation including, without limitation, FSMA, the
FS Act, MAR, the Listing Rules, the DTRs, the Securities Act and the rules and regulations promulgated thereunder; and 

  

	 	(b)	 for a further period of 45 days following the date of expiry of the Restricted Period, it or he will not at any
time circulate, distribute, publish, issue or make (nor authorise any other person to circulate, distribute, publish, issue or make) any press or public announcement or advertisement, statement or communication, either individually or jointly with
any other person, in relation to the Company or the Offer or otherwise relating to the assets, liabilities, profits, losses, financial or trading condition or the earnings, business affairs or business prospects of the Company (except for routine
communications in the ordinary course of business), whether in response to enquiries or otherwise, without prior consultation with the Banks (taking into account the Banks’ reasonable requests). 

  
 77 

	1.14	 Each of the Company, each of the Directors, each of the Founder Entities and each of the Founders undertake
that none of them will, at any time between the date of this Agreement and the date falling 90 days after Admission, make any public announcement, advertisement, statement or communication as is referred to in paragraph 1.13 of this Schedule 3 or
relating to any matters, events or circumstances which may be necessary to be made known to the public in order to enable the shareholders of the Company and the public to appraise the position of the Company or to avoid the establishment of a false
market in its securities, either individually or jointly with any other person, (including, without limitation, any matter whatsoever which would require notification by the Company to Regulatory Information Service in accordance with the provisions
of the Listing Rules) without first, where reasonably practicable, (a) notifying the Banks as to the content, form and manner of publication of such announcement, advertisement, statement or communication, (b) making available drafts of
any such announcement, advertisement, statement or communication to the Banks in sufficient time prior to its publication to allow the Banks an opportunity to consider and comment on the same, (c) consulting with the Banks as to the content,
form and manner of publication of such announcement, advertisement, statement or communication, and (d) taking account of the Banks’ reasonable requirements. 

 

	1.15	 The Company, each of the Directors, each of the Founder Entities and each of the Founders undertakes that it or
he will not take any action following the date hereof which may prejudice the Applications for Admission or otherwise result in Admission not becoming effective. 

 

	1.16	 For a period of 180 days following Admission, the Company agrees that it will furnish to the Banks copies of
all reports or other communications (financial or other) furnished to shareholders or warrant holders, and to deliver to the Banks (i) as soon as they are available, copies of any reports and financial statements furnished to or filed with the
FCA, the London Stock Exchange or any securities exchange on which any class of securities of the Company is listed; and (ii) such additional information concerning the business and financial condition of the Company as the Banks may from time
to time reasonably request. 

  

	1.17	 The Company and the Directors undertake to comply and act in accordance with the Company’s
responsibilities and obligations as a listed company as contained in MAR, the Listing Rules, the UK Corporate Governance Code, the Prospectus Regulation Rules, the DTRs, FSMA, the FS Act, the City Code and any other requirements (statutory or
otherwise) from time to time in force in relation to listed companies. 

  

	1.18	 Each of the Founders and each of the Founder Entities undertakes and agrees that they will use their best
endeavours to ensure (to the extent it is within their respective powers to do so) that the Company will not acquire an entity that is an Affiliate of any of the Directors. 

  
 78 

	1.19	 The Company, each of the Directors, each of the Founder Entities and each of the Founders shall procure, so far
as it is able to do so, that the documents specified in Schedule 5 are delivered to the Banks’ Counsel by not later than the times and dates specified in Schedule 5. 

 

	1.20	 During the period from the date of this Agreement until the date which is 135 days after Admission, neither the
Company nor any of the Directors nor any director from time to time of the Company shall take any steps which would be inconsistent with any expression of intention in the Offer Documents without prior consultation with each of the Banks.

  

	2	 Lock-up 

 

	2.1	 The Company undertakes to each of the Banks that during a period of 180 days from the date of Admission that it
will not, without the prior written consent of the Banks: (a) undertake any consolidation or sub-division of its share capital or any capitalisation issue, or (b) directly or indirectly, allot,
offer, issue, lend, sell, pledge or contract to sell or issue, issue or sell options or warrants in respect of, or otherwise dispose of, directly or indirectly, or announce an offering or issue of, any Ordinary Shares (or any interest therein or in
respect thereof) or any other securities exchangeable for or convertible into, or substantially similar to, Ordinary Shares (including, without limitation, any Warrants) or enter into any transaction with the same economic effect as, or agree to do,
any of the foregoing, save that the above restrictions shall not apply in respect of the issue of New Shares: 

  

	 	(a)	 pursuant to the Offer; 

 

	 	(b)	 in connection with an Acquisition; 

 

	 	(c)	 upon conversion of the Founder Shares; or 

 

	 	(d)	 to satisfy the exercise of Warrants by holders thereof. 

 

	2.2	 Each of the Directors, each of the Founder Entities and each of the Founders severally undertake to each of the
Banks that, during the period commencing on the date of this Agreement and ending on the earlier of (i) the 365th day following the completion of an Acquisition by the Company and (ii) the
passing of a resolution to voluntarily wind up the Company for failure to complete an Acquisition (the Lock-up Period), he will not and shall procure that no Affiliate of his shall, without the prior
written consent of each of the Banks, directly or indirectly, offer, allot, issue, lend, mortgage, assign, charge, pledge, sell, distribute, or contract to sell or issue, issue or sell options or warrants in respect of, or otherwise dispose of,
directly or indirectly, or announce an offering or issue of, any Ordinary Shares (or any interest therein or in respect thereof) or any other securities exchangeable for or convertible into, or substantially similar to, Ordinary Shares (including,
without limitation, any Warrants or Founder Shares) or otherwise enter into any transaction (including any derivative transaction) with the same economic effect as, or agree to do, or announce publicly any intention to enter into any transaction to
carry out, any of the foregoing, except that this undertaking will not apply to or prohibit a Director, a Founder Entity or a Founder from effecting: 

  

	 	(a)	 a transfer by way of gift or for estate planning purposes to a member of the transferor’s Close Relatives
or to a trust (including to any direct or indirect wholly-owned subsidiary of such trust) the sole beneficiaries of which are the transferor, one or more of the transferor’s Close Relatives and/or a recognised charitable organisation;

  
 79 

	 	(b)	 a transfer to any of the Directors; 

 

	 	(c)	 a transfer to an Affiliate of a Founder or a Founder Entity or a member of a Founder Entity or a direct or
indirect holder of an equity or partnership interest in a Founder Entity or an employee of an Affiliate of a Founder Entity; 

  

	 	(d)	 a transfer between and among any of the Founders and/or any of the Founder Entities (including between and
among any Affiliate of a Founder or a Founder Entity or member of a Founder Entity or direct or indirect holder of an equity or partnership interest in a Founder Entity or an employee of an Affiliate of a Founder Entity); 

 

	 	(e)	 a transfer to any direct or indirect subsidiary of the Company, a target company or shareholders of a target
company, in connection with an Acquisition; 

  

	 	(f)	 a transfer of any Ordinary Shares and/or Warrants acquired by a Founder or Director after the date of Admission
in any open-market transaction; 

  

	 	(g)	 the acceptance of, or provision of an irrevocable commitment or undertaking to accept (without any further
agreement to transfer or dispose of any Ordinary Shares or interest therein), a general offer made to all holders of issued and allotted Ordinary Shares for the time being on terms which treat all such holders alike; 

 

	 	(h)	 following completion of an Acquisition: 

 

	 	(i)	 a transfer to satisfy any tax liabilities incurred as a direct result of the completion of an Acquisition, the
exercise of any Warrants or the receipt from the Company of scrip dividends on the Ordinary Shares; or 

  

	 	(ii)	 a transfer by way of gift of up to 10 per cent. of the transferor’s interest in Ordinary Shares to a
recognised charitable organisation, 

 provided that: 

 

	 	(i)	 in the case of each of 2.2(a) to 2.2(f) (inclusive) the relevant transferee enters into a lock up agreement for
the remainder of the Lock-up Period on terms identical to those set out in this paragraph 2.2; and 

  
 80 

	 	(j)	 each Director and each Founder severally undertakes to each of the Banks and the Company that any transfer by
it in accordance with this paragraph 2.2 shall, to the extent permitted by relevant law or regulation, be notified in writing to each of the Banks and the Company no later than five Business Days after the entry into of any agreement relating to the
same. 

  

	3	 Securities laws compliance and exercise of Warrants 

 

	3.1	 The Company, the Founders and the Directors severally undertakes that it has (and undertakes that each of its
Affiliates has) complied, and will (and will procure that each of their respective Affiliates will) comply with all relevant laws and regulations of each relevant jurisdiction (including, without prejudice to the generality of the foregoing, all
requirements of all applicable regulatory authorities in each such jurisdiction) in connection with: (a) the Offer; (b) purchases and sales of New Shares, Warrants, Founder Shares and Ordinary Shares issued and delivered upon exercise of
the Warrants; and (c) the release or distribution of any document or information relating to the Offer in each such jurisdiction. 

  

	3.2	 For so long as any of the New Shares, the Warrants, the Founder Shares and any Ordinary Shares issued and
delivered upon exercise of the Warrants remain outstanding and are “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Company undertakes that during any period in which it is not subject to
Section 13 or 15(d) of the Exchange Act nor exempt from reporting pursuant to Rule 12g3-2(b) under the Exchange Act, it will make available to any holder or beneficial owner of New Shares, Warrants,
Founder Shares or Ordinary Shares and to any prospective purchaser of New Shares, Warrants, Founder Shares or Ordinary Shares from such holder or beneficial owner, in each case upon request, the information specified in, and meeting the requirements
of, Rule 144A(d)(4) under the Securities Act. This undertaking is intended to be for the benefit of the holders and prospective purchasers of such “restricted securities”. The undertaking of the Company in this paragraph is enforceable by
such holders who are not parties to this Agreement by virtue of the Contracts (Rights of Third Parties) Act 1999 provided however that the parties to this Agreement may terminate or vary this Agreement in any way at any time without the consent of
any such person. 

  

	3.3	 Neither the Company, the Directors, the Founders, the Founder Entities nor any of their Affiliates, nor any
person acting on their behalf will, prior to the later to occur of (a) Admission and (b) completion of the distribution of the New Shares and Warrants, distribute any offering material in the United States (including a website posting that
is accessible to residents of the United States) other than the Pathfinder Prospectus, the Disclosure Package and the Final Prospectus (and any amendment or supplement to any of them) or other materials, if any, permitted by the Securities Act and
approved by the Banks. Any information contained in such other materials, if any, shall be consistent with the information contained in the Disclosure Package and the Final Prospectus. 

  
 81 

	3.4	 The Company, each of the Directors, the Founder Entities and each of the Founders undertakes that they will not
take, directly or indirectly, any action which is designed to, or might reasonably be expected to, constitute or result in, the stabilisation, maintenance or manipulation of the price of the New Shares, the Warrants or the Founder Shares or any
other security of the Company or any instrument evidencing rights to Ordinary Shares or any such other security and each confirms that it has not previously taken any such action. 

 

	3.5	 The Company shall cause the proceeds from the sale of the New Shares and Warrants to be invested only in United
States government treasury bills or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act as disclosed the Prospectus. The Company will otherwise conduct its
business in a manner so that it is not and will not be required to register as an investment company under the Investment Company Act. 

  

	3.6	 The Company, each of the Directors, each of the Founder Entities and each of the Founders undertake that
neither they nor any of their Affiliates, nor any person acting on their behalf (other than the Banks, as to whom it makes no representation) will engage, either directly or indirectly, in connection with the offering of the New Shares, the Warrants
or the Founder Shares, in any form of “general solicitation” or “general advertising” in the United States (within the meaning of Rule 502(c) of Regulation D). 

 

	3.7	 The Company, each of the Directors, each of the Founder Entities and each of the Founders undertake that
neither they nor any of their Affiliates, nor any person acting on their behalf (other than the Banks, as to whom it makes no representation) will engage in any “directed selling efforts” (within the meaning of Regulation S) with respect
to the New Shares, the Warrants or the Founder Shares. 

  

	3.8	 None of the Company, the Directors, each of the Founder Entities, the Founders, their Affiliates nor any person
acting on their behalf (other than the Banks, as to whom it makes no representation) will, directly or indirectly, make offers or sales of any security, or solicit offers to buy any security, or otherwise negotiate in respect of any security under
circumstances that would require the registration of the New Shares, the Warrants or the Founder Shares under the Securities Act. 

  

	3.9	 For so long as the New Shares, the Warrants and Ordinary Shares issued and delivered upon exercise of the
Warrants are “restricted securities” within the meaning of Rule 144(a)(3) of the Securities Act, the Company agrees not to, and will cause its Affiliates not to, resell any New Shares or Warrants comprising the Units or Ordinary Shares
issued and delivered upon exercise of the Warrants acquired by it or them into the United States. 

  

	3.10	 The Company agrees that it will not and will cause its Affiliates not to, directly or indirectly, solicit any
offer to buy, sell or make any offer or sale of, or otherwise negotiate in respect of, shares of the Company of any class if, as a result of the doctrine of integration referred to in Rule 502 under

  
 82 

	 	
the Securities Act, such offer or sale would render invalid (for the purpose of (a) the sale of the New Shares or the Warrants by the Company to the Banks or to the purchasers procured by
the Banks or by the Company to the Founders, (b) the resale of the New Shares or Warrants by the Banks to subsequent purchasers, or (c) the resale of the New Shares or Warrants by such subsequent purchasers to others) the exemption from
the registration requirements of the Securities Act provided by Section 4(a)(2) thereof or Rule 144A or the safe harbour provided by Regulation S thereunder or otherwise. 

 

	3.11	 The Company will take such actions as the Banks may reasonably request to qualify the New Shares and Warrants
for offer and sale by the Banks through their Affiliates or agents under the laws of such states of the United States or other jurisdictions as the Banks may designate and shall maintain such qualifications in effect so long as required for the sale
of the New Shares, the Warrants and the Founder Shares; provided, however, that, in connection therewith, the Company shall not be obliged to file any general consent to service of process or to qualify as a foreign corporation in any jurisdiction
in which it is not qualified. The Company will immediately advise the Banks of the receipt by the Company of any notification with respect to the suspension of the qualification of the New Shares, the Warrants or the Founder Shares for sale in any
jurisdiction or the initiation or threatening of any proceedings for such purposes. 

  

	3.12	 The Company, the Directors and the Founders severally undertakes that it will and undertakes that its
Affiliates and any person acting on its behalf (other than the Banks, as to whom no undertaking is made) will comply with all applicable provisions of the US federal securities laws in connection with the issue and delivery of any Ordinary Shares
upon any exercise of Warrants. 

  

	4	 Related party transactions 

 

	4.1	 For so long as the Company has a listing on the standard listing segment of the Official List, the Company will
not enter into any transaction which would constitute a “related party transaction” as defined in Chapter 11 of the Listing Rules (were Chapter 11 of the Listing Rules to apply to the Company) without the specific prior approval of a
majority of the Independent Non-Founder Directors. 

  

	5	 Acquisition 

  

	5.1	 The Company will not enter into an Acquisition without the specific prior approval of a majority of the Board
of Directors, including: 

  

	 	(a)	 a majority of those Directors of the Board from time to time considered by the Board to be independent for the
purposes of the UK Corporate Governance Code (or any other appropriate corporate governance regime complied with by the Company from time to time); and 

  
 83 

	 	(b)	 provided they are Directors at the relevant time, both of William N. Thorndike, Jr. and W. Nicholas Howley.

  

	6	 Authority of Registrar, Depositary and Administrator 

 

	6.1	 The Company undertakes to provide the Registrar, the Depositary and the Administrator respectively with all
necessary authorisations, information and instructions to enable the Registrar, the Depositary and the Administrator respectively to perform their duties in accordance with, and as contemplated by, this Agreement, the Final Prospectus (as amended or
supplemented from time to time), the Registrar Agreement, the Depositary Agreement, the Corporate Administration Agreement and the Depositary Interest Deed Poll. Prior to completion of an Acquisition, the Company undertakes not to exercise any right
to terminate the Registrar Agreement, the Depositary Agreement, or the Corporate Administration Agreement without the written consent of the Banks. 

  

	7	 Board composition 

 

	7.1	 Until the completion of an Acquisition, the Company, each of the Founder Entities and each of the Directors
undertakes that it or he will not approve the appointment of a director to the Board of Directors unless the Board of Directors at the relevant time is satisfied that the Company will maintain its status as a foreign private issuer (as defined in
Rule 405 under the Securities Act). 

  

	7.2	 EverArc Founders confirms that it does not intend to exercise its rights under the Founder Advisory Agreement
or otherwise to appoint director(s) to the Board of Directors if the Company is not in compliance with provisions 10 and 11 of the UK Corporate Governance Code regarding the independence of the Board, or if exercising such rights would result in the
Company ceasing to be in compliance with such provisions of the UK Corporate Governance Code (in each case as if the Company was required to comply with the UK Corporate Governance Code). 

 

	8	 Register of members 

 

	8.1	 The Company undertakes that it has not maintained, does not currently maintain and will not maintain any
register of members, warrant holders or depositary interests in the United Kingdom at any time prior to completion of an Acquisition. 

  

	9	 Reorganisation in connection with an Acquisition 

 

	9.1	 Without prejudice to paragraph 2 of this Schedule 3, in the event that any of the Directors or the Founders
receive, in connection with an Acquisition, an interest in an entity other than the Company (such securities, the “New Securities”), the Directors and the Founders acknowledge and agree that the New Securities shall be:
(a) subject to the transfer restrictions set forth in paragraph 2.1 of this Schedule 3; and (b) entitled to the benefits of the same exceptions to such transfer restrictions permitted by paragraph 2.2 of this Schedule 3.

  
 84 

	10	 Issuance of Founder Shares or Warrants 

 

	10.1	 The Company undertakes that, except as set out in this Agreement and until after the completion of an
Acquisition, it will not issue any Founder Shares or Warrants unless such issuance has first been approved by a majority of Independent Non-Founder Directors. 

  
 85 

 Schedule 4 

Selling Restrictions 
  

	1	 United States 

 

	    	 Each of the Banks severally, and not jointly or jointly and severally, acknowledges that the New Shares, the
Warrants and the Founder Shares have not been and will not be registered under the Securities Act and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act; and represents, warrants and agrees that (a) neither such Bank nor any of its Affiliates, nor any person acting on its or their behalf has solicited and/or will solicit offers for, or has offered, sold or
procured subscribers or purchasers for or will offer, sell or procure subscribers or purchasers for, New Shares or Warrants by means of any general solicitation or general advertising in the United States, (b) neither it, nor any of its
Affiliates, nor any person acting on its or their behalf, has engaged or will engage in any directed selling efforts with respect to the New Shares or the Warrants, and (c) such Bank and any person acting on its behalf, has offered or sold or
solicited offers for or procured subscribers or purchasers for and will offer or sell, or solicit offers for or procure subscribers or purchasers for, the New Shares or the Warrants, as part of their initial distribution, (i) in the United
States only to or from persons whom it reasonably believes are Qualified Institutional Buyers or Accredited Investors, or if any such person is buying for one or more institutional accounts of which such person is acting as fiduciary or agent, only
when such Bank reasonably believes that each such account is a Qualified Institutional Buyer or Accredited Investor, in reliance on Rule 144A under the Securities Act or pursuant to another exemption from or in a transaction not subject to the
registration requirements of the Securities Act; or (ii) outside the United States only in offshore transactions within the meaning and meeting the requirements of Rule 903 under the Securities Act. 

 

	2	 EEA 

  

	2.1	 In relation to each Member State of the European Economic Area (each a “Member State”), no
Shares have been offered or will be offered pursuant to the Offer to the public in that Member State prior to the publication of a prospectus in relation to the Shares which has been approved by the competent authority in that Member State or, where
appropriate, approved in another Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation), except that offers of Shares may be made to the public in that Member State at any time
under the following exemptions under the Prospectus Regulation: 

  

	 	(a)	 to any legal entity which is a qualified investor as defined under the Prospectus Regulation;

  
 86 

	 	(b)	 to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the Banks for any such offer; or 

  

	 	(c)	 in any other circumstances falling within Article 1(4) of the Prospectus Regulation, 

 

	    	 provided that no such offer of Shares shall require the Company or any Bank to publish a prospectus pursuant to
Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. 

  

	2.2	 For the purposes of paragraph 2.1, the expression an “offer to the public” in relation to any
Shares in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any Shares to be offered so as to enable an investor to decide to purchase or subscribe for any Shares, and the
expression “Prospectus Regulation” means Regulation (EU) 2017/1129. 

  

	2.3	 Each of the Banks severally, and not jointly or jointly and severally, represents, warrants and agrees that:

  

	 	(a)	 it has only communicated or caused to be communicated and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity (within the meaning of Section 21 of FSMA) in connection with the issue or sale of the New Shares in circumstances in which Section 21(1) of FSMA does not apply to the Company; and

  

	 	(b)	 it has complied and will comply with all applicable provisions of FSMA with respect to anything done by it in
relation to the New Shares in, from or otherwise involving the United Kingdom. 

  
 87 

 Schedule 5 

Documents for delivery 

Part A – Delivery of documents on the date of this Agreement 

Forms 
  

	1	 A copy of the completed application for admission of securities to the Official List (in the form required by
the Listing Rules) and a copy of the completed Form A as referred to in the Prospectus Regulation Rules, in each case signed by a Director or the Secretary of the Company. 

 

	2	 A copy of the signed application for admission to trading on the London Stock Exchange (LSE Form 1) in relation
to the Ordinary Shares and the Warrants signed by a Director or the Secretary of the Company. 

  

	3	 A copy of the final cross reference list identifying the pages of the Final Prospectus on which each item
required by the schedules and building blocks of the Prospectus Regulation can be found. 

 Directors’ responsibility letters and
memoranda 
  

	4	 Two certified copies of the signed Directors’ responsibility letters addressed to the Banks
(a) accepting responsibility for information contained in the Final Prospectus and any Supplementary Prospectus, (b) confirming that the Final Prospectus contains, or will contain when published, all such information as investors and their
professional advisers would reasonably require and would reasonably expect to find therein (regard being had to the matters referred to in section 87A of FSMA) for the purposes of making an informed assessment of the matters specified in section
87A(2) of FSMA, and (c) acknowledging the relevant Directors’ understanding of the nature and extent of his responsibilities under MAR, the Listing Rules and the DTRs. 

 

	5	 Two copies of the memorandum prepared by the Company’s Counsel and addressed to the Directors explaining
the nature of their responsibilities and obligations as directors of a public company listed on the Official List, in the agreed form. 

  

	6	 Two copies of the memorandum prepared by the Company’s Counsel and addressed to the Directors explaining
the nature and extent of their responsibilities and possible liabilities in relation to the Pathfinder Prospectus and Final Prospectus, in the agreed form. 

  

	7	 Two copies of the memorandum addressed to the Directors in relation to their duties under the BVI Companies
Act, in the agreed form. 

  

	8	 Two copies of the share dealing code and dealing procedures manual prepared by the Company’s Counsel in
relation to the Company and addressed to the Directors. 

  
 88 

 Prospectus 
  

	9	 Two copies of the Final Prospectus and two copies of the formal approval notice issued by the FCA.

  

	10	 Two certified copies of the Verification Notes, duly signed by or on behalf of each Director or by each of the
persons responsible for the replies thereto and dated the same date as the Final Prospectus. 

  

	11	 Two copies of each of the Offer Documents (other than any Supplementary Prospectus and any press release
required to be issued in connection with any Supplementary Prospectus). 

 Corporate documents 

 

	12	 Two certified copies of the minutes of the meetings of the Board of Directors of the Company, or a duly
authorised committee thereof, in the agreed form, approving the Offer Documents and (where appropriate) the other documents referred to in this Agreement and authorising the steps to be taken by the Company in connection with the Offer, including
the execution of this Agreement in the agreed form and the Offer Price and authorising the Directors to allot the New Shares, the Founder Shares and the Warrants. 

 

	13	 Two certified copies of the minutes of the meeting of the Board of Directors of the Company appointing any
committee such as is referred to in paragraph 12 above. 

  

	14	 Two certified copies of the inaugural written resolution of the first Director(s) of the Company.

  

	15	 Two certified copies of the written resolution of the Company approving the appointment of each of the
Directors. 

  

	16	 Two certified copies of the certificate of incorporation and the Memorandum and Articles of Association of the
Company. 

  

	17	 Two certified copies of each of the letters pursuant to which each of the Directors is appointed.

  

	18	 Two certified copies of a letter of consent from each of the Directors in respect of their appointment,
pursuant to the BVI Companies Act. 

  

	19	 Two certified copies of a letter from each of the Founders to each of the Independent Non-Founder Directors giving certain undertakings in relation to the termination of the Independent Non- Founder Directors’ appointment. 

 

	20	 Two certified copies of the Director’s Questionnaire in respect of each of the Directors.

  
 89 

 Reporting accountants’ letters/reports 

Letters 
 Two original copies of the following letters
addressed to the Company and the Banks duly signed by the Reporting Accountants, in form and substance to the satisfaction of the Banks: 
  

	21	 Letter relating to the Pathfinder Prospectus; 

 

	22	 Letter providing comfort in relation to the tax section of the Final Prospectus relating to UK and US taxation;

  

	23	 Letter reporting on the statement in the Final Prospectus that there has been no significant change in the
financial or trading position of the Group since the date of incorporation of the Company; 

  

	24	 Letter providing comfort in relation to correct extraction of financial information in the Final Prospectus;

  

	25	 US “SAS 72” comfort letter in form and substance satisfactory to the Banks, dated the date hereof;

  

	26	 International “lookalike” comfort letter in form and substance satisfactory to the Banks, dated the
date hereof; and 

  

	27	 Letter consenting to the inclusion of each of the reports and their name in the Final Prospectus in the form
and context in which they appear. 

 Two certified copies of: 
  

	28	 Letter from the Company to the Reporting Accountants, duly signed by a Director, containing certain
representations regarding the financial information contained in the Final Prospectus and there being no significant change. 

 Reports

 Two original copies of the following reports duly signed by the Reporting Accountants, in form and substance to the satisfaction of the Banks: 

 

	29	 Accountants’ report addressed to the Company in relation to the historical financial information of the
Company included in the Final Prospectus; and 

  

	30	 Report on the financial position and prospects procedures of the Company addressed to the Company and the
Banks. 

  
 90 

 Other 
  

	31	 Two certified copies of the memorandum on financial position and prospects (FPP) procedures prepared by the
Company in the agreed form. 

  

	32	 Two copies of the schedule on working capital prepared by the Company in the agreed form.

  

	33	 Two certified copies of the opinion in the agreed form from Company’s Counsel addressed to the Banks
confirming the accuracy of the section headed “British Virgin Islands taxation” in Part VII 

  

	(Taxation)	 of the Final Prospectus and other matters in the Final Prospectus regarding the law of the British Virgin
Islands, duly signed and dated the date of the Final Prospectus. 

  

	34	 Two copies of the form of warrant certificate in respect of the Warrants. 

 

	35	 Two certified copies of the Corporate Administration Agreement, duly signed by the Administrator and the
Company. 

  

	36	 Two certified copies of the Depositary Agreement, duly executed by the Depositary and the Company.

  

	37	 Two certified copies of the Depositary Interest Deed Poll, duly executed by the Depositary.

  

	38	 Two certified copies of the Warrant Instrument, duly executed by the Company. 

 

	39	 Two certified copies of each of the Insider Letters, duly executed by the Founders or the Independent Non-Founder Directors (as the case may be). 

  

	40	 Two certified copies of the Registrar Agreement, duly executed by the Registrar and the Company.

  

	41	 Two certified copies of the Founder Advisory Agreement, duly executed by the EverArc Founders and the Company.

  

	42	 Two certified copies of each power of attorney pursuant to which any party executes this Agreement.

  

	43	 Such other documents as may be reasonably requested by the Banks. 

The Banks may, in their absolute discretion, elect that delivery of any of the documents referred to in this Part A of Schedule 5 (Delivery of
Documents) may be deferred and in lieu of any such delivery require delivery of the relevant document in a form satisfactory to them at a later time specified by the Banks. Any requirement to deliver any document which is specified as being an
original may, with the Banks’ prior consent (not to be unreasonably withheld or delayed) be satisfied by the delivery by the relevant party of a certified copy of such document with the original to follow as soon as reasonably practicable
thereafter. 

  
 91 

 Part B – Delivery of documents on the Closing Date prior to Admission 

Counsel opinions 
  

	1	 Two originals of opinions: 

 

	 	(a)	 in the agreed form from Company’s Counsel (in respect of both English and BVI law) dated the Closing Date;

  

	 	(b)	 in the form reasonably satisfactory to the Banks from Banks’ Counsel (in respect of English law) dated the
Closing Date; 

  

	 	(c)	 in the agreed form from EverArc Founders’ Counsel (in respect of Delaware law) dated the Closing Date;

  

	 	(d)	 in the agreed form from Llanerch Everarc’s Counsel (in respect of Ohio law) dated the Closing Date;

  

	 	(e)	 in the agreed form from TVR Everarc’s Counsel (in respect of Texas law) dated the Closing Date.

  

	2	 Two originals of so-called “Rule
10b-5 disclosure letters” with respect to the Final Prospectus as at the Applicable Time and the Closing Date, and the Final Prospectus as of its date and the Closing Date, in form and substance
satisfactory to the Banks from each of Company’s Counsel and Banks’ Counsel, each dated the Closing Date. 

  

	3	 Two originals of “no registration” opinions and other US opinions (which for the avoidance of doubt
shall include from Company’s Counsel an opinion that the Company is not, and after the receipt of the proceeds of the Offer will not be, an investment company within the meaning of the Investment Company Act and an opinion as to the US tax
disclosure in the Pathfinder Prospectus and the Final Prospectus) in the agreed form from Company’s Counsel and Banks’ Counsel dated the Closing Date. 

 

	4	 Two certified copies of the opinion from the Company’s Counsel to Euroclear in relation to the Depositary
Interest Deed Poll, dated the Closing Date, together with two certified copies of the related confirmations from the Company. 

  

	5	 Two certified copies of the opinion from the Company’s Counsel to the Depositary Euroclear in connection
with the Depositary Interests, dated the Closing Date. 

 Corporate documents 

 

	6	 Two certified copies of the minutes of the meetings of the Board of Directors of the Company, or a duly
authorised committee thereof, authorising any steps to be taken in connection with 

  
 92 

 Admission and closing and settlement of the Offer, including the allotment and issuance,
conditional only on Admission, of the New Shares and Warrants to subscribers in the proportions and as otherwise directed by the Banks, and, to the extent not previously provided, approving any Offer Documents issued after the date of this Agreement
(and, if the said minutes are of such a committee, to the extent not previously provided, a certified copy of the minutes of the Board of Directors appointing such committee). 
  

	7	 A copy of the security application form in respect of the Depositary Interests that has been given to
Euroclear, in the agreed form. 

  

	8	 A copy of the CREST enablement letters confirming that the conditions for admission of the Depositary Interests
to CREST are satisfied. 

 Company and Directors’ certificates 

 

	9	 Two originals of the certificate in the agreed form set out in Part A of Schedule 6 signed by a Director for
and on behalf of the Company dated the Closing Date. 

  

	10	 Two originals of the certificate in the agreed form set out in Part A of Schedule 6 signed by a Founder
Director for and on behalf of himself and the other Directors dated the Closing Date. 

  

	11	 Two originals of the certificate in the agreed form set out in Part B of Schedule 6 signed by each Non-Founder Director dated the Closing Date. 

 Founders’ and Founder Entities certificates

  

	12	 Two originals of the certificate in the agreed form set out in Part C of Schedule 6 signed by each Founder
dated the Closing Date. 

  

	13	 Two originals of the certificate in the agreed form set out in Part C of Schedule 6 signed on behalf of each
Founder on behalf of the relevant the Founder Entity dated the Closing Date. 

 Reporting Accountants’ letters 

 

	14	 Two originals of bring-down UK comfort letters in form and substance to the satisfaction of the Banks, dated
the Closing Date. 

  

	15	 Two originals of bring-down US comfort letters in form and substance to the satisfaction of the Banks, dated
the Closing Date. 

  

	16	 Two originals of bring-down international comfort letters in form and substance to the satisfaction of the
Banks, dated the Closing Date. 

  
 93 

	17	 Two originals of the letter from the Company to the Reporting Accountants, duly signed by a Director,
containing certain representations regarding the bring-down comfort letters, dated the Closing Date. 

 The Banks may, in their absolute
discretion, elect that delivery of any of the documents referred to in this Part B of Schedule 5 (Delivery of Documents) may be deferred and in lieu of any such delivery require delivery of the relevant document in a form satisfactory to them
at a later time specified by the Banks. Any requirement to deliver any document which is specified as being an original may, with the Banks’ prior consent (not to be unreasonably withheld or delayed) be satisfied by the deliver by the relevant
party of a certified copy of such document with the original to follow as soon as reasonably practicable thereafter. 

  
 94 

 Part C – Delivery of documents on the Date of Publication of any 

Supplementary Prospectus 
 Supplementary
Prospectus 
  

	1	 Two certified copies of the Supplementary Prospectus bearing evidence of the formal approval of the FCA as a
supplementary prospectus pursuant to the Prospectus Regulation Rules and the Listing Rules. 

  

	2	 Two originals of the verification notes prepared in connection with the Supplementary Prospectus and in the
agreed form, duly signed by or on behalf of each Director or by each of the persons responsible for the replies thereto and dated the same date as the Supplementary Prospectus. 

 

	3	 Two certified copies of the press announcement issued in connection with the Supplementary Prospectus and in
the agreed form. 

  

	4	 Two certified copies of each of the documents stated in the Supplementary Prospectus as being available for
inspection, to the extent not already provided to the Banks. 

  

	5	 A copy of the completed Form A as referred to in the Prospectus Regulation Rules signed by a Director or the
Secretary of the Company. 

 Corporate documents 
  

	6	 Two certified copies of the minutes of the meetings of the Board of Directors of the Company (or a duly
authorised committee thereof), approving the Supplementary Prospectus, the press announcement to be issued in connection with publication of the Supplementary Prospectus and (where appropriate) the other documents referred to in this Agreement and
authorising the steps to be taken by the Company in connection with the Supplementary Prospectus, in the agreed form (and, if the said minutes are of such a committee, to the extent not previously provided, a certified copy of the minutes of the
Board of Directors appointing such committee). 

 Counsel opinions 

 

	7	 If requested by the Banks, two originals of so-called “Rule 10b-5 disclosure letters”, in form and substance satisfactory to the Banks from each of Company’s Counsel and Banks’ Counsel, each dated the date of the Supplementary Prospectus.

  

	8	 If requested by the Banks, two originals of “no registration” opinions and other US opinions (which
for the avoidance of doubt shall include an opinion from Company’s Counsel that the Company is not, and after the receipt of the proceeds of the Offer will not be, an investment company within the meaning of the Investment Company Act and an
opinion as to the US tax disclosure in the Pathfinder Prospectus and the Final Prospectus) in the agreed form from Company’s Counsel and Banks’ Counsel dated the date of the Supplementary Prospectus. 

  
 95 

 Company and Directors’ certificates 

 

	9	 Two originals of the certificate in the agreed form set out in Part A of Schedule 6 signed by a Director for
and on behalf of the Company dated the date of publication of the Supplementary Prospectus. 

  

	10	 Two originals of the certificate in the agreed form set out in Part A of Schedule 6 signed by a Founder
Director for and on behalf of himself and the other Founder Directors dated the date of publication of the Supplementary Prospectus. 

  

	11	 Two originals of the certificate in the agreed form set out in Part B of Schedule 6 signed by each Non-Founder Director dated the Closing Date. 

 Founders’ and Founder Entities certificates

  

	12	 Two originals of the certificate in the agreed form set out in Part C of Schedule 6 signed by each Founder
dated the date of publication of the Supplementary Prospectus. 

  

	13	 Two originals of the certificate in the agreed form set out in Part C of Schedule 6 signed on behalf of each
Founder on behalf of the relevant Founder Entity dated the date of publication of the Supplementary Prospectus. 

 Reporting
Accountants’ letters 
  

	14	 If requested by the Banks, two originals of bring-down UK comfort letters in form and substance to the
satisfaction of the Banks, dated the date of the Supplementary Prospectus. 

  

	15	 If requested by the Banks, two originals of bring-down US comfort letters in form and substance to the
satisfaction of the Banks, dated the date of the Supplementary Prospectus. 

  

	16	 If requested by the Banks, two originals of bring-down international comfort letters in form and substance to
the satisfaction of the Banks, dated the date of the Supplementary Prospectus. 

  

	17	 If requested by the Banks, two originals of the letter from the Company to the Reporting Accountants, duly
signed by a Director, containing certain representations regarding the bring-down comfort letters, dated the date of the Supplementary Prospectus. 

Directors responsibility letters 
  

	18	 Two original copies of the signed Directors’ responsibility letters in the agreed form.

  
 96 

 Other 
  

	19	 Two original letters in the form previously provided to the Banks duly signed by the Company in relation to
item 18.7 of Annex 1 to the Prospectus Regulation Rules (“no significant change”) and dated the same date as the Supplementary Prospectus. 

  

	20	 Such other documents as may be reasonably requested by the Banks. 

The Banks may, in their absolute discretion, elect that delivery of any of the documents referred to in this Part C of Schedule 5 (Delivery of
Documents) may be deferred and in lieu of any such delivery require delivery of the relevant document in a form satisfactory to them at a later time specified by the Banks. Any requirement to deliver any document which is specified as being an
original may, with the Banks’ prior consent (not to be unreasonably withheld or delayed) be satisfied by the deliver by the relevant party of a certified copy of such document with the original to follow as soon as reasonably practicable
thereafter. 

  
 97 

 Schedule 6 

Form of certificate 

Part A – Company and Founder Directors’ Certificate 

[Insert name of Company / Founder Director] 

[Insert address] 
 UBS AG, London Branch

 5 Broadgate 
 London EC2M 2QS 

Morgan Stanley & Co. International plc 
 25 Cabot
Square 
 Canary Wharf 
 London E14 4QA 

                 [●] 2019 

Dear Sirs 
 Offer of
                     new ordinary shares with no par value in EverArc Holdings Limited (“Ordinary Shares”) together with warrants to
subscribe for Ordinary Shares (the “Offer”) 
 [We / I] refer to the placing agreement dated
             12 December 2019 entered into between us in relation to the Offer (the Placing Agreement). Words and expressions defined in the Placing Agreement have the same
meanings when used in this letter. 
  

	1	 [We / I] confirm that: 

 

	 	(a)	 each of the Conditions (other than the Condition specified in clause 15.1(p) (Admission) of the Placing
Agreement) has been fulfilled in accordance with its terms; 

  

	 	(b)	 the Company and the Directors have complied with all of their undertakings and obligations under the Placing
Agreement in all respects to the extent that the same fall to be performed prior to Admission; 

  

	 	(c)	 none of the Warranties given by the Company or any of the Directors in the Placing Agreement was untrue,
inaccurate or misleading in any respect at the date of the Placing Agreement or is untrue, inaccurate or misleading in any respect by reference to the facts and circumstances existing as at the date hereof; 

  
 98 

	 	(d)	 since the date of the Final Prospectus, there has been no significant change affecting any matter contained in
the Final Prospectus and no significant new matter has arisen for the purposes of section 87G FSMA which requires a Supplementary Prospectus to be published; and 

 

	 	(e)	 since the date of the Placing Agreement there has been no Material Adverse Change. 

This letter shall be governed by and construed in accordance with English law. 

Yours faithfully 
  

                                         
                                        

[Director, duly authorised, for and on behalf of EverArc Holdings Limited] / [Insert name of Founder Director] 

  
 99 

 Part B – Independent Non-Founder
Director’s Certificate 
 [Insert name of Independent Non-Founder Director] 

[Insert Address] 
 UBS AG, London Branch

 5 Broadgate 
 London EC2M 2QS 

Morgan Stanley & Co. International plc 
 25 Cabot
Square 
 Canary Wharf 
 London E14 4QA 

             [●] 2019 

Dear Sirs 
 Offer of
                     new ordinary shares with no par value in EverArc Holdings Limited (“Ordinary Shares”) together with warrants to
subscribe for Ordinary Shares (the “Offer”) 
 I refer to the placing agreement dated
             12 December 2019 entered into between us in relation to the Offer (the Placing Agreement). Words and expressions defined in the Placing Agreement have the same
meanings when used in this letter. 
  

	1	 I confirm that: 

  

	 	(a)	 I have complied with my undertakings and obligations under the Placing Agreement in all respects to the extent
that the same fall to be performed prior to Admission; 

  

	 	(b)	 none of the Warranties given by me in the Placing Agreement was untrue, inaccurate or misleading in any respect
at the date of the Placing Agreement or is untrue, inaccurate or misleading in any respect by reference to the facts and circumstances existing as at the date hereof, 

and, so far as I am aware, after due and careful enquiry: 
  

	 	(c)	 since the date of the Final Prospectus, there has been no significant change affecting any matter contained in
the Final Prospectus and no significant new matter has arisen for the purposes of section 87G FSMA which requires a Supplementary Prospectus to be published; and 

 

	 	(d)	 since the date of the Placing Agreement there has been no Material Adverse Change. 

  
 100 

 This letter shall be governed by and construed in accordance with English law. 

Yours faithfully 
  

                                         
                                         
   
 [Insert name of Independent Non-Founder Director] 

  
 101 

 Part C – Founders’ and Founder Entities’ Certificate 

[Insert name of Founder / Founder Entity] 

[Insert Address] 
 UBS AG, London Branch

 5 Broadgate 
 London EC2M 2QS 

Morgan Stanley & Co. International plc 
 25 Cabot
Square 
 Canary Wharf 
 London E14 4QA 

             [●] 2019 

Dear Sirs 
 Offer of
                     new ordinary shares with no par value in EverArc Holdings Limited (“Ordinary Shares”) together with warrants to
subscribe for Ordinary Shares (the “Offer”) 
 [I / We] refer to the placing agreement dated
             12 December 2019 entered into between us in relation to the Offer (the Placing Agreement). Words and expressions defined in the Placing Agreement have the same
meanings when used in this letter. 
  

	1	 [I / We] confirm that: 

 

	 	(a)	 each of the Conditions (other than the Condition specified in clause 15.1(p) (Admission) of the Placing
Agreement) has been fulfilled in accordance with its terms; 

  

	 	(b)	 [I / We] have complied with [my / our] undertakings and obligations under the Placing Agreement in all respects
to the extent that the same fall to be performed prior to Admission; 

  

	 	(c)	 none of the Warranties given by [me / us] in the Placing Agreement was untrue, inaccurate or misleading in any
respect at the date of the Placing Agreement or is untrue, inaccurate or misleading in any respect by reference to the facts and circumstances existing as at the date hereof; 

 

	 	(d)	 since the date of the Final Prospectus, there has been no significant change affecting any matter contained in
the Final Prospectus and no significant new matter has arisen for the purposes of section 87G FSMA which requires a Supplementary Prospectus to be published; and 

  
 102 

	 	(e)	 since the date of the Placing Agreement there has been no Material Adverse Change. 

This letter shall be governed by and construed in accordance with English law. 

Yours faithfully 
  

    
                                         
                                        

[Insert name of Founder] / [Director, duly authorised, for and on behalf of [Founder Entity] 

  
 103 

 Schedule 7 

Definitions 
 Accountants’ Reports
means the reports in the agreed form prepared by the Reporting Accountants on: 
  

	 	(a)	 the Historical Financial Information; 

 

	 	(b)	 the Company’s financial position and prospects procedures, established by the Directors; and

  

	 	(c)	 any significant change in the financial or trading position of the Company since incorporation,

 including any updates and supplements thereto 

Accounts Date means 8 November 2019 
 Accredited
Investor means an accredited investor within the meaning of Rule 501(a) of Regulation D 
 Accredited Investor Letter means an investor letter
substantially in the form set out in Appendix 1 hereto, to be delivered by any Placee who is located in the United States and to whom New Shares and Warrants have been placed but who is not a Qualified Institutional Buyer 

Acquisition means the initial acquisition by the Company or by any subsidiary thereof (which may be in the form of a merger, capital stock exchange,
asset acquisition, stock purchase, scheme of arrangement, reorganisation or similar business combination) of an interest in an operating company or business as described in the Pathfinder Prospectus and the Final Prospectus 

Administrator means Oak Fund Services (Guernsey) Limited or such other administrator as may be appointed by the Company from time to time  

Admission means the admission of the whole of the Company’s Ordinary Share capital, issued and to be issued under the arrangement referred to in
this Agreement, and the Warrants to the standard listing segment of the Official List becoming effective in accordance with the Listing Rules and the admission of such share capital to trading on the London Stock Exchange’s main market for
listed securities becoming effective in accordance with the Admission and Disclosure Standards 
 Admission and Disclosure Standards means the
Admission and Disclosure Standards of the London Stock Exchange (as amended from time to time) 
 Affiliate has the meaning given in Rule 501(b) of
Regulation D or Rule 405 under the Securities Act, as applicable, and Affiliates shall be construed accordingly 

  
 104 

 Agreed Rate means the rate of 2% per annum above the base rate set by the Bank of England from time
to time 
 AIFMD means the Alternative Investment Fund Managers Directive (2011/61/EU)  

AI Placee means each accredited investor whose name, contact details and allocation of AI Placee Units is set out in clause 6.1 (together, the AI
Placees) 
 AI Placee Units has the meaning given to that term in clause 6.1  

Anti-Corruption Laws means any applicable law, rule, regulation or other legally binding measure relating to the prevention of bribery, corruption,
fraud or similar related activities in any country, including (without limitation) the FCPA, the OECD Convention or the Bribery Act 
 Applicable Time
means 7.00 a.m. (London time) on 12 December 2019, or such other time as agreed by the Company and the Banks 
 Applications for Admission
means the applications to (i) the FCA for admission of the Shares and Warrants to the standard listing segment of the Official List; (ii) the London Stock Exchange for admission of the Shares and Warrants to trading on its main market for
listed securities, and (iii) Euroclear for admission of the Depositary Interests as participating securities (as defined in the CREST Regulations) in CREST 

Articles of Association means the articles of association of the Company in force from time to time 

associate means a company or undertaking in which the party has or, at the relevant time to which any provision of this Agreement in which the term is
used relates, had a direct or indirect interest entitling it to receive, or to include or reflect in its accounts, more than 30 per cent of the annual income or profits of the company or undertaking concerned or in relation to which the
relevant party to this Agreement is able to remove directors (or their equivalent) able to cast the majority of votes on any material matter, and associates shall be construed accordingly 

Associated Person has the meaning given in of section 8 of the Bribery Act 

Banks means UBS, and Morgan Stanley and Bank shall be construed accordingly 

Banks’ Counsel means Herbert Smith Freehills LLP of Exchange House, Primrose Street, London EC2A 2EG, legal counsel to the Banks 

Board of Directors or Board means the board of directors of the Company (or a duly constituted and authorised committee thereof) 

Bribery Act means the Bribery Act 2010 (as amended) 

  
 105 

 Business Day means a day not being a Saturday or a Sunday on which Banks are open for business in
London and the British Virgin Islands 
 BVI or British Virgin Islands means the territory of the British Virgin Islands 

BVI Companies Act means the BVI Business Companies Act, 2004 (as amended) 

Certificated Units means any New Shares and Warrants comprising Units to be held in certificated form after Admission 

City Code means The City Code on Takeovers and Mergers (as amended from time to time) CJA means the Criminal Justice Act 1993 (as amended)
Claim has the meaning set out in clause 10 and Claims shall be construed accordingly 
 Close Relatives means, in respect of any
person: 
  

	 	(a)	 the person’s spouse, civil partner or co-habitant;

  

	 	(b)	 the person’s children, parents, brothers, sisters, grand-children and grand-parents, and those of any
person described in (a); and 

  

	 	(c)	 the spouse, civil partner or co-habitant of any person described in (b)

 Closing Date means 17 December 2019 or such later date (being not later than the Long Stop Date) for settlement of
subscriptions (as the case may be) under the Offer, as the Company and the Banks may agree in writing (including as a result of any postponement by the Banks pursuant to clauses 15.5 or 16.4) 

Company’s Counsel means 
  

	 	•	 	 as to US law, Greenberg Traurig, LLP, 200 Park Avenue, New York, New York 10166; 

 

	 	•	 	 as to English law, Greenberg Traurig, LLP, The Shard, Level 8, 32 London Bridge Street, London SE1 9SG; and

  

	 	•	 	 as to British Virgin Islands law, Maples and Calder, Kingston Chambers, PO Box 173, Road Town, Tortola, British
Virgin Islands 

 Company Secretary means the Company’s company secretary, Oak Fund Services (Guernsey) Limited of Regency
Court, Glategny Esplanade, St. Peter Port, Guernsey 
 Conditions means the conditions set out in clause 15.1 of this Agreement and Condition
shall be construed accordingly 

  
 106 

 Corporate Administration Agreement means the corporate administration agreement dated on or around
12 December 2019 between the Company and the Administrator 
 CREST means the system of paperless settlement of trades and holding of
uncertificated shares administered by Euroclear 
 CREST Application Form means a security application form in the form published by Euroclear
applying for the Depositary Interests to be admitted to CREST as a participating security 
 CREST Enablement Letter means a letter in the agreed
form confirming that all conditions relating to the admission of the Depositary Interests to CREST (including Admission) have been satisfied and requesting that the Depositary Interests be enabled immediately for settlement in CREST 

CREST Rules means the rules published by Euroclear from time to time with respect to the provision and operation of CREST 

Default AI Placee Units has the meaning given to that term in clause 6.4 Defaulted Underwritten Units has the meaning given to that term in
clause 16.1 Defaulting Bank has the meaning given to that term in clause 16.1 
 Depositary means Computershare Investor Services PLC or any
other depositary appointed by the Company from time to time 
 Depositary Agreement means the depositary agreement dated on or around
12 December 2019 between the Company and the Depositary under which the Company appoints the Depositary to constitute and issue, from time to time, upon the terms of the Depositary Interest Deed Poll, a series of depositary interests of the
Company representing Ordinary Shares and Warrants, as the case may be, and to provide certain other services in connection with such Depositary Interests 

Depositary Interest Deed Poll means the deed poll dated 5 December 2019 and executed by the Depositary in favour of the holders of Depositary
Interests from time to time, pursuant to which the Depositary Interests are created and issued  
 Depositary Interests means the
dematerialised depositary interests in respect of the Ordinary Shares and Warrants issued or to be issued by the Depositary 
 directed selling
efforts has the meaning given in Regulation S 
 Directors means the Founder Directors and the Independent
Non-Founder Directors and Director shall be construed accordingly 

  
 107 

 Director’s Questionnaire means, in relation to any Director, his declaration to the Banks in the
agreed form concerning certain personal, employment and business matters relating to him and duly signed and dated by the relevant Director 

Director’s Responsibility Statement means, in relation to any Director, the letter completed by him and addressed to the Company and the Banks in
the agreed form, among other things, accepting responsibility for the information contained in the Pathfinder Prospectus, the Final Prospectus and any Supplementary Prospectus, duly signed for, or on behalf of, the relevant Director on or prior to
the date of this Agreement 
 Disclosure Package means the Pathfinder Prospectus (as amended or supplemented at the Applicable Time) together with
the placing announcement giving details of the Offer, to be dated on or around 12 December 2019  
 Disclosure Requirements means
Articles 17, 18 and 19 of MAR 
 DTRs means the disclosure guidance provided by the FCA and the Transparency Rules (each as amended from time to
time)  
 EEA means the European Economic Area 

Encumbrance means any pledge, lien, security interest, claim, equity, mortgage, charge, encumbrance and/or third party right or interest of any nature
whatsoever or any agreement or arrangement having the effect of conferring any of the foregoing 
 Euroclear means Euroclear UK & Ireland
Limited, a company incorporated in England and Wales, being the Operator of CREST 
 Exchange Act means the US Securities Exchange Act of 1934 (as
amended) 
 FCA means the Financial Conduct Authority acting in the exercise of its functions under Part VI FSMA and in the exercise of its functions
in respect of admission to the Official List otherwise than in accordance with Part VI FSMA, including (where the context so permits) any committee, employee, officer or servant to whom any function of the Financial Conduct Authority may for the
time being be delegated 
 FCA Handbook means the Financial Conduct Authority Handbook of Rules and Guidance and all other rules and regulations made
by the FCA under FSMA 
 FCPA means the US Foreign Corrupt Practices Act of 1977 (as amended) 

Final Prospectus means the prospectus in the agreed form to be published by the Company in relation to the Offer and dated the same date as this
Agreement 

  
 108 

 Foreign Jurisdiction has the meaning given in clause 19 

Foreign Proceedings has the meaning given in clause 19 

Founder means William N. Thorndike, Jr., W. Nicholas Howley, Tracy Britt Cool, Vivek Raj and Haitham Khouri 

Founder Advisory Agreement means the founder advisory agreement dated 12 December 2019 between the Company and EverArc Founders 

Founder Committed Units has the meaning given to that term in clause 5.1  

Founder Directors means William N. Thorndike, Jr., W. Nicholas Howley and Tracy Britt Cool, acting in their capacity as
non-executive directors of the Company  
 Founder Shares means the founder shares subscribed for by
EverArc Founders on 14 November 2019 
 Founders’ Insider Letters means the insider letters, in the agreed form, to be entered into by each
of the Founders and the Founder Entities in relation to (inter alia) potential acquisition opportunities and addressed to the Company and the Banks, dated on or around the date of this Agreement (each a Founder Insider Letter) 

FS Act means the Financial Services Act 2012 
 FSMA
means the Financial Services and Markets Act 2000 (as amended) 
 general advertising shall be construed in the manner that such term is used in
Rule 502 under the Securities Act; 
 general solicitation shall be construed in the manner that such term is used in Rule 502 under the Securities
Act; 
 Group means a company together with its subsidiaries, subsidiary undertakings, Affiliates and associates and Group Company or
member of a Group shall be construed accordingly 
 Historical Financial Information means the balance sheet of the Company as at
8 November 2019, including the notes thereto, contained in Part VI (Financial Information on the Company) of the Pathfinder Prospectus and the Final Prospectus  

IFRS means international financial reporting standards issued by the International Accounting Standards Board and as adopted by the European Union 

Implementation Date has the meaning given in paragraph 2 of Schedule 4 

  
 109 

 Indemnified Person means each UBS Indemnified Person and each Morgan Stanley Indemnified Person and
Indemnified Persons shall be construed accordingly 
 Indemnity Letter means the indemnity letter dated 28 November 2019 between EverArc
Founders and the Banks  
 Independent Non-Founder Director Committed Units has the meaning given to
that term in clause 5.3 
 Independent Non-Founder Director Insider Letters means the insider letters, in the
agreed form, to be entered into by each of the Independent Non-Founder Directors in relation to (inter alia) potential acquisition opportunities and addressed to the Company and the Banks, dated on or
around the date of this Agreement (each an Insider Non-Founder Director Insider Letter) 
 Independent Non-Founder Directors means Adam L. Hall, Bram Belzberg, John Staer and Michael Tobin OBE 
 Insider Letters
means, together, the Founders’ Insider Letters and the Independent Non-Founder Directors’ Insider Letters 

Investment Company Act means the US Investment Company Act of 1940 (as amended); 

Listing Rules or LR means the listing rules made by the FCA under Part VI FSMA and forming part of the FCA’s Handbook of rules and guidance
(as amended from time to time) 
 London Stock Exchange means London Stock Exchange plc 

Long Stop Date means 31 December 2019 
 Loss
has the meaning ascribed to it in clause 10 and Losses shall be construed accordingly 
 MAR means the EU Market Abuse Regulation
(EU596/2014) and all delegated or implementing regulations relating to that Regulation  
 Material Adverse Change means any material adverse
change in, or any development involving a prospective material adverse change in or affecting, the condition (financial, operational, legal or otherwise), or in the earnings, management, business affairs, business prospects, financial prospects or
solvency of the Company, whether or not arising in the ordinary course of business, whether or not foreseeable at the date of this Agreement and whether or not covered by insurance 

Memorandum of Association means the memorandum of association of the Company, from time to time  

Morgan Stanley Indemnified Person means any of the following: 

  
 110 

	 	(a)	 any member of Morgan Stanley’s Group or any of its or their respective Affiliates; 

 

	 	(a)	 a person who is, on or at any time after the date of this Agreement, a director, officer, employee or agent of
any undertaking specified in sub paragraph (a) above, 

 and Morgan Stanley Indemnified Persons shall be construed accordingly

 New Shares means the 34,000,000 new Ordinary Shares to be issued by the Company pursuant to the Offer 

OECD Convention means the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions 

Offer means the offer of the Units to institutional investors in certain jurisdictions on the terms and conditions set out in the Offer Documents 

Offer Documents means the pre-Pathfinder prospectus dated 28 November 2019 shared with certain potential
investors, the Pathfinder Prospectus and the Final Prospectus (and any amendment or supplement to either of them); the Presentation Materials; the Press Announcements; and any other announcement or document published or issued by or on behalf of the
Company, the Founders and/or the Founder Entities in connection with the Offer (including any presentation or presentation materials) 
 Offer
Expenses means all properly and reasonably incurred costs, fees, charges and expenses of, or incidental to, the Offer, the Applications for Admission, Admission and the arrangements referred to in, or contemplated by, this Agreement including,
without limitation: the listing fees; all costs and expenses incurred by the Banks in connection with the offer of Units to the AI Placees; all expenses in connection with the preparation, printing and distribution or circulation (including courier
costs) of any documents in relation to the Offer; any filing fees and other expenses in connection with the qualification of the Units to be offered and sold in any jurisdiction, including costs in relation to the bookbuild; travel and accommodation
costs; costs and expenses incurred in connection with investor meetings and presentations, including the costs of Netroadshow software; the costs and expenses of the Registrar and any transfer agent, custodian or depository; the Company’s and
the Banks’ legal fees (provided that the fees payable to the Banks’ legal counsel in connection with the matters contemplated by this Agreement shall not exceed the amount agreed separately in writing between the Banks and the Founders)
and reporting accountants, and other professional fees, disbursements and expenses; 
 Offer Price means USD 10.00 in cash per Unit 

Official List means the list maintained by FCA in accordance with Section 74(1) of FSMA for the purposes of Part VI of FSMA 

Ordinary Shares means ordinary shares of no par value in the capital of the Company excluding, for the avoidance of doubt, the Founder Shares

  
 111 

 Pathfinder Prospectus means the document in the agreed form issued on 5 December
2019 in connection with the Offer 
 PFIC means passive foreign investment company and has the meaning given in Section 1297 of the United
States Internal Revenue Code of 1986, as amended 
 Placees means persons procured by the Banks in accordance with this Agreement to subscribe for
Underwritten Units pursuant to the Offer 
 Presentation Materials means the investor roadshow presentations and presentation materials dated
5 December 2019 and investor term sheet dated 5 December 2019 and used by the Company, the Founders and/or the Founder Entities in meetings with institutional investors in connection with the Offer 

Press Announcements means: 
  

	 	(a)	 the placing announcement giving details of the Offer, to be dated on or around 12 December 2019;

  

	 	(b)	 the announcement of the publication of the Final Prospectus, to be dated on or around 12 December 2019;

  

	 	(c)	 the announcement of Admission, to be dated on or around 17 December 2019; and 

 

	 	(d)	 any other press release relating to the Offer (including any press release issued in connection with the
publication of any Supplementary Prospectus), 

 in each case in the agreed form 

Prospectus Regulation has the meaning given in paragraph 2 of Schedule 4 

Prospectus Regulation Rules or PRR means the prospectus regulation rules made by the FCA under Part VI FSMA and forming part of the
FCA’s Handbook of rules and guidance (as amended from time to time) 
 Qualified Institutional Buyer means qualified institutional buyer within
the meaning of Rule 144A under the Securities Act 
 Registrar means Computershare Investor Services (BVI) Limited or any other registrar appointed
by the Company from time to time 
 Registrar Agreement means the registrar agreement dated on or around 12 December 2019 between the Company
and the Registrar, details of which are disclosed in paragraph 14.4 of Part VIII (Additional Information) of the Final Prospectus 
 Regulation D
means Regulation D under the Securities Act 

  
 112 

 Regulation S means Regulation S under the Securities Act 

Regulatory Information Service means any of the services set out in Appendix 3 to the Listing Rules 

Relevant Proportion means: 
  

	 	(a)	 in respect of UBS, 50 per cent.; and 

 

	 	(b)	 in respect of Morgan Stanley, 50 per cent. 

Relief means any loss, allowance, credit or other relief relating to any Taxation or to the computation of income, profits or chargeable gains for the
purposes of any Taxation 
 Reporting Accountants means Grant Thornton UK LLP of 30 Finsbury Square, London EC2A 1AG 

Rule 144A means Rule 144A under the Securities Act 

Sanctions Laws and Regulations means any sanctions administered or enforced by the US Government (including without limitation by the Office of Foreign
Assets Control of the US Treasury Department (“OFAC”) or The US Department of State and including, without limitation, a designation as a “Specially designated national” or “blocked person” or inclusion in any
other Sanctions List) or any equivalent sanctions or measures imposed by the United Nations Security Council , the European Union, Her Majesty’s Treasury or other relevant sanctions authority 

Sanctions List means the “Specially Designated Nationals and Blocked Persons List” maintained by OFAC which can be found at:
https://www.treasury.gov/ofac/downloads/sdnlist.pdf, the list of Foreign Financial Institution, subject to Part 561 maintained by OFAC, or any similar sanctions list maintained by, or public announcement of sanctions designation made by, any US
government agency, the United Nations, the European Union, Her Majesty’s Treasury or other relevant sanctions authority 
 Securities Act means
the US Securities Act of 1933 (as amended) 
 Settlement Bank means Morgan Stanley 

Shareholder means any holder of Ordinary Shares from time to time 

subsidiary means a subsidiary or a subsidiary undertaking as defined in sections 1159 or 1162 Companies Act respectively and in interpreting those
sections for the purposes of this Agreement, a company is to be treated as a member of a subsidiary or a subsidiary undertaking as the case may be even if its shares are registered in the name of (a) a nominee, or (b) any party holding
security over those shares, or that secured party’s nominee 
 Supplementary Prospectus means any supplementary Prospectus required by section
87G FSMA to be published by the Company in connection with Admission and the Offer 

  
 113 

 Tax or Taxation means all taxes, levies, imposts or duties whether of the United Kingdom or
elsewhere and any withholdings of or on account of any of the foregoing, together with all penalties, charges and interest relating to any of the foregoing and regardless of whether the person concerned is primarily or directly liable or not and
regardless of whether such taxes, levies, imposts, duties, withholdings, penalties and interest are attributable directly or primarily to the person concerned or not, including (without limitation) corporation tax, income tax, capital gains tax,
VAT, national insurance contributions, stamp duty, stamp duty reserve tax, and all other taxes on gross or net income, profits or gains, distributions, receipts, sales, use, occupation, franchise, value added, and personal property 

Tax Authority means any taxing or other authority (whether within or outside the United Kingdom) legally competent to impose any liability to Tax 

Transparency Rules means the transparency rules made by the FCA under section 73A(6) of FSMA (as amended from time to time)  

UBS Indemnified Person means any of the following: 
  

	 	(a)	 any member of UBS’s Group or any of its or their respective Affiliates; 

 

	 	(b)	 a person who is, on or at any time after the date of this Agreement, a director, officer, employee or agent of
any undertaking specified in sub-paragraph (a) above, 

 and UBS Indemnified Persons
shall be construed accordingly 
 Underwritten Units has the meaning given to that term in Recital G  

Units has the meaning given to that term in Recital D, and comprises the Underwritten Units and the Founder Committed Units and the Independent Non-Founder Committed Units  
 US or United States has the meaning given to such term in Regulation
S 
 VAT means value added tax chargeable under Council Directive 2006/112/EC or any laws implementing such Directive in any jurisdiction or any
similar tax in any jurisdiction 
 Verification Notes means the verification notes, in the agreed form, comprising the verification bundle index and
the supporting materials, prepared in connection with the Offer Documents and the Presentation Materials 
 Warrant means a warrant to subscribe for one-fourth of an Ordinary Share, issued (or to be issued) pursuant to the Warrant Instrument 
 Warranties means
the representations and warranties given pursuant to clause 9 and Schedule 2 and Warranty means any one of them 

  
 114 

 Warrant Instrument means the instrument constituting the Warrants, executed by the Company on or
around 12 December 2019 
 Warrantor means, in relation to any Warranty, the party expressed in this Agreement to be giving a Warranty in the
terms of that Warranty 
 Working Hours means 9.30 a.m. to 5.30 p.m. in the relevant location on a Business Day 

  
 115 

 Appendix 1 

Form of Accredited Investor Letter 

EverArc Holdings Limited 
 Kingston Chambers 

PO Box 173 
 Road Town, Tortola 

British Virgin Islands 
 UBS AG, London Branch 

5 Broadgate 
 London EC2M 2QS 

Morgan Stanley & Co. International plc 
 25 Cabot Square

 London 
 E14 4QA 

(each of UBS AG, London Branch and Morgan Stanley & Co. International plc being a Placing Bank and together, the Placing Banks) 

Ladies and Gentlemen 
 Subscription for new ordinary shares
of no par value (the New Ordinary Shares) and matching warrants (Matching Warrants and together the Securities) of EverArc Holdings Limited (the Company) 

In connection with our subscription for Securities of the Company, we represent, warrant, agree and acknowledge as follows: 

 

	1	 We are subscribing for the Securities for investment purposes, and not with a view to distribution or resale,
directly or indirectly, in the United States. 

  

	2	 We acknowledge that we have received and read a copy of the pathfinder prospectus dated 5 December 2019
and the placing announcement dated 12 December 2019 relating to the Securities (together the Prospectus). In particular, we have read the section titled “Risk Factors” as set out in the Prospectus. We have had access to such
information regarding the Company and the Securities and have made such investigation with respect thereto as we deem necessary to make our investment decision and we have made our own assessment and have satisfied ourselves concerning the relevant
tax, legal, currency and other economic considerations relevant to our investment in the Securities. We have had the opportunity to ask questions and receive answers concerning the terms and conditions of the offering of the Securities.

  
 116 

	3	 We acknowledge that neither of the Placing Banks is making any recommendations to us or advising us regarding
the suitability or merits of any transaction we may enter into in connection with the Placing, and we acknowledge that participation in the Placing is on the basis that we are not and will not be a client of either of the Placing Banks and that the
Placing Banks are acting for the Company and no one else in connection with the Placing, and will not be responsible to anyone other than their respective clients for the protections afforded to their clients, nor for providing advice in relation to
the Placing, the contents of the Prospectus or any transaction, arrangements or other matters referred to herein, or in respect of any representations, warranties, undertakings or indemnities contained in the Placing Agreement or for the exercise or
performance of the Placing Banks’ rights and obligations under the Placing Agreement, including any right to waive or vary any condition or exercise any termination right contained therein. 

 

	4	 We hereby acknowledge to the Placing Banks and the Company that we have been warned that an investment in the
Securities is only suitable for acquisition by the person who: 

  

	 	(a)	 has a significantly substantial asset base such that would enable the person to sustain any loss that might be
incurred as a result of acquiring the Securities; and 

  

	 	(b)	 is sufficiently financially sophisticated to be reasonably expected to know the risks involved in acquiring the
Securities. 

  

	5	 We are an “accredited investor” (AI) within the meaning of Regulation D under the US
Securities Act of 1933, as amended (the Securities Act), and are acquiring the Securities for our own account or for the account of an AI. We meet the criteria for being an AI on the basis that we are one of the following:

  

	 	(a)	 a bank, insurance company, registered investment company, business development company, or small business
investment company; 

  

	 	(b)	 a charitable organisation, corporation, or partnership with assets exceeding $5 million;

  

	 	(c)	 a business in which all the equity owners are AIs; 

 

	 	(d)	 a natural person who has individual net worth, or joint net worth with the person’s spouse, that exceeds
$1 million at the time of the purchase, excluding the value of the primary residence of such person; or 

  

	 	(e)	 a trust with assets in excess of $5 million not formed to acquire the securities offered, whose purchases
a sophisticated person makes. 

  
 117 

	6	 If we are acquiring Securities for the account of one or more AIs, we represent that we have sole investment
discretion with respect to each such account and that we have full power to make the acknowledgements, representations and agreements contained herein on behalf of each such account. 

 

	7	 Except with the express consent of the Company given in respect of a subscription for the Securities, no
portion of the assets used by us to purchase, and no portion of the assets used by us to hold the Securities or any beneficial interest therein constitutes or will constitute the assets of (a) an “employee benefit plan” that is
subject to Part 4 of Subtitle B of Title I of the Employee Retirement Income Security Act of 1974, as amended, (ERISA), (b) a plan, individual retirement account or other arrangement that is subject to Section 4975 of the Code, or
(c) entities whose underlying assets include “plan assets” of any plan, account or arrangement described in (a) or (b) above, or (d) any governmental plan, church plan, non-US plan or
other investor whose purchase or holding of Securities would be subject to any state, local, non-US or other laws or regulations similar to Part 4 of Subtitle B of Title I of ERISA or section 4975 of the Code
or that would have the effect of the regulations issued by the US Department of Labor set forth at 29 CFR section 251 0.3-1 01, as modified by section 3(42) of ERISA. 

 

	8	 If an entity, we were not formed for the purposes of investing in Securities of the Company.

  

	9	 We acknowledge that we are not acquiring the Securities as a result of any general solicitation or general
advertising (as those terms are defined in Regulation D under the Securities Act). 

  

	10	 We understand that the Securities are being offered in a transaction not involving any public offering in the
United States within the meaning of the Securities Act and have not been and will not be registered under the Securities Act, and that the Securities are “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act
and (a) we agree that the Securities may not be offered, resold, pledged or otherwise transferred except (i) outside the United States in a transaction complying with the provisions of Rule 903 or Rule 904 of Regulation S under the
Securities Act, (ii) to a person whom we reasonably believe is a “qualified institutional buyer” (QIB) within the meaning of Rule 144A under the Securities Act (Rule 144A) purchasing for its own account or for the
account of a QIB in a transaction meeting the requirements of Rule 144A, (iii) in accordance with Rule 144 under the Securities Act (if available), (iv) pursuant to another available exemption from the registration requirements of the Securities Act
or (v) pursuant to an effective registration statement under the Securities Act, in each case in accordance with any applicable securities laws of any state of the United States, and (b) we will, and each subsequent holder will be required
to, notify any subsequent purchaser of the Securities from us or it of the resale restrictions referred to in (a) above. 

  

	11	 We understand that the Company is not, and does not propose to be, registered as an investment company under
the Investment Company Act and the rules thereunder. If in the future we decide to offer, sell, transfer, assign, novate or otherwise dispose of the Securities, we will do so only under the circumstances which will not require the Company to
register under the US Investment Company Act. 

  
 118 

	12	 We are aware, and each beneficial owner of the Securities has been advised, that the issue of the Securities to
us is being made in reliance on Rule 144A or another exemption from the registration requirements of the Securities Act. 

  

	13	 We understand that no representation has been made as to the availability of Rule 144 or any other exemption
under the Securities Act for the reoffer, resale, pledge or transfer of the Securities. We understand that the Securities may not be deposited into any unrestricted depositary facility established or maintained by a depository bank, unless and until
such time as the Securities are no longer “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act. 

  

	14	 We acknowledge that any sale, transfer, assignment, novation, pledge or other disposal made other than in
compliance with such laws and the above-stated restrictions will be subject to the forfeiture and/or compulsory transfer provisions as provided in the Company’s articles of association. 

 

	15	 We satisfy any and all standards for investors in investments of the type subscribed for herein imposed by the
jurisdiction of our residence or otherwise applicable to us. 

  

	16	 We are empowered, authorised and qualified to purchase the Securities and the person signing this letter on our
behalf has been duly authorised by us to do so. 

  

	17	 We acknowledge the content of the Prospectus is exclusively the responsibility of the Company and the Directors
and none of the Placing Banks, the Registrars nor any person acting on their behalf nor any of their respective affiliates is responsible for or shall have any liability for any information, representation or statement contained in this letter or
any information published by or on behalf of the Company, and none of the Placing Banks, the Registrars nor any person acting on their behalf nor any of their respective affiliates will be liable for our decision to participate in the Placing based
on any information, representation or statement contained in this letter or otherwise. 

  

	18	 We have not relied on any information given or representations, warranties or statements made by the Company,
the Directors, the Founders, the Founder Entities, the Placing Banks, the Registrars or any other person in connection with the Placing other than information contained in the Prospectus and/or any supplementary prospectus or regulatory announcement
issued by or on behalf of the Company on or after the date hereof and prior to Admission. We irrevocably and unconditionally waive any rights we may have in respect of any other information or representation. 

  
 119 

 We understand that the foregoing representations, warranties, agreements and acknowledgments are required in
connection with United States and other securities laws and you and your respective affiliates, the Placing Banks and their respective affiliates and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations,
warranties and agreements. If any of the representations, warranties, agreements or acknowledgements made by us are no longer accurate or have not been complied with, we will immediately notify the Company. We irrevocably authorise you and your
respective affiliates and the Placing Banks and their respective affiliates to produce this letter to any interested party in any administrative or legal proceeding or official enquiry with respect to the matters set forth herein. 

Very truly yours 
  

                                         
                
 [Name of Investor] 

By: 
 Title: 

Address: 

  
 120 

							
	Signed by	  	  )  	 	 

        

            
	 	
		  	  )  	 	
		  	  )  	 	
	  
	  	  )  	 	
	for and on behalf of	  	  )  	 	Director	 	
	EVERARC HOLDINGS LIMITED                    	  	  )  	 		 	
		  	  )  	 		 	

 12 DECEMBER 
  

							
	 Signed for and on behalf of
 EVERARC
FOUNDERS, LLC
 a company incorporated in Delaware, USA,

acting by
	  	   )  

  )  
   )  
	  	 

 

    

                
  
	  	
		  	  )  	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	 who, in accordance with the laws of that
territory, is acting under the authority of the
Company

 
	  	   )  

  )  
   )  
	  		  	
	 Signed for and on behalf of
 LLANERCH
EVERARC, LLC
 a company incorporated in Ohio, USA, acting by
	  	   )  

  )  
   )  
	  		  	
		  	  )  	  	 	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	who, in accordance with the laws of that
territory, is acting under the authority of the
Company	  	   )  

  )  
	  		  	
				
	 Signed for and on behalf of
 TVR EVERARC,
LLC
 a company incorporated in Texas, USA,
acting by
	  	   )  

  )  
   )  
	  		  	
		  	  )  	  	 	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	who, in accordance with the laws of that
territory, is acting under the authority of the Company	  	   )  

  )  
	  		  	

 12 DECEMBER 
  

							
	 Signed for and on behalf of
 EVERARC
FOUNDERS, LLC
 a company incorporated in Delaware, USA,
acting by
	  	  )  
   )  

  )  
	  		  	
		  	  )  	  	 	  	
	  

who, in accordance with the laws of that
territory, is acting under the authority of the
Company
	  	  )  
   )  

  )  
   )  
	  	 (Signature of authorised person)
	  	
	  		  	
		  		  		  	
	 Signed for and on behalf of

LLANERCH EVERARC, LLC
 a company incorporated in Ohio, USA,
acting
by
	  	  )  
   )  

  )  
	  	 
     

  
	  	
	  		  	
	  	  )  	  	
	  

who, in accordance with the laws of that
territory, is acting under the authority of the
Company
	  	  )  
   )  

  )  
	  	 (Signature of authorised person)
	  	
	  		  	
		  		  		  	
	 Signed for and on behalf of
 TVR EVERARC,
LLC
 a company incorporated in Texas, USA,
acting by
	  	  )  
   )  

  )  
	  		  	
		  		  		  	
		  	  )  	  	 	  	
	  

who, in accordance with the laws of that
territory, is acting under the authority of the
Company
	  	  )  
   )  

  )  
	  	 (Signature of authorised person)
	  	
	  		  	

 12 DECEMBER 
  

							
	 Signed for and on behalf of
 EVERARC
FOUNDERS, LLC
 a company incorporated in Delaware, USA,

acting by
	  	  )  
   )  

  )  
	  		  	
		  	  )  	  	 	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	 who, in accordance with the laws of that

territory, is acting under the authority of the
 Company
	  	  )  
   )  

  )  
	  		  	
				
	 Signed for and on behalf of
 LLANERCH
EVERARC, LLC
 a company incorporated in Ohio, USA, acting

by
	  	  )  
   )  

  )  
	  		  	
		  	  )  	  	 	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	 who, in accordance with the laws of that

territory, is acting under the authority of the
 Company
	  	  )  
   )  
	  		  	
				
	 Signed for and on behalf of
 TVR EVERARC,
LLC
 a company incorporated in Texas, USA,
 acting
by
	  	  )  
   )  

  )  
	  	 

  
	  	
		  	  )  	  	
	  
	  	  )  	  	 (Signature of authorised person)
	  	
	 who, in accordance with the laws of that

territory, is acting under the authority of the
 Company
	  	  )  
   )  
	  		  	

							
	Signed by WILLIAM N. THORNDIKE, JR. 	  	  )	  	 

  
	  	
		  	  )	  	Signature	  	
				
	Signed by W. NICHOLAS HOWLEY 	  	  )	  	  
	  	
		  	  )	  	Signature	  	
				
	Signed by TRACY BRITT COOL 	  	  )	  	  
	  	
		  	  )	  	Signature	  	
				
	Signed by VIVEK RAJ 	  	  )	  	  
	  	
		  	  )	  	Signature	  	
				
	Signed by HAITHAM KHOURI 	  	  )	  	  
	  	
		  	  )	  	Signature	  	

							
	Signed by WILLIAM N. THORNDIKE, JR. 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by W. NICHOLAS HOWLEY 	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by TRACY BRITT COOL 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by VIVEK RAJ 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by HAITHAM KHOURI 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by WILLIAM N. THORNDIKE, JR. 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by W. NICHOLAS HOWLEY 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by TRACY BRITT COOL 	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by VIVEK RAJ 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by HAITHAM KHOURI 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by WILLIAM N. THORNDIKE, JR. 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by W. NICHOLAS HOWLEY 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by TRACY BRITT COOL 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by VIVEK RAJ 	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by HAITHAM KHOURI 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by WILLIAM N. THORNDIKE, JR. 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by W. NICHOLAS HOWLEY 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by TRACY BRITT COOL 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by VIVEK RAJ 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by HAITHAM KHOURI 	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	

							
	Signed by ADAM L. HALL	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by BRAM BELZBERG	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by JOHN STAER 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by MICHAEL TOBIN	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by ADAM L. HALL	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by BRAM BELZBERG	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by JOHN STAER 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by MICHAEL TOBIN	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by ADAM L. HALL	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by BRAM BELZBERG	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by JOHN STAER 	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	
				
	Signed by MICHAEL TOBIN	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	

							
	Signed by ADAM L. HALL	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by BRAM BELZBERG	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by JOHN STAER 	  	  )  	  	  
	  	
		  	  )  	  	Signature	  	
				
	Signed by MICHAEL TOBIN	  	  )  	  	 

  
	  	
		  	  )  	  	Signature	  	

							
	Signed by	  	  )  
   )  

  )  
   )  
	  	 

  
	  	
	
	
	 GORDON CHARLTON

	For and on behalf of	  	  )  	  	Duly authorised	  	
	MORGAN STANLEY & CO.	  	  )  	  		  	
	INTERNATIONAL PLC	  	  )  	  		  	
				
	Signed by	  	  )  	  		  	
		  	  )  	  		  	
		  	  )  	  		  	
	  
	  	  )  	  	  
	  	
		  	  )  	  	Duly authorised	  	
		  	  )  	  		  	
	and	  	  )  	  		  	
		  	  )  	  		  	
		  	  )  	  		  	
	  
	  	  )  	  	  
	  	
	For and on behalf of	  	  )  	  	Duly authorised	  	
	UBS AG, LONDON BRANCH	  	  )  	  		  	
		  	  )  	  		  	
		  	  )EX-10.5

 Exhibit 10.5 

EMPLOYMENT AGREEMENT 

THIS AGREEMENT, dated as of October 1, 2021 (this “Agreement”) is made by and between Perimeter Solutions, SA, a public
company limited by shares duly incorporated and validly existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 12E, rue Guillaume Kroll, L-1882 Luxembourg, Grand Duchy of
Luxembourg and registered with the Registre de Commerce et des Sociétés, Luxembourg (Luxembourg Trade and Companies Register) under number B 256.548 (the “Parent”), Perimeter Solutions LP, a Delaware limited
partnership (the “Company”), and Barry Lederman (the “Executive”). 
 RECITALS: 

WHEREAS, the Executive is currently employed by the Company; 

WHEREAS, upon the consummation of the transactions contemplated by the Business Combination Agreement (as defined herein) (the
“Closing”), the Company will become an indirect wholly owned subsidiary of the Parent; 
 WHEREAS, each party desires the
Executive to continue to provide his or her services to and be employed by the Company following the Closing, subject to and upon the terms and conditions set forth herein; and 

WHEREAS, the parties intend that this Agreement shall be conditioned and effective upon the Closing and, upon becoming effective, shall
supersede all prior employment related agreements between the Executive and the Company or any of its Affiliates. 
 NOW, THEREFORE, in
consideration of the foregoing and of the respective covenants and agreements set forth below, the parties hereto agree as follows: 

1.    Certain Definitions. 

(a)    “Affiliates” shall mean any entity, individual, firm, or corporation, directly or indirectly,
through one or more intermediaries, controlling, controlled by, or under common control with the Company. 

(b)    “Annual Base Salary” shall have the meaning set forth in Section 4(a). 

(c)    “Board” shall mean the Board of Directors of the Parent. 

(d)    “Business” shall mean the business of serving as a global solutions provider for the fire safety
and oil additives industries and any other business or operations conducted and operated by the Company and/or any of its Affiliates during the Term. 

(e)    “Business Combination Agreement” means that certain Business Combination Agreement, dated
June 15, 2021, by and among Parent, EverArc Holdings Limited, SK Invictus Holdings S.à r.l., SK Invictus Intermediate S.à r.l., and EverArc (BVI) Merger Sub Limited, as it may be amended, supplemented or otherwise modified from
time to time. 
 (f)    “Cause” shall mean either of the following: (i) the repeated failure by
the Executive, after written notice from the Board, substantially to perform his or her material duties and responsibilities as an officer or employee or director of the Company or any of its Affiliates, as applicable (other than any such

 
failure resulting from incapacity due to reasonably documented physical or mental illness), or (ii) any willful misconduct by the Executive that has the effect of materially injuring the
Business, including, without limitation, the disclosure of material secret or confidential information of the Company or any of its Affiliates. 

(g)    “COBRA” shall mean the Consolidated Omnibus Budget Reconciliation Act of 1985, as may be amended
from time to time. 
 (h)    “Code” shall mean the Internal Revenue Code of 1986, as amended. Reference
to a Section of the Code includes all rulings, regulations, notices, announcements, decisions, orders and other pronouncements that are issued by the United States Department of the Treasury, the Internal Revenue Service, or any court of competent
jurisdiction that are lawful and pertinent to the interpretation, application or effectiveness of such Section. 

(i)    “Company” shall have the meaning set forth in the preamble hereto. 

(j)    “Compensation Committee” shall mean the Compensation Committee of the Board whose members shall be
appointed by the Board from time to time. 
 (k)    “Competitor” shall mean any corporation,
partnership, firm, proprietorship or other business organization that engages in any Competitive Activity. 

(l)    “Competitive Activities” shall mean any activity or service that competes with the Business;
provided that it shall not include the passive ownership of securities of entities which are listed on a national securities exchange or traded in the national
over-the-counter market in an amount which shall not exceed two percent (2%) of the outstanding shares of any such entity. 

(m)    “Date of Termination” shall mean (i) if the Executive’s employment is terminated by
reason of his or her death, the date of his or her death, and (ii) if the Executive’s employment is terminated pursuant to Sections 5(a)(ii) – (vi), the date specified in the Notice of Termination. 

(n)    “Disability” shall mean the Executive’s absence from employment with the Company due to:
(i) his or her inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which, with a very high degree of medical certainty, can be expected to result in death or to last for
a continuous period of not less than twelve months; or (ii) such medically determinable physical or mental impairment, which, with a high degree of medical certainty, can be expected to result in death or to last for a continuous period of not
less than twelve months, and for which the Executive is receiving income replacement benefits for a period of not less than three months under an accident and health plan covering the Company’s employees. 

(o)    “Effective Date” shall mean the date of the Closing. 

(p)    “Equity Compensation Agreements” shall mean any written agreements between the Parent and the
Executive pursuant to which the Executive holds or is granted any equity incentive awards, including, without limitation, agreements evidencing options granted under any equity incentive plan adopted or maintained by the Parent for Company employees
generally, and any management deferred compensation or similar plans of the Parent. 
 (q)    “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended. 
 (r)    “Executive” shall
have the meaning set forth in the preamble hereto. 

 (s)    “Good Reason” shall mean the occurrence of any
of the following: (i) a material diminution in the Executive’s title, duties or responsibilities without Cause and without his or her prior written consent, (ii) a reduction of the Executive’s base salary or target annual bonus
opportunity or a reduction in other benefits or perquisites that is material in the aggregate (except where such reduction is in connection with a diminution in role for Cause), without his or her prior written consent, (iv) any relocation of
more than forty (40) miles of Executive’s primary work place as of the Effective Date without his or her prior written consent, or (iv) any material breach of (x) this Agreement by the Company, or (y) the Equity Compensation
Agreements by the Parent. 
 (t)    “Notice of Termination” shall have the meaning set forth in
Section 5(b). 
 (u)    “Payment Period” shall have the meaning set forth in Section 6(b).

 (v)    “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange
Act and used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) thereof. 

(w)    “Restricted Territory” shall mean anywhere in the world where the Company (directly or indirectly
through any of its Affiliates) conducts its Business during the Term. 
 (x)    “Specified Employee”
shall have the meaning set forth in Code Section 409A. 
 (y)    “Term” shall have the meaning set
forth in Section 2. 
 2.    Employment. The Company shall employ the Executive, for the period set forth in this
Section 2, in the position(s) set forth in Section 3 and upon the other terms and conditions herein provided. The term of employment under this Agreement (the “Term”) shall commence on the Effective Date and shall continue
until terminated pursuant to Section 5. 
 3.    Position and Duties. During the Term, the Executive shall serve as Chief
Financial Officer of the Company and any reasonably corresponding officer position of the Parent to the extent appointed by the Board, in each case with such customary responsibilities, duties and authority as may from time to time be assigned to
the Executive by the Chief Executive Officer or the Board or the board of directors of the Company. During the Term, the Executive shall devote substantially all his or her working time and efforts to the business and affairs of the Company and its
Affiliates; provided, that it shall not be considered a violation of the foregoing for the Executive to (i) with the prior consent of the Board (which consent shall not unreasonably be withheld), serve on corporate, industry, civic or
charitable boards or committees, and (ii) manage his or her personal investments, so long as none of such activities significantly interferes with the Executive’s duties hereunder. 

4.    Compensation and Related Matters. 

(a)    Annual Base Salary. During the Term (commencing as of the first pay period following the Effective Date),
the Executive shall receive a base salary at a rate of $380,000 per annum, payable in accordance with the Company’s normal payroll practices, which shall be reviewed by the Compensation Committee annually and may be increased, but not
decreased, upon such review (the “Annual Base Salary”). 
 (b)    Bonus. For each fiscal year
during the Term, the Executive shall be eligible to participate in any annual cash bonus plan of the Company or Parent, as applicable, in effect from time to time. The Executive’s bonus for fiscal year 2021 shall be the amount determined in
accordance with the bonus plan in effect at the Company as of the date of this Agreement, and thereafter Executive’s target bonus will be 50% of his or her Annual Base Salary and may be pro rated based on time in position. 

 (c)    Long Term Incentive Compensation. During the Term, the
Executive shall be entitled to participate in the 2021 Equity Incentive Plan or any other equity incentive plan adopted by the Parent. 

(d)    Benefits. During the Term, the Executive shall be entitled to participate in the other employee benefit
plans, programs and arrangements of the Company or Parent, as applicable, now (or, to the extent determined by the Board or Compensation Committee, hereafter) in effect which are applicable to the senior officers of the Company or Parent generally,
as applicable, subject to and on a basis consistent with the terms, conditions and overall administration thereof (including the right of the Company or Parent to amend, modify or terminate such plans). 

(e)    Expenses. Pursuant to any customary policies of the Company in force at the time of payment, the Executive
shall be reimbursed for all expenses properly incurred by the Executive on the Company’s behalf in the performance of the Executive’s duties hereunder. 

(f)    Vacation. The Executive shall be entitled to an amount of annual vacation days, and to compensation in
respect of earned but unused vacation days, in an amount not less than twenty (20) days (not including paid holidays) or such higher amount in accordance with the Company’s vacation policy as in effect from time to time applicable to
senior officers of the Company or Parent generally. 
 (g)    Living Expenses. For so long as the Executive does
not live in the St. Louis metro area, the Executive will be entitled to a reasonable reimbursement amount to be mutually agreed upon by the Executive and the Company for Executive’s reasonable out-of-pocket living expenses associated with Executive commuting to the St. Louis metro area. Such living expenses shall consist of monthly rent, a rental car, meals and the price of a first class airfare
ticket associated with Executive traveling to/from Wayne, New Jersey to the St. Louis metro area; provided that, Executive shall use commercially reasonable efforts to minimize the price of such first class airfare, including by booking tickets in
advance and utilizing any available free upgrades. 
 5.    Termination. 

(a)    This Agreement shall terminate, and be void ab initio, with no further action by or liability to any party upon the
earlier of (1) termination of the Business Combination Agreement and the transactions contemplated therein for any reason, and (2) termination of Executive’s employment with the Company or Perimeter Solutions North America, Inc., a
Delaware corporation, prior to the Effective Date for any reason. During the Term, the Executive’s employment hereunder may be terminated by the Company or the Executive, as applicable, without any breach of this Agreement only under the
following circumstances and in accordance with subsection (b): 
 (i)    Death. The
Executive’s employment hereunder shall terminate upon his or her death. 

(ii)    Disability. If the Company determines in good faith that the Executive has incurred a
Disability, the Company may give the Executive written notice of its intention to terminate the Executive’s employment. In such event, the Executive’s employment with the Company shall terminate effective on the 30th day after receipt of
such notice by the Executive, provided that within such 30 day period the Executive shall not have returned to full-time performance of his or her duties. The Executive shall continue to receive his or her Annual Base Salary until the 90th day
following the date of the Notice of Termination. 

 (iii)    Termination for Cause. The Company may
terminate the Executive’s employment hereunder for Cause. 
 (iv)    Resignation for Good
Reason. The Executive may terminate his or her employment hereunder for Good Reason. 

(v)    Termination without Cause. The Company may terminate the Executive’s employment
hereunder without Cause. 
 (vi)    Resignation without Good Reason. The Executive may resign his
or her employment hereunder without Good Reason. 
 (b)    Notice of Termination. Any termination of the
Executive’s employment by the Company or by the Executive under this Section 5 (other than termination pursuant to subsection (a)(i)) shall be communicated by a written notice from the Chief Executive Officer of the Company or the
Executive to the other indicating the specific termination provision in this Agreement relied upon (and, in the case of Resignation for Good Reason, setting forth in reasonable detail the facts and circumstances claimed to provide a basis for
termination of the Executive’s employment under Section 5(a)(iv)), and specifying a Date of Termination which, in the case of Resignation for Good Reason or Resignation without Good Reason pursuant to Section 5(a)(iv) or 5(a)(vi),
respectively, shall be at least 90 days following the date of such notice (a “Notice of Termination”). In the event of the Executive’s Resignation for Good Reason pursuant to Section 5(a)(iv), the Company shall have the
right, if the basis for such Good Reason is curable, to cure the same within 30 days following the receipt of the Notice of Termination, and Good Reason shall not be deemed to exist if the Company cures the event giving rise to Good Reason within
such 30 day period. The Executive shall continue to receive his or her Annual Base Salary, annual bonus and all other compensation and perquisites referenced in Section 4 through the Date of Termination. 

6.    Severance Payments. 

(a)    Termination for any Reason. In the event the Executive’s employment with the Company is terminated for
any reason, the Company shall pay the Executive (or his or her beneficiary in the event of his or her death) any unpaid Annual Base Salary that has accrued as of the Date of Termination, any unreimbursed expenses due to the Executive in accordance
with the Company’s expense reimbursement policy and an amount equal to compensation for accrued but unused sick days and vacation days. The Company shall permit the Executive to elect to continue health plan coverage in accordance with the
requirements of applicable law (e.g., COBRA coverage), at the applicable monthly cost charged for such coverage (the “Monthly COBRA Coverage Continuation Rate”). The Company may require the Executive to complete and file any
election forms that are generally required of other employees to obtain COBRA coverage; and the Executive’s COBRA coverage may be terminable in accordance with applicable law. The Executive shall also be entitled to accrued, vested benefits
under the Company’s benefit plans and programs as provided therein. The Executive shall be entitled to the additional payments and benefits described below only as set forth herein. 

(b)    Termination without Cause, Resignation for Good Reason or Termination by Reason of Death or Disability.
Subject to Sections 6(c) and (d) and the restrictions contained herein, in the event of the Executive’s Termination without Cause (pursuant to Section 5(a)(v)), Resignation for Good Reason (pursuant to Section 5(a)(iv)) or
termination by reason of death or Disability (pursuant to Section 5(a)(i) or (ii), respectively), the Company shall pay to the Executive the amounts described in subsection (a). In addition, subject to Sections 6(c) and (d) and the
restrictions contained herein, and in the case of Termination without Cause (pursuant to Section 5(a)(v)), Resignation for Good Reason (pursuant to Section 5(a)(iv)) or Disability (pursuant to Section 5(a)(ii)), subject to the
Executive’s execution and non-

 
revocation of a release in in the form attached hereto as Exhibit A (the “Release”) no later than thirty (30) days following the Date of Termination, the Company
shall pay to the Executive (or his or her beneficiary in the event of his or her death) an amount equal to the “Severance Amount” described below. For purposes of this Agreement the Severance Amount is equal to the sum of: 

(i)    1.25 times the Executive’s Annual Base Salary, 

(ii)    1.0 times the Executive’s target bonus for the fiscal year in which the Date of Termination
falls, determined in accordance with Section 4(b); and 
 (iii)    15.0 times the difference of
(A) the Monthly COBRA Continuation Coverage Rate determined as of the Date of Termination for the Executive’s applicable health and welfare plan coverages as in effect on such date, less (B) the monthly cost to Executive that is being
charged for such coverage as of the Date of Termination. 
 The Severance Amount as so determined shall be payable to the Executive (or his or her
beneficiary) in substantially equal installments over the 15-month period following the Date of Termination (the “Payment Period”) commencing no later than thirty (30) days following the
execution and non-revocation of the Release, in accordance with the Company’s regular payroll practices. The first installment payment shall include all amounts that would have otherwise been paid to the
Executive during the period beginning on the Date of Termination and ending on the first installment payment date. Notwithstanding the foregoing, in the event that the end of the thirty (30) day notice and revocation period for the Release
would result in the first installment payment occurring in the taxable year following the year in which the Date of Termination occurs, the first installment payment shall be made in the taxable year following the year in which the Date of
Termination occurs. 
 (c)    Benefits Provided Upon Termination of Employment. If the Executive’s
termination or resignation does not constitute a “separation from service,” as such term is defined under Code Section 409A, the Executive shall nevertheless be entitled to receive all of the payments and benefits that the Executive
is entitled to receive under this Agreement on account of his or her termination of employment. However, the payments and benefits that the Executive is entitled to under this Agreement shall not be provided to the Executive until such time as the
Executive has incurred a “separation from services” within the meaning of Code Section 409A. 

(d)    Payments on Account of Termination to a Specified Employee. Notwithstanding the foregoing provisions of
Sections 6(a) or 6(b), in the event that the Executive is determined to be a Specified Employee at the time of his or her termination of employment under this Agreement (or, if later, his or her “separation from service” under Code
Section 409A), to the extent that a payment, reimbursement or benefit under Section 6(b) is considered to provide for a “deferral of compensation” (as determined under Code Section 409A), then such payment, reimbursement or
benefit shall not be paid or provided until six months after the Executive’s separation from service, or his or her death, whichever occurs first. Any payments, reimbursements or benefits that are withheld under this provision for the first six
months shall be payable in a lump sum on the 181st day after such termination of employment (or, if later, separation from service). The restrictions in this Section 6(d) shall be interpreted and applied solely to the minimum extent necessary
to comply with the requirements of Code Section 409A(a)(2)(B). Accordingly, payments, benefits or reimbursements under Section 6(b) or any other part of this Agreement may nevertheless be provided to Executive with the six-month period following the date of Executive’s termination of employment under this Agreement (or, if later, his or her “separation from service” under Code Section 409A), to the extent that
it would nevertheless be permissible to do so under Code Section 409A because those payments, reimbursements or benefits are (i) described in Treasury Regulations Section 1.409A-1(b)(9)(iii)
(i.e., payments within the limitations therein that are being made on account 

 
of an involuntary termination or termination for good reason, within the meaning of the Treasury Regulations), or (ii) described in Treasury Regulation
Section 1.409A-1(b)(4) (i.e., payments which are treated as short-term deferrals within the meaning of the Treasury Regulations), or (iii) benefits described in Treasury Regulations Section 1.409A-1(b)(9)(v) (e.g. health care benefits). 
 (e)    Notwithstanding
any other provision of this Agreement or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company or its affiliates to the Executive or for the Executive’s benefit
pursuant to the terms of this Agreement or otherwise (“Covered Payments”) constitute parachute payments (“Parachute Payments”) within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended
(the “Code”) and would, but for this Section 6(e) be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or
penalties with respect to such taxes (collectively, the “Excise Tax”), then prior to making the Covered Payments, a calculation shall be made comparing (i) the Net Benefit (as defined below) to the Executive of the Covered
Payments after payment of the Excise Tax to (ii) the Net Benefit to the Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less
than the amount under (ii) above will the Covered Payments be reduced to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax (that amount, the “Reduced Amount”).
“Net Benefit” shall mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes. Any such reduction shall be made in accordance with Section 409A of
the Code and the following: (x) the Covered Payments which do not constitute nonqualified deferred compensation subject to Section 409A of the Code shall be reduced first; and (y) all other Covered Payments shall then be reduced as
follows: (A) cash payments shall be reduced before non-cash payments; and (B) payments to be made on a later payment date shall be reduced before payments to be made on an earlier payment date. Any
determination required under this Section 6(e), including whether any payments or benefits are Parachute Payments, shall be made by the Company in its sole discretion. The Executive shall provide the Company with such information and documents
as the Company may reasonably request in order to make a determination under this Section 6(e). The Company’s determination shall be final and binding on the Executive. 

7.    Competition; Non-solicitation. 

(a)    During the Term and, following any termination of Executive’s employment, for a period equal to (i) the
Payment Period, in the case of a termination of employment for which payments are made pursuant to Section 6(b) hereof, or (ii) 24 months from the date of such termination in the event of a voluntary termination of employment by the Executive
without Good Reason, or a termination by the Company for Cause, the Executive shall not, and shall cause each of his or her affiliates not to, anywhere in the Restricted Territory, directly or indirectly engage in any Competitive Activities. The
Executive acknowledges that the Company and/or its Affiliates conducted its Business throughout the Restricted Territory and the Executive provided services to the Company and/or its Affiliates throughout the Restricted Territory. The Executive
shall be deemed to be engaged in Competitive Activities if such Restricted Party or any of his or her affiliates (i) serves as a shareholder, owner, officer, director, member, manager, trustee or partner of, or consults with, advises or assists
in any way, whether or not for consideration, any Competitor; or (ii) endorses the services of any Competitor, solicits customers, provides or otherwise serves as an intermediary for any such Competitor or loans money or renders any other form
of financial assistance to any such Competitor. 
 (b)    During the Term and for a period of two (2) years
following any termination of the Executive’s employment, the Executive shall not, and shall cause each of his or her affiliates not to, directly or indirectly: (i) solicit or transact any business with, or assist any third party in
soliciting or transacting any business with, any Persons who are, or were in the past twelve (12) months, customers or suppliers of the 

 
Business; (ii) cause any customers or suppliers referred to in clause (i) to cease doing business with or to terminate its business relationship with the Company or any of its
Affiliates; or (iii) solicit for employment or hire any employees of the Company or any of its Affiliates, unless such employee’s employment has been terminated by the Parent or any of its affiliates, as the case may be, at least six
(6) months before any such solicitation or hiring. 
 (c)    In the event a court of competent jurisdiction
determines that the provisions in this Section 7 are excessively broad as to duration, geographical scope or activity, it is expressly agreed that this Section 7 shall be construed so that the remaining provisions shall not be affected,
but shall remain in full force and effect, and any such overbroad provisions shall be deemed, without further action on the part of any Person, to be modified, amended and/or limited, but only to the extent necessary to render the same valid and
enforceable in such jurisdiction. 
 (d)    For the avoidance of doubt, nothing in this Section 7 shall in any way
limit the covenants set forth in Sections 2 and 3 of that certain Letter Agreement, by and among Executive, Parent and EverArc Holdings Limited, dated June 15, 2021, which shall remain in effect in accordance with its terms. 

8.    Nondisclosure of Proprietary Information. 

(a)    Except as required in the faithful performance of the Executive’s duties hereunder or pursuant to subsection
(c), the Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for his or her benefit or the benefit of any person, firm, corporation or other entity any
confidential or proprietary information or trade secrets of or relating to the Company and its Affiliates, including, without limitation, information with respect to their operations, processes, products, inventions, business practices, finances,
principals, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, compensation paid to employees or other terms of employment, except for such information which is or
becomes publicly available other than as a result of a breach by the Executive of this Section 8, or deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or
containing any such confidential or proprietary information or trade secrets. The parties hereby stipulate and agree that as between them the foregoing matters are important, material and confidential proprietary information and trade secrets and
affect the successful conduct of the businesses of the Company and its Affiliates (and any of their successors or assignees). 

(b)    Upon termination of the Executive’s employment with the Company for any reason, the Executive shall promptly
deliver to the Company all correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents concerning the customers, business plans, marketing strategies, products or
processes of the Company and any of its Affiliates and/or which contain proprietary information or trade secrets. 

(c)    The Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the
earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and shall assist such counsel in resisting or otherwise responding
to such process. 
 9.    Injunctive Relief. It is recognized and acknowledged by the Executive that a breach of the covenants
contained in Sections 7 and 8 may cause irreparable damage to the Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate.
Accordingly, the Executive agrees that in the event of a breach of any of the covenants contained in Sections 7 and 8, in addition to any other remedy which may be available at law or in equity, the Company shall be entitled to seek specific
performance and injunctive relief. 

 10.    Whistleblower Protection. 

(a)    Nothing in this Agreement or any other agreement between the parties or any policy of the Company or any of its
Affiliates shall prohibit or restrict any party or their respective attorneys from: (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as
required by law or legal process, including with respect to possible violations of law; (ii) participating, cooperating or testifying in any action, investigation or proceeding with, or providing information to, any governmental agency or
legislative body, any self-regulatory organization, and/or pursuant to the Sarbanes-Oxley Act; or (iii) accepting any U.S. Securities and Exchange Commission awards. In addition, nothing in this Agreement or any other agreement among the
parties or any policy of the Company or any of its Affiliates prohibits or restricts the any such party from initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns
about possible violations of law or regulation. 
 (b)    Pursuant to 18 U.S.C. § 1833(b), the Executive will not
be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret of the Company or its Affiliates that (i) is made (A) in confidence to a federal, state, or local government official,
either directly or indirectly, or to the Executive’s attorney and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document that is filed under seal in a
lawsuit or other proceeding. If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the trade secret to the Executive’s attorney and use the trade secret
information in the court proceeding, if the Executive files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement or any other agreement between the
parties or any policy of the Company or any of its Affiliates is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. 

11.    Survival. The expiration or termination of the Term shall not impair the rights or obligations of any party hereto which
shall have accrued hereunder prior to such expiration. 
 12.    Binding on Successors. This Agreement shall be binding upon and
inure to the benefit of the Company, Parent, the Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. 

13.    Governing Law. This Agreement shall be governed, construed, interpreted and enforced in accordance with the substantive laws
of Delaware. 
 14.    Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not
affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

15.    Notices. Any notice, request, claim, demand, document or other communication hereunder to any party shall be effective upon
receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by telex, telecopy, or certified or registered mail, postage prepaid, as follows: 

(a)    If to the Company or Parent, to: 

Perimeter Solutions LP 
 8000
Maryland Ave, Suite 350, Clayton, MO 63105 
 Attn: General Counsel 

[***] 

 (b)    If to the Executive, to him or her at the address set forth below
under his or her signature; or at any other address as any party shall have specified by notice in writing to the other party in accordance with this Section 15. 

16.    Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but
all of which together shall constitute one and the same agreement. The signatures to this Agreement need not all be on a single copy of this Agreement, and may be electronic signatures (e.g., DocuSign) or copies on portable document format (.pdf)
rather than originals, and in each case shall be fully effective as though all signatures were originals on the same copy. 

17.    Entire Agreement; Prior Employment Agreement. Upon the Closing, the terms of this Agreement shall supersede in their
entirety any and all prior employment related agreements between the Executive and the Company or any of its Affiliates. The terms of this Agreement, together with the Equity Compensation Agreements, are intended by the parties to be the final
expression of their agreement with respect to the employment of the Executive by the Company and may not be contradicted by evidence of any prior or contemporaneous agreement. The parties further intend that this Agreement, and any Equity
Compensation Agreements, shall constitute the complete and exclusive statement of its terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.

 18.    Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in writing,
signed by the Executive and the Chief Executive Officer. By an instrument in writing similarly executed, the Executive or the Company or Parent may waive compliance by the other party or parties with any provision of this Agreement that such other
party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right,
remedy or power hereunder shall preclude any other or further exercise of any other right, remedy or power provided herein or by law or in equity. 

19.    No Inconsistent Actions. The parties hereto shall not voluntarily undertake or fail to undertake any action or course of
action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this
Agreement. 
 20.    Arbitration. Except as expressly provided elsewhere in this Agreement, any dispute arising out of, relating
to, or having any connection with, this Agreement, including any question regarding its existence, validity, interpretation, performance, breach or termination, and any tort or other extra-contractual or statutory claims arising out of or relating
to its negotiation, execution or performance, shall be exclusively and finally settled by arbitration in accordance with the Rules of the International Court of Arbitration of the International Chamber of Commerce (the “ICC Rules”)
by one or more arbitrators appointed in accordance with the ICC Rules; provided, however, that nothing in this Section 20 shall prohibit: (i) a party from instituting litigation to enforce any final award in any court of competent
jurisdiction; or (ii) the Company from seeking a restraining order or injunction in any court of competent jurisdiction to prevent any continuation of any violation of the provisions of Section 7 or 8 of this Agreement and the Executive
hereby consents that such restraining order or injunction may be granted without the necessity of the Company’s posting any bond. The seat of the arbitration shall be in St. Louis, Missouri. The language of the arbitration shall be English. The
parties undertake to carry out any award of the tribunal without delay, and waive their right to refer any question of law and any right of appeal on the law or merits to a court of law or other judicial authority, insofar as such waiver may be
validly made. The parties agree that an arbitral tribunal appointed under this Agreement may exercise jurisdiction with respect to this Agreement and any amendments or exhibits or schedules hereto (except as otherwise

 
expressly provided therein), and that any disputes involving more than one of such agreements, exhibits or schedules shall proceed as a consolidated arbitration in accordance with Article 10 of
the ICC Rules. The arbitrator selected pursuant to this Section 20 shall award to the prevailing party, if any, the costs and attorneys’ fees reasonably incurred by the prevailing party in connection with the arbitration and, if the
arbitrator determines a party to be the prevailing party under circumstances where the prevailing party won on some but not all of the claims and counterclaims, the arbitrator may award the prevailing party an appropriate percentage of the costs and
attorneys’ fees reasonably incurred by the prevailing party in connection with the arbitration and the enforcement of its rights under this Agreement. 

21.    Indemnification and Insurance; Legal Expenses. During the Term and so long as the Executive has not breached any of his or
her obligations set forth in Sections 7 and 8, the Company and Parent shall indemnify the Executive to the fullest extent permitted by the laws of Delaware and Luxembourg, respectively, as in effect at the time of the subject act or omission, and
shall advance to the Executive reasonable attorneys’ fees and expenses as such fees and expenses are incurred (subject to an undertaking from the Executive to repay such advances if it shall be finally determined by a judicial decision which is
not subject to further appeal that the Executive was not entitled to the reimbursement of such fees and expenses) and Executive shall be entitled to the protection of any insurance policies the Company and/or Parent shall maintain generally for the
benefit of their respective directors and officers (“Directors and Officers Insurance”) against all costs, charges and expenses incurred or sustained by Executive in connection with any action, suit or proceeding to which Executive
may be made a party by reason of his or her being or having been a director, officer or employee of the Company or any of its Affiliates or his or her serving or having served any other enterprise as a director, officer or employee at the request of
the Company (other than any dispute, claim or controversy arising under or relating to this Agreement). The Company and/or Parent will maintain during the Term for the benefit of the Executive (in his or her capacity as an officer and/or director of
the Company and Parent, as applicable) Directors and Officers Insurance providing customary benefits to the Executive. 
 (SIGNATURE PAGE
FOLLOWS) 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first
above written. 
  

			
	PERIMETER SOLUTIONS S.A.
		
	By:	 	 /s/ Haitham Khouri

	Name:	 	Haitham Khouri
	Title:	 	Director 

		
	By:	 	 /s/ Vivek Raj

	Name:	 	Vivek Raj
	Title:	 	Director
	
	PERIMETER SOLUTIONS LP
		
	By:	 	 /s/ Noriko Yokozuka

	Name:	 	Noriko Yokozuka
	Title:	 	General Counsel and Secretary
	
	EXECUTIVE
	
	 /s/ Barry Lederman

	Barry Lederman
	
	 Address:
 [***] 

[***] 

	 Email address:
 [***]

 Exhibit A 

Form of Release 

GENERAL RELEASE 

I, [                ], in consideration of and subject to the
performance by Perimeter Solutions LP, a Delaware limited partnership (together with its subsidiaries, the “Company”), of its obligations under the Employment Agreement dated as of
[                ], 2021 (the “Agreement”), do hereby release and forever discharge as of the date hereof the Company, Perimeter Solutions, SA, a public
company limited by shares duly incorporated and validly existing under the laws of the Grand Duchy of Luxembourg (“Parent”), and their respective affiliates and all present, former and future managers, directors, officers,
employees, successors and assigns of the Company, Parent and their respective affiliates and direct or indirect owners (collectively, the “Released Parties”) to the extent provided below (this “General Release”).
The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Released Parties
hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement. 

Section 1.    My employment or service with the Company and its affiliates terminated as of
[                ], and I hereby resign from any position as an officer, member of the board of managers or directors (as applicable) or fiduciary of the Company, Parent
or their affiliates (or reaffirm any such resignation that may have already occurred). I understand that any payments or benefits paid or granted to me under Section 6 of the Agreement (other than the accrued obligations described in
Section 6(a) (the “Accrued Obligations”)) represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive
certain of the payments and benefits specified in Section 6 of the Agreement (other than the Accrued Obligations) unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such
payments and benefits will not be considered compensation for purposes of any employee benefit plan, program, policy or arrangement maintained or hereafter established by the Company or its affiliates. 

Section 2.    Except as provided in Sections 4 and 5 below and except for the provisions of the Agreement which
expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all
claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys’ fees, or liabilities
of any nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released
Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected with my employment with or service for, or my separation or termination from, the Company, Parent or their affiliates
(including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older
Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income
Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law,
regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any 

 
policies, practices or procedures of the Company, Parent or their affiliates; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim
for costs, fees, or other expenses, including attorneys’ fees incurred in these matters) (all of the foregoing collectively referred to herein as the “Claims”). 

Section 3.    I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or
other matter covered by Section 2 above. 
 Section 4.    I agree that this General Release does not waive or
release any rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance
with the terms of the Agreement shall not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). 

Section 5.    I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any
or all Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and
am not being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding, including with the Equal Employment Opportunity
Commission (“EEOC”); provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution of such EEOC charge or investigation or proceeding. Additionally, I am not
waiving (i) any right to the Accrued Obligations or any severance benefits to which I am entitled under the Agreement or (ii) any claim relating to any right of indemnification under the Company’s organizational documents or
otherwise. 
 Section 6.    In signing this General Release, I acknowledge and intend that it shall be effective as
a bar to each and every one of the Claims hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to
unknown and unsuspected Claims (notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims
hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that
in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense
to such Claims to the maximum extent permitted by law. I further agree that I am not aware of any pending claim of the type described in Section 2 above as of the execution of this General Release. 

Section 7.    I agree that neither this General Release, nor the furnishing of the consideration for this General
Release, shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. 

Section 8.    I agree that if I violate this General Release by suing the Company or the other Released Parties, I
will pay all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees. 

Section 9.    I represent that I am not aware of any claim by me other than the claims that are released by this
General Release. I acknowledge that I may hereafter discover claims or facts in addition to or 

 
different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of entering
into this General Release, may have materially affected this General Release and my decision to enter into it. 

Section 10.    I represent and warrant that I have returned all property of the Company and its affiliates, including
identification cards or badges, access codes or devices, keys, laptops, computers, telephones, mobile phones, hand-held electronic devices, credit cards, electronically stored documents or files, physical files, and any other property of the Company
or its affiliates in my possession. I further represent and warrant that I no longer have access to and do no claim ownership of any cloud storage or social media accounts of the Company or any of its affiliates. 

Section 11.    Notwithstanding anything in this General Release to the contrary, this General Release shall not
relinquish, diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof. 

Section 12.    Whenever possible, each provision of this General Release shall be interpreted in, such manner as to
be effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein. 
 BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: 
  

	 	(a)	 I HAVE READ IT CAREFULLY; 

 

	 	(b)	 I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO,
RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT
OF 1974, AS AMENDED; 

  

	 	(c)	 I VOLUNTARILY CONSENT TO EVERYTHING IN IT; 

 

	 	(d)	 I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; 

  

	 	(e)	 I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE CHANGES
MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD; 

 

	 	(f)	 I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; 

  

	 	(g)	 I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO
ADVISE ME WITH RESPECT TO IT; AND 

	 	(h)	 I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY
AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. 

  

									
	SIGNED:	 	
                          
                                         
     
  
	 		 	DATED:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]